[
  {
    "id": 41386,
    "drug": {
      "current_status": "MARKETED",
      "id": 6946,
      "drug_code": 47216,
      "updated_date": "2025-12-03T00:30:38-05:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253205,
          "ingredient": {
            "id": 2292,
            "ingredient_code": 11081,
            "en_name": "ROPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de ropivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02229411",
      "brand_name": "NAROPIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133273001"
    },
    "created_date": "2018-03-01T14:03:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229411",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB09",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2018-03-05T00:00:00-05:00",
    "estimated_end_date": "2018-07-02T00:00:00-04:00",
    "actual_start_date": "2018-03-01T00:00:00-05:00",
    "actual_end_date": "2018-07-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-04T12:43:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NAROPIN",
    "en_drug_common_name": "Naropin® 2mg/mL 5x200mL SU Polybag® Duofit®",
    "fr_drug_brand_name": "Naropin®",
    "fr_drug_common_name": "Naropin® 2mg/mL 5x200mL SU Polybag® Duofit®",
    "en_ingredients": "ROPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de ropivacaïne",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Épidurale\r\nBloc/Infiltration",
    "drug_package_quantity": "5x200mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41389,
    "drug": {
      "current_status": "MARKETED",
      "id": 6946,
      "drug_code": 47216,
      "updated_date": "2025-12-03T00:30:38-05:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253205,
          "ingredient": {
            "id": 2292,
            "ingredient_code": 11081,
            "en_name": "ROPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de ropivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02229411",
      "brand_name": "NAROPIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133273001"
    },
    "created_date": "2018-03-01T14:05:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229411",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB09",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2018-03-02T00:00:00-05:00",
    "estimated_end_date": "2018-07-20T00:00:00-04:00",
    "actual_end_date": "2018-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-25T13:19:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NAROPIN",
    "en_drug_common_name": "Naropin® 2mg/mL 5x100mL SU Polybag® Duofit®",
    "fr_drug_brand_name": "Naropin®",
    "fr_drug_common_name": "Naropin® 2mg/mL 5x100mL SU Polybag® Duofit®",
    "en_ingredients": "ROPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de ropivacaïne",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Épidurale\r\nBloc/Infiltration",
    "drug_package_quantity": "5x100mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41428,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2760,
      "drug_code": 16635,
      "updated_date": "2025-05-15T03:42:53-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8297468,
          "ingredient": {
            "id": 854,
            "ingredient_code": 6161,
            "en_name": "HYDROCODONE BITARTRATE",
            "fr_name": "Bitartrate d'hydrocodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8297467,
          "ingredient": {
            "id": 78,
            "ingredient_code": 10258,
            "en_name": "PHENYLEPHRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de phényléphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02049481",
      "brand_name": "NOVAHISTEX DH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78535",
      "number_of_ais": "2",
      "ai_group_no": "0216953002"
    },
    "created_date": "2018-03-01T16:53:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02049481",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "R05DA20",
    "atc_description": "COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS",
    "anticipated_start_date": "2018-03-21T00:00:00-04:00",
    "estimated_end_date": "2018-05-16T00:00:00-04:00",
    "actual_end_date": "2018-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-05-08T13:25:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NOVAHISTEX DH",
    "en_drug_common_name": "Novahistex DH 100ml",
    "fr_drug_brand_name": "Novahistex DH",
    "fr_drug_common_name": "Novahistex DH 100ml",
    "en_ingredients": "PHENYLEPHRINE HYDROCHLORIDE\r\nHYDROCODONE BITARTRATE",
    "fr_ingredients": "Chlorhydrate de phényléphrine\r\nBitartrate d'hydrocodone",
    "drug_strength": "20MG\r\n5MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41472,
    "drug": {
      "current_status": "MARKETED",
      "id": 10444,
      "drug_code": 65700,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253941,
          "ingredient": {
            "id": 1492,
            "ingredient_code": 7567,
            "en_name": "BECLOMETHASONE DIPROPIONATE",
            "fr_name": "Dipropionate de béclométhasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02242029",
      "brand_name": "QVAR",
      "brand_name_fr": "",
      "descriptor": "SOLUTION FOR ORAL INHALATION ONLY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106320002"
    },
    "created_date": "2018-03-01T20:35:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242029",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "R03BA01",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "actual_start_date": "2018-03-01T00:00:00-05:00",
    "actual_end_date": "2018-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-04-20T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QVAR",
    "en_drug_common_name": "QVAR",
    "fr_drug_brand_name": "QVAR",
    "fr_drug_common_name": "QVAR",
    "en_ingredients": "BECLOMETHASONE DIPROPIONATE",
    "fr_ingredients": "Dipropionate de béclométhasone",
    "drug_strength": "50MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "NA",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41479,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 82,
      "drug_code": 10173,
      "updated_date": "2025-05-15T03:36:52-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8286368,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00786535",
      "brand_name": "DILAUDID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69886",
      "number_of_ais": "1",
      "ai_group_no": "0108698004"
    },
    "created_date": "2018-03-01T21:18:43-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00786535",
    "company_name": "PURDUE PHARMA",
    "discontinuation_date": "2018-03-01T00:00:00-05:00",
    "anticipated_discontinuation_date": "2018-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-03-02T06:00:08-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "DILAUDID",
    "en_drug_common_name": "hydromorphone hydrochloride",
    "fr_drug_brand_name": "Dilaudid",
    "fr_drug_common_name": "hydromorphone hydrochloride",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "1MG",
    "drug_dosage_form_fr": "Liquide",
    "drug_route_fr": "Oral",
    "drug_package_quantity": "450ml",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41523,
    "drug": {
      "current_status": "MARKETED",
      "id": 6250,
      "drug_code": 43078,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253028,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02212188",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "AUTO-INJECTOR",
      "pediatric_flag": false,
      "accession_number": "P9370",
      "number_of_ais": "1",
      "ai_group_no": "0123238006"
    },
    "created_date": "2018-03-02T14:28:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02212188",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC01",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2018-06-05T00:00:00-04:00",
    "actual_start_date": "2018-03-07T00:00:00-05:00",
    "actual_end_date": "2018-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-05-31T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX",
    "en_drug_common_name": "Sumatriptan succinate injection",
    "fr_drug_brand_name": "IMITREX",
    "fr_drug_common_name": "Solution injectable de succinate de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "SUMATRIPTAN",
    "drug_strength": "12MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "2x0.5mL (Refill pack/L’emballage de recharge)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41530,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11818,
      "drug_code": 69411,
      "updated_date": "2025-05-15T04:04:33-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8336069,
          "ingredient": {
            "id": 2870,
            "ingredient_code": 1893,
            "en_name": "PROPAFENONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propafénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245372",
      "brand_name": "MYL-PROPAFENONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116258001"
    },
    "created_date": "2018-03-02T14:55:38-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02245372",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C01BC03",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "discontinuation_date": "2018-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 23160. Last lot 8045062 and expiry date 31-jul-19",
    "fr_discontinuation_comments": "Discontinued in shortage ID 23160. Last lot 8045062 and expiry date 31-jul-19",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-03-02T14:56:10-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYL-PROPAFENONE",
    "en_drug_common_name": "PROPAFENONE",
    "fr_drug_brand_name": "MYL-PROPAFENONE",
    "fr_drug_common_name": "PROPAFENONE",
    "en_ingredients": "PROPAFENONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propafénone",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 41533,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11820,
      "drug_code": 69412,
      "updated_date": "2025-05-15T04:04:33-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8336070,
          "ingredient": {
            "id": 2870,
            "ingredient_code": 1893,
            "en_name": "PROPAFENONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propafénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245373",
      "brand_name": "MYL-PROPAFENONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116258002"
    },
    "created_date": "2018-03-02T14:57:24-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02245373",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C01BC03",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "discontinuation_date": "2018-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 23163. Last lot 8042905 exp 31-oct-19",
    "fr_discontinuation_comments": "Discontinued in shortage ID 23163. Last lot 8042905 exp 31-oct-19",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-03-02T14:57:44-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYL-PROPAFENONE",
    "en_drug_common_name": "PROPAFENONE",
    "fr_drug_brand_name": "MYL-PROPAFENONE",
    "fr_drug_common_name": "PROPAFENONE",
    "en_ingredients": "PROPAFENONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propafénone",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 41540,
    "drug": {
      "current_status": "MARKETED",
      "id": 3560,
      "drug_code": 18936,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252401,
          "ingredient": {
            "id": 1044,
            "ingredient_code": 4808,
            "en_name": "CALCIUM GLUCONATE",
            "fr_name": "Gluconate de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02141019",
      "brand_name": "CALCIUM GLUCONATE INJECTION, USP 10%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81222",
      "number_of_ais": "1",
      "ai_group_no": "0108566002"
    },
    "created_date": "2018-03-02T15:32:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02141019",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA30",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2018-03-14T00:00:00-04:00",
    "estimated_end_date": "2018-04-04T00:00:00-04:00",
    "actual_end_date": "2018-04-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-10T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CALCIUM GLUCONATE INJECTION, USP 10%",
    "en_drug_common_name": "Calcium Gluconate Injection USP 10% 100 mg/mL",
    "fr_drug_brand_name": "Gluconate de calcium injectable, USP à 10 %",
    "fr_drug_common_name": "Gluconate de calcium injectable, USP à 10 %, 100 mg/mL",
    "en_ingredients": "CALCIUM GLUCONATE\r\nCALCIUM SACCHARATE",
    "fr_ingredients": "Gluconate de calcium\r\nSaccharate de calcium",
    "drug_strength": "94MG\r\n4.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 mL Vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41543,
    "drug": {
      "current_status": "MARKETED",
      "id": 25210,
      "drug_code": 87699,
      "updated_date": "2025-05-15T02:33:39-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259123,
          "ingredient": {
            "id": 3728,
            "ingredient_code": 933,
            "en_name": "ZOLPIDEM TARTRATE",
            "fr_name": "Tartrate de zolpidem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391678",
      "brand_name": "SUBLINOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122857001"
    },
    "created_date": "2018-03-02T16:40:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02391678",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "N05CF02",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2018-03-28T00:00:00-04:00",
    "actual_end_date": "2018-06-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-06-30T05:00:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SUBLINOX",
    "en_drug_common_name": "SUBLINOX",
    "fr_drug_brand_name": "sublinox",
    "fr_drug_common_name": "sublinox",
    "en_ingredients": "ZOLPIDEM TARTRATE",
    "fr_ingredients": "Tartrate de zolpidem",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "SUBLINGUAL",
    "drug_route_fr": "Sublinguale",
    "drug_package_quantity": "na",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41546,
    "drug": {
      "current_status": "MARKETED",
      "id": 22978,
      "drug_code": 85559,
      "updated_date": "2025-05-15T02:32:59-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258309,
          "ingredient": {
            "id": 3728,
            "ingredient_code": 933,
            "en_name": "ZOLPIDEM TARTRATE",
            "fr_name": "Tartrate de zolpidem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02370433",
      "brand_name": "SUBLINOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122857002"
    },
    "created_date": "2018-03-02T16:41:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02370433",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "N05CF02",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2018-03-21T00:00:00-04:00",
    "actual_end_date": "2018-06-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-06-20T17:22:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SUBLINOX",
    "en_drug_common_name": "SUBLINOX",
    "fr_drug_brand_name": "sublinox",
    "fr_drug_common_name": "sublinox",
    "en_ingredients": "ZOLPIDEM TARTRATE",
    "fr_ingredients": "Tartrate de zolpidem",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "SUBLINGUAL",
    "drug_route_fr": "Sublinguale",
    "drug_package_quantity": "na",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41549,
    "drug": {
      "current_status": "MARKETED",
      "id": 16634,
      "drug_code": 77563,
      "updated_date": "2025-12-03T00:31:11-05:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255901,
          "ingredient": {
            "id": 1058,
            "ingredient_code": 1215,
            "en_name": "BENAZEPRIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bénazépril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02290332",
      "brand_name": "BENAZEPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122438001"
    },
    "created_date": "2018-03-02T16:47:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02290332",
    "company_name": "AA PHARMA INC",
    "atc_number": "C09AA07",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2018-03-13T00:00:00-04:00",
    "actual_start_date": "2018-03-02T00:00:00-05:00",
    "actual_end_date": "2018-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-16T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BENAZEPRIL",
    "en_drug_common_name": "Benazepril",
    "fr_drug_brand_name": "BENAZEPRIL",
    "fr_drug_common_name": "BENAZEPRIL",
    "en_ingredients": "BENAZEPRIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bénazépril",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Bottle",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41552,
    "drug": {
      "current_status": "MARKETED",
      "id": 7316,
      "drug_code": 49403,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253276,
          "ingredient": {
            "id": 1238,
            "ingredient_code": 11220,
            "en_name": "BROMOCRIPTINE",
            "fr_name": "Bromocriptine (Mésylate de bromocriptine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230454",
      "brand_name": "BROMOCRIPTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111278002"
    },
    "created_date": "2018-03-02T16:48:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230454",
    "company_name": "AA PHARMA INC",
    "atc_number": "N04BC01",
    "atc_description": "DOPAMINERGIC AGENTS",
    "actual_start_date": "2018-03-02T00:00:00-05:00",
    "actual_end_date": "2018-03-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-10T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "BROMOCRIPTINE",
    "en_drug_common_name": "BRMOCRIPTINE",
    "fr_drug_brand_name": "BRMOCRIPTINE",
    "fr_drug_common_name": "BRMOCRIPTINE",
    "en_ingredients": "BROMOCRIPTINE",
    "fr_ingredients": "Bromocriptine Mesylate",
    "drug_strength": "5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Bottle",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41557,
    "drug": {
      "current_status": "MARKETED",
      "id": 7936,
      "drug_code": 51594,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253422,
          "ingredient": {
            "id": 840,
            "ingredient_code": 7943,
            "en_name": "MOCLOBEMIDE",
            "fr_name": "Moclobémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02232148",
      "brand_name": "MOCLOBEMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122658001"
    },
    "created_date": "2018-03-02T16:56:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02232148",
    "company_name": "AA PHARMA INC",
    "atc_number": "N06AG02",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-04-09T00:00:00-04:00",
    "actual_start_date": "2018-03-02T00:00:00-05:00",
    "actual_end_date": "2018-03-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-23T16:36:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MOCLOBEMIDE",
    "en_drug_common_name": "Moclobemide",
    "fr_drug_brand_name": "MOCLOBEMIDE",
    "fr_drug_common_name": "MOCLOBEMIDE",
    "en_ingredients": "MOCLOBEMIDE",
    "fr_ingredients": "Moclobémide",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Bottle",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41584,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27904,
      "drug_code": 90105,
      "updated_date": "2025-05-15T04:21:52-04:00",
      "company": {
        "id": 264,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7259,
        "mfr_code": "JSO08",
        "name": "JANSSEN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "19 GREEN BELT DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M3C 1L9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8354002,
          "ingredient": {
            "id": 3918,
            "ingredient_code": 22171,
            "en_name": "SIMEPREVIR",
            "fr_name": "Siméprévir (Siméprévir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02416441",
      "brand_name": "GALEXOS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0154990001"
    },
    "created_date": "2018-03-02T19:46:57-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02416441",
    "company_name": "JANSSEN INC",
    "atc_number": "J05AP05",
    "discontinuation_date": "2018-03-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-04-01T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "GALEXOS",
    "en_drug_common_name": "simeprevir capsules",
    "fr_drug_brand_name": "Galexos",
    "fr_drug_common_name": "capsules de siméprévir",
    "en_ingredients": "simeprevir",
    "fr_ingredients": "siméprévir",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1x28",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41597,
    "drug": {
      "current_status": "MARKETED",
      "id": 20476,
      "drug_code": 82129,
      "updated_date": "2025-05-15T02:32:32-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257254,
          "ingredient": {
            "id": 1162,
            "ingredient_code": 6731,
            "en_name": "DIGOXIN",
            "fr_name": "Digoxine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.0625",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02335700",
      "brand_name": "PMS-DIGOXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107281004"
    },
    "created_date": "2018-03-02T20:53:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02335700",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "C01AA05",
    "atc_description": "CARDIAC GLYCOSIDES",
    "anticipated_start_date": "2018-03-02T00:00:00-05:00",
    "estimated_end_date": "2018-06-12T00:00:00-04:00",
    "actual_start_date": "2018-03-02T00:00:00-05:00",
    "actual_end_date": "2018-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-06-12T15:43:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TOLOXIN",
    "en_drug_common_name": "TOLOXIN 0.0625mg TABS 250",
    "fr_drug_brand_name": "TOLOXIN",
    "fr_drug_common_name": "TOLOXIN 0.0625mg TABS 250",
    "en_ingredients": "DIGOXIN",
    "fr_ingredients": "Digoxine",
    "drug_strength": "0.0625MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "250",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41604,
    "drug": {
      "current_status": "MARKETED",
      "id": 8658,
      "drug_code": 60463,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8253495,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237145",
      "brand_name": "MIRAPEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169001"
    },
    "created_date": "2018-03-02T21:05:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237145",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "N04BC05",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2018-03-21T00:00:00-04:00",
    "estimated_end_date": "2018-07-18T00:00:00-04:00",
    "actual_start_date": "2018-03-15T00:00:00-04:00",
    "actual_end_date": "2018-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-11T05:00:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIRAPEX",
    "en_drug_common_name": "Mirapex",
    "fr_drug_brand_name": "MIRAPEX",
    "fr_drug_common_name": "Mirapex",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90s",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41609,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8660,
      "drug_code": 60464,
      "updated_date": "2025-05-15T03:56:18-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8324761,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237146",
      "brand_name": "MIRAPEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169003"
    },
    "created_date": "2018-03-02T21:09:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237146",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "N04BC05",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2018-03-31T00:00:00-04:00",
    "actual_start_date": "2018-03-31T00:00:00-04:00",
    "actual_end_date": "2018-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-02T13:30:48-04:00",
    "status": "resolved",
    "en_comments": "To be discontinued after March 31 2018",
    "en_drug_brand_name": "MIRAPEX",
    "en_drug_common_name": "Mirapex",
    "fr_drug_brand_name": "MIRAPEX",
    "fr_drug_common_name": "Mirapex",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "1.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90s",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41626,
    "drug": {
      "current_status": "MARKETED",
      "id": 17968,
      "drug_code": 79097,
      "updated_date": "2025-05-15T02:32:06-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256313,
          "ingredient": {
            "id": 2534,
            "ingredient_code": 11710,
            "en_name": "BRIMONIDINE TARTRATE",
            "fr_name": "Tartrate de brimonidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02305429",
      "brand_name": "SANDOZ BRIMONIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131859001"
    },
    "created_date": "2018-03-02T21:53:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02305429",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01EA05",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2018-03-05T00:00:00-05:00",
    "estimated_end_date": "2018-05-18T00:00:00-04:00",
    "actual_start_date": "2018-03-16T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2018-05-24T01:42:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ BRIMONIDINE",
    "en_drug_common_name": "BRIMONIDINE",
    "fr_drug_brand_name": "BRIMONIDINE",
    "fr_drug_common_name": "BRIMONIDINE",
    "en_ingredients": "BRIMONIDINE TARTRATE",
    "fr_ingredients": "Tartrate de brimonidine",
    "drug_strength": "0.2%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41635,
    "drug": {
      "current_status": "MARKETED",
      "id": 8428,
      "drug_code": 587,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250159,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00036641",
      "brand_name": "XYLOCAINE 2%",
      "brand_name_fr": "",
      "descriptor": "2ML, 5ML, 10ML SINGLE USE AMPOULES",
      "pediatric_flag": false,
      "accession_number": "23888",
      "number_of_ais": "1",
      "ai_group_no": "0101280001"
    },
    "created_date": "2018-03-02T23:01:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00036641",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB02",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2018-03-02T00:00:00-05:00",
    "estimated_end_date": "2018-03-16T00:00:00-04:00",
    "actual_start_date": "2018-03-02T00:00:00-05:00",
    "actual_end_date": "2018-04-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-04-26T12:29:37-04:00",
    "status": "resolved",
    "en_comments": "Delay in releasing the drug",
    "fr_comments": "Retard dans le relâchement du produit",
    "en_drug_brand_name": "XYLOCAINE 2%",
    "en_drug_common_name": "Xylocaine® 2% Plain 50x2mL SU Polyamp® Duofit®",
    "fr_drug_brand_name": "Xylocaine®",
    "fr_drug_common_name": "Xylocaine® 2% Plain 50x2mL SU Polyamp® Duofit",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lidocaïne",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "50x2mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41693,
    "drug": {
      "current_status": "MARKETED",
      "id": 22670,
      "drug_code": 85196,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258174,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02367157",
      "brand_name": "TARO-MOMETASONE CREAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732001"
    },
    "created_date": "2018-03-05T14:46:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02367157",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AC13",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2019-01-18T00:00:00-05:00",
    "actual_start_date": "2018-12-10T00:00:00-05:00",
    "actual_end_date": "2018-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-04T21:49:45-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-MOMETASONE CREAM",
    "en_drug_common_name": "TARO MOMETASONE CREAM",
    "fr_drug_brand_name": "TARO MOMETASONE CREAM",
    "fr_drug_common_name": "TARO MOMETASONE CREAM",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "15G",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41696,
    "drug": {
      "current_status": "MARKETED",
      "id": 10738,
      "drug_code": 66474,
      "updated_date": "2025-05-15T02:31:11-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254064,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02242684",
      "brand_name": "TARO-WARFARIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104597003"
    },
    "created_date": "2018-03-05T14:48:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242684",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "B01AA03",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_start_date": "2018-03-02T00:00:00-05:00",
    "actual_end_date": "2018-04-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-27T21:29:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-WARFARIN",
    "en_drug_common_name": "TARO WARFARIN",
    "fr_drug_brand_name": "TARO WARFARIN",
    "fr_drug_common_name": "TARO WARFARIN",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41713,
    "drug": {
      "current_status": "MARKETED",
      "id": 30992,
      "drug_code": 93129,
      "updated_date": "2025-05-15T02:35:06-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261453,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02446022",
      "brand_name": "DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863008"
    },
    "created_date": "2018-03-05T16:30:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02446022",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C08DB01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "anticipated_start_date": "2018-04-10T00:00:00-04:00",
    "estimated_end_date": "2019-05-31T00:00:00-04:00",
    "actual_start_date": "2018-04-10T00:00:00-04:00",
    "actual_end_date": "2019-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2019-06-01T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "UNAVAILABLE",
    "fr_comments": "INDISPONIBLE",
    "en_drug_brand_name": "DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM CD",
    "fr_drug_brand_name": "DILTIAZEM CD",
    "fr_drug_common_name": "DILTIAZEM CD",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41719,
    "drug": {
      "current_status": "MARKETED",
      "id": 29340,
      "drug_code": 91345,
      "updated_date": "2025-12-03T00:32:39-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260640,
          "ingredient": {
            "id": 3066,
            "ingredient_code": 12580,
            "en_name": "DUTASTERIDE",
            "fr_name": "Dutastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429012",
      "brand_name": "DUTASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149361001"
    },
    "created_date": "2018-03-05T16:36:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429012",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "G04CB02",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_start_date": "2018-03-18T00:00:00-04:00",
    "estimated_end_date": "2018-04-13T00:00:00-04:00",
    "actual_start_date": "2018-03-15T00:00:00-04:00",
    "actual_end_date": "2018-04-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-04-16T18:44:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DUTASTERIDE",
    "en_drug_common_name": "DUTASTERIDE",
    "fr_drug_brand_name": "DUTASTERIDE",
    "fr_drug_common_name": "DUTASTERIDE",
    "en_ingredients": "DUTASTERIDE",
    "fr_ingredients": "Dutastéride",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41753,
    "drug": {
      "current_status": "MARKETED",
      "id": 18660,
      "drug_code": 79925,
      "updated_date": "2025-05-15T02:32:13-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256533,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313758",
      "brand_name": "TARO-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055004"
    },
    "created_date": "2018-03-05T17:53:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313758",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C10AA05",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2018-03-05T00:00:00-05:00",
    "estimated_end_date": "2018-03-13T00:00:00-04:00",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2018-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-24T19:09:50-04:00",
    "status": "resolved",
    "en_comments": "Received back in stock",
    "en_drug_brand_name": "RAN-ATORVASTATIN",
    "en_drug_common_name": "RAN-ATORVASTATIN",
    "fr_drug_brand_name": "RAN-ATORVASTATIN",
    "fr_drug_common_name": "RAN-ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41756,
    "drug": {
      "current_status": "MARKETED",
      "id": 24992,
      "drug_code": 87502,
      "updated_date": "2025-12-03T00:32:03-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259037,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389517",
      "brand_name": "SPC-MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823002"
    },
    "created_date": "2018-03-05T17:59:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389517",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "R03DC03",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "anticipated_start_date": "2018-03-05T00:00:00-05:00",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-23T17:23:21-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-MONTELUKAST",
    "en_drug_common_name": "RAN-MONTELUKAST",
    "fr_drug_brand_name": "RAN-MONTELUKAST",
    "fr_drug_common_name": "RAN-MONTELUKAST",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "MONTELUKAST",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41759,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20136,
      "drug_code": 81590,
      "updated_date": "2025-05-15T04:15:05-04:00",
      "company": {
        "id": 1184,
        "created_date": "2017-03-09T13:23:54-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 11271,
        "mfr_code": "",
        "name": "RANBAXY PHARMACEUTICALS CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8347339,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02330156",
      "brand_name": "RAN-FENTANYL MATRIX PATCH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302012"
    },
    "created_date": "2018-03-05T18:05:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330156",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N02AB03",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2018-03-05T00:00:00-05:00",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-23T17:06:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-FENTANYL MATRIX PATCH",
    "en_drug_common_name": "RAN-FENTANYL MATRIX PATCH",
    "fr_drug_brand_name": "RAN-FENTANYL MATRIX PATCH",
    "fr_drug_common_name": "RAN-FENTANYL MATRIX PATCH",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "100MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41762,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20130,
      "drug_code": 81587,
      "updated_date": "2025-05-15T04:15:05-04:00",
      "company": {
        "id": 1184,
        "created_date": "2017-03-09T13:23:54-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 11271,
        "mfr_code": "",
        "name": "RANBAXY PHARMACEUTICALS CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8347336,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02330113",
      "brand_name": "RAN-FENTANYL MATRIX PATCH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302014"
    },
    "created_date": "2018-03-05T18:18:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330113",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N02AB03",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2018-03-05T00:00:00-05:00",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-23T17:08:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-FENTANYL MATRIX PATCH",
    "en_drug_common_name": "RAN-FENTANYL MATRIX PATCH",
    "fr_drug_brand_name": "RAN-FENTANYL MATRIX PATCH",
    "fr_drug_common_name": "RAN-FENTANYL MATRIX PATCH",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "25MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41767,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9964,
      "drug_code": 64281,
      "updated_date": "2025-05-15T03:59:55-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8329926,
          "ingredient": {
            "id": 2174,
            "ingredient_code": 1751,
            "en_name": "INTERFERON ALFA-2B",
            "fr_name": "Interféron alfa-2b"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25000000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02240694",
      "brand_name": "INTRON A",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118647006"
    },
    "created_date": "2018-03-05T18:55:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240694",
    "company_name": "MERCK CANADA INC",
    "atc_number": "L03AB05",
    "atc_description": "IMMUNOSTIMULANTS",
    "anticipated_start_date": "2018-03-12T00:00:00-04:00",
    "estimated_end_date": "2018-03-16T00:00:00-04:00",
    "actual_start_date": "2018-03-13T00:00:00-04:00",
    "actual_end_date": "2018-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-03-16T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Limited Quantities available",
    "fr_comments": "Quantités limitées disponibles",
    "en_drug_brand_name": "INTRON A",
    "en_drug_common_name": "interferon alfa-2b solution for injection (multi-dose pen)",
    "fr_drug_brand_name": "INTRON A",
    "fr_drug_common_name": "interféron alfa-2b solution injectable  en stylo multidose",
    "en_ingredients": "INTERFERON ALFA-2B",
    "fr_ingredients": "Interféron alfa-2b",
    "drug_strength": "25000000UNIT",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "30MIU",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41780,
    "drug": {
      "current_status": "MARKETED",
      "id": 28686,
      "drug_code": 90815,
      "updated_date": "2025-05-15T02:34:17-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8260409,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02423421",
      "brand_name": "MYLAN-RIVASTIGMINE PATCH 10",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521008"
    },
    "created_date": "2018-03-05T19:30:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423421",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06DA03",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2018-04-02T00:00:00-04:00",
    "estimated_end_date": "2018-04-10T00:00:00-04:00",
    "actual_start_date": "2018-04-02T00:00:00-04:00",
    "actual_end_date": "2018-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-04-05T11:55:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-RIVASTIGMINE PATCH 10",
    "en_drug_common_name": "RIVASTIGMINE",
    "fr_drug_brand_name": "MYLAN-RIVASTIGMINE PATCH 10",
    "fr_drug_common_name": "RIVASTIGMINE",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine",
    "drug_strength": "18MG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "30 Patches",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41789,
    "drug": {
      "current_status": "MARKETED",
      "id": 10616,
      "drug_code": 66198,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8254021,
          "ingredient": {
            "id": 2808,
            "ingredient_code": 12006,
            "en_name": "CABERGOLINE",
            "fr_name": "Cabergoline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242471",
      "brand_name": "DOSTINEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141281001"
    },
    "created_date": "2018-03-05T21:18:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242471",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "G02CB03",
    "atc_description": "OTHER GYNECOLOGICALS",
    "actual_start_date": "2018-02-19T00:00:00-05:00",
    "actual_end_date": "2018-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-03-08T17:45:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DOSTINEX",
    "en_drug_common_name": "Dostinex",
    "fr_drug_brand_name": "Dostinex",
    "fr_drug_common_name": "Dostinex",
    "en_ingredients": "CABERGOLINE",
    "fr_ingredients": "Cabergoline",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "8",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 41792,
    "drug": {
      "current_status": "MARKETED",
      "id": 6324,
      "drug_code": 43212,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253040,
          "ingredient": {
            "id": 2152,
            "ingredient_code": 8317,
            "en_name": "ATOVAQUONE",
            "fr_name": "Atovaquone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02217422",
      "brand_name": "MEPRON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9539",
      "number_of_ais": "1",
      "ai_group_no": "0124073001"
    },
    "created_date": "2018-03-05T21:40:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02217422",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "P01AX06",
    "atc_description": "AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS.",
    "estimated_end_date": "2018-05-07T00:00:00-04:00",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2018-03-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-29T15:19:19-04:00",
    "status": "resolved",
    "en_comments": "For emergency supply, contact GSK Customer Service 1-800-387-7374.",
    "fr_comments": "Pour un approvisionnement d’urgence, communiquez avec le Service à la clientèle de GSK au 1-800-387-7374.",
    "en_drug_brand_name": "MEPRON",
    "en_drug_common_name": "Atovaquone Oral Suspension",
    "fr_drug_brand_name": "MEPRON",
    "fr_drug_common_name": "Suspension orale d’atovaquone",
    "en_ingredients": "ATOVAQUONE",
    "fr_ingredients": "Atovaquone",
    "drug_strength": "750MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "210 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41834,
    "drug": {
      "current_status": "MARKETED",
      "id": 6228,
      "drug_code": 43018,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253024,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02207621",
      "brand_name": "APO-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9274",
      "number_of_ais": "1",
      "ai_group_no": "0115506002"
    },
    "created_date": "2018-03-06T02:13:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02207621",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB01",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2018-07-16T00:00:00-04:00",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2018-06-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-03T09:52:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ACYCLOVIR - TAB 200MG",
    "en_drug_common_name": "ACYCLOVIR",
    "fr_drug_brand_name": "APO-ACYCLOVIR - TAB 200MG",
    "fr_drug_common_name": "ACYCLOVIR",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41838,
    "drug": {
      "current_status": "MARKETED",
      "id": 6230,
      "drug_code": 43019,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253025,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02207648",
      "brand_name": "APO-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9275",
      "number_of_ais": "1",
      "ai_group_no": "0115506004"
    },
    "created_date": "2018-03-06T02:15:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02207648",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB01",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2018-06-29T00:00:00-04:00",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2018-05-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-24T11:58:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ACYCLOVIR - TAB 400MG",
    "en_drug_common_name": "ACYCLOVIR",
    "fr_drug_brand_name": "APO-ACYCLOVIR - TAB 400MG",
    "fr_drug_common_name": "ACYCLOVIR",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41841,
    "drug": {
      "current_status": "MARKETED",
      "id": 6234,
      "drug_code": 43020,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253026,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "800",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02207656",
      "brand_name": "APO-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9276",
      "number_of_ais": "1",
      "ai_group_no": "0115506005"
    },
    "created_date": "2018-03-06T02:17:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02207656",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB01",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2018-06-29T00:00:00-04:00",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2018-06-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-03T09:52:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ACYCLOVIR",
    "en_drug_common_name": "ACYCLOVIR",
    "fr_drug_brand_name": "APO-ACYCLOVIR",
    "fr_drug_common_name": "ACYCLOVIR",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "800MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41844,
    "drug": {
      "current_status": "MARKETED",
      "id": 3512,
      "drug_code": 18806,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252389,
          "ingredient": {
            "id": 1182,
            "ingredient_code": 2143,
            "en_name": "CYCLOBENZAPRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de cyclobenzaprine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02177145",
      "brand_name": "APO-CYCLOBENZAPRINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81083",
      "number_of_ais": "1",
      "ai_group_no": "0112363001"
    },
    "created_date": "2018-03-06T02:22:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02177145",
    "company_name": "APOTEX INC",
    "atc_number": "M03BX08",
    "atc_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
    "estimated_end_date": "2018-05-31T00:00:00-04:00",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2018-04-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-14T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CYCLOBENZAPRINE",
    "en_drug_common_name": "CYCLOBENZAPRINE",
    "fr_drug_brand_name": "APO-CYCLOBENZAPRINE",
    "fr_drug_common_name": "CYCLOBENZAPRINE",
    "en_ingredients": "CYCLOBENZAPRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de cyclobenzaprine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41847,
    "drug": {
      "current_status": "MARKETED",
      "id": 15348,
      "drug_code": 75887,
      "updated_date": "2025-05-15T02:31:42-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255494,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02273381",
      "brand_name": "APO-AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131437001"
    },
    "created_date": "2018-03-06T02:25:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02273381",
    "company_name": "APOTEX INC",
    "atc_number": "C08CA01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "estimated_end_date": "2018-08-31T00:00:00-04:00",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2018-08-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-14T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMLODIPINE",
    "en_drug_common_name": "AMLODIPINE",
    "fr_drug_brand_name": "APO-AMLODIPINE",
    "fr_drug_common_name": "AMLODIPINE",
    "en_ingredients": "AMLODIPINE",
    "fr_ingredients": "AMLODIPINE",
    "drug_strength": "10.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41852,
    "drug": {
      "current_status": "MARKETED",
      "id": 16356,
      "drug_code": 77141,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255826,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02285924",
      "brand_name": "APO-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843001"
    },
    "created_date": "2018-03-06T02:30:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02285924",
    "company_name": "APOTEX INC",
    "atc_number": "N03AX14",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-06-08T00:00:00-04:00",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2018-06-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-08T13:09:42-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM",
    "fr_drug_brand_name": "APO-LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41855,
    "drug": {
      "current_status": "MARKETED",
      "id": 29074,
      "drug_code": 91113,
      "updated_date": "2025-05-15T02:34:23-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260555,
          "ingredient": {
            "id": 2880,
            "ingredient_code": 12110,
            "en_name": "LINEZOLID",
            "fr_name": "Linézolide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02426552",
      "brand_name": "APO-LINEZOLID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143501002"
    },
    "created_date": "2018-03-06T02:31:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02426552",
    "company_name": "APOTEX INC",
    "atc_number": "J01XX08",
    "atc_description": "OTHER ANTIBACTERIALS",
    "estimated_end_date": "2019-11-01T00:00:00-04:00",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2019-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-11-04T16:42:28-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LINEZOLID",
    "en_drug_common_name": "LINEZOLID",
    "fr_drug_brand_name": "APO-LINEZOLID",
    "fr_drug_common_name": "LINEZOLID",
    "en_ingredients": "LINEZOLID",
    "fr_ingredients": "Linézolide",
    "drug_strength": "600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41858,
    "drug": {
      "current_status": "MARKETED",
      "id": 13600,
      "drug_code": 73416,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254914,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02249324",
      "brand_name": "APO-METHYLPHENIDATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548001"
    },
    "created_date": "2018-03-06T02:33:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02249324",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA04",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2018-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-20T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "500 BTL available",
    "en_drug_brand_name": "APO-METHYLPHENIDATE",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "APO-METHYLPHENIDATE",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41862,
    "drug": {
      "current_status": "MARKETED",
      "id": 11050,
      "drug_code": 6714,
      "updated_date": "2025-05-15T02:30:37-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250933,
          "ingredient": {
            "id": 2866,
            "ingredient_code": 1996,
            "en_name": "PIROXICAM",
            "fr_name": "Piroxicam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00642886",
      "brand_name": "APO PIROXICAM CAP 10MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63889",
      "number_of_ais": "1",
      "ai_group_no": "0114612002"
    },
    "created_date": "2018-03-06T02:36:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00642886",
    "company_name": "APOTEX INC",
    "atc_number": "M01AC01",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2018-10-31T00:00:00-04:00",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2018-10-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-30T13:33:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO PIROXICAM CAP 10MG",
    "en_drug_common_name": "PIROXICAM",
    "fr_drug_brand_name": "APO PIROXICAM CAP 10MG",
    "fr_drug_common_name": "PIROXICAM",
    "en_ingredients": "PIROXICAM",
    "fr_ingredients": "Piroxicam",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41865,
    "drug": {
      "current_status": "DORMANT",
      "id": 13278,
      "drug_code": 72853,
      "updated_date": "2025-05-15T06:55:31-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367658,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248501",
      "brand_name": "APO-QUINAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123206003"
    },
    "created_date": "2018-03-06T02:38:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248501",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA06",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2018-06-08T00:00:00-04:00",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2018-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-25T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-QUINAPRIL",
    "en_drug_common_name": "QUINAPRIL",
    "fr_drug_brand_name": "APO-QUINAPRIL",
    "fr_drug_common_name": "QUINAPRIL",
    "en_ingredients": "QUINAPRIL",
    "fr_ingredients": "QUINAPRIL",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41868,
    "drug": {
      "current_status": "MARKETED",
      "id": 51713,
      "drug_code": 93840,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261774,
          "ingredient": {
            "id": 3254,
            "ingredient_code": 16516,
            "en_name": "EMTRICITABINE",
            "fr_name": "Emtricitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261773,
          "ingredient": {
            "id": 3020,
            "ingredient_code": 12251,
            "en_name": "TENOFOVIR DISOPROXIL FUMARATE",
            "fr_name": "Fumarate de ténofovir disoproxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452006",
      "brand_name": "APO-EMTRICITABINE-TENOFOVIR",
      "brand_name_fr": "APO-EMTRICITABINE-TÉNOFOVIR",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251568001"
    },
    "created_date": "2018-03-06T02:43:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452006",
    "company_name": "APOTEX INC",
    "atc_number": "J05AR03",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2018-03-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-20T12:47:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-EMTRICITABINE-TENOFOVIR",
    "en_drug_common_name": "EMTRICITABINE-TENOFOVIR",
    "fr_drug_brand_name": "APO-EMTRICITABINE-TENOFOVIR",
    "fr_drug_common_name": "EMTRICITABINE-TENOFOVIR",
    "en_ingredients": "TENOFOVIR DISOPROXIL FUMARATE\r\nEMTRICITABINE",
    "fr_ingredients": "Fumarate de ténofovir disoproxil\r\nEmtricitabine",
    "drug_strength": "300MG\r\n200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41935,
    "drug": {
      "current_status": "MARKETED",
      "id": 18476,
      "drug_code": 79749,
      "updated_date": "2025-05-15T02:32:11-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8256467,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02311968",
      "brand_name": "OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783001"
    },
    "created_date": "2018-03-06T15:50:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02311968",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2018-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-04-18T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41938,
    "drug": {
      "current_status": "MARKETED",
      "id": 19652,
      "drug_code": 81009,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8256865,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324652",
      "brand_name": "SUMATRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238002"
    },
    "created_date": "2018-03-06T15:53:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324652",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N02CC01",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "actual_start_date": "2018-03-06T00:00:00-05:00",
    "actual_end_date": "2018-05-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-05-10T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SUMATRIPTAN",
    "en_drug_common_name": "SUMATRIPTAN",
    "fr_drug_brand_name": "SUMATRIPTAN",
    "fr_drug_common_name": "SUMATRIPTAN",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "SUMATRIPTAN",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41954,
    "drug": {
      "current_status": "MARKETED",
      "id": 3224,
      "drug_code": 18228,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 17273,
        "created_date": "2023-06-19T22:00:16-04:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 18865,
        "mfr_code": "",
        "name": "ESSENTIAL PHARMA SWITZERLAND GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "LANDIS + GYR-STRASSE 1",
        "province": "--",
        "country": "SWITZERLAND",
        "city": "ZUG",
        "postal_code": "6300",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252277,
          "ingredient": {
            "id": 794,
            "ingredient_code": 11372,
            "en_name": "APRACLONIDINE",
            "fr_name": "ApraclonidinE (Chlorhydrate d'apraclonidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02076306",
      "brand_name": "IOPIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80451",
      "number_of_ais": "1",
      "ai_group_no": "0122471002"
    },
    "created_date": "2018-03-06T16:21:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02076306",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01EA03",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2018-03-29T00:00:00-04:00",
    "actual_start_date": "2018-03-06T00:00:00-05:00",
    "actual_end_date": "2018-04-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-04-13T20:17:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IOPIDINE",
    "en_drug_common_name": "IOPIDINE 0.5% SOLN 5ML",
    "fr_drug_brand_name": "IOPIDINE",
    "fr_drug_common_name": "IOPIDINE 0.5% SOLN 5ML",
    "en_ingredients": "APRACLONIDINE",
    "fr_ingredients": "apraclonidine hydrochloride",
    "drug_strength": ".5%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 41957,
    "drug": {
      "current_status": "MARKETED",
      "id": 2324,
      "drug_code": 1530,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 16,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 3594,
        "mfr_code": "ALC08",
        "name": "ALCON CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2665 MEADOWPINE BLVD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 8C7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250273,
          "ingredient": {
            "id": 1132,
            "ingredient_code": 4179,
            "en_name": "CYCLOPENTOLATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de cyclopentolate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "00252506",
      "brand_name": "CYCLOGYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "41143",
      "number_of_ais": "1",
      "ai_group_no": "0108675001"
    },
    "created_date": "2018-03-06T16:29:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00252506",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01FA04",
    "atc_description": "MYDRIATICSAND CYCLOPLEGICS",
    "estimated_end_date": "2018-03-12T00:00:00-04:00",
    "actual_start_date": "2018-03-06T00:00:00-05:00",
    "actual_end_date": "2018-03-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-03-20T18:01:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CYCLOGYL",
    "en_drug_common_name": "CYCLOGYL 1% SOLN 15ML",
    "fr_drug_brand_name": "CYCLOGYL",
    "fr_drug_common_name": "CYCLOGYL 1% SOLN 15ML",
    "en_ingredients": "CYCLOPENTOLATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de cyclopentolate",
    "drug_strength": "1%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "15ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42092,
    "drug": {
      "current_status": "MARKETED",
      "id": 9150,
      "drug_code": 61971,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253594,
          "ingredient": {
            "id": 82,
            "ingredient_code": 150,
            "en_name": "ACETYLSALICYLIC ACID",
            "fr_name": "Acide acétylsalicylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238545",
      "brand_name": "ASAPHEN E.C. 80 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101169013"
    },
    "created_date": "2018-03-07T15:12:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238545",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02BA01",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "anticipated_start_date": "2018-04-25T00:00:00-04:00",
    "actual_start_date": "2018-04-20T00:00:00-04:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-04T15:50:00-04:00",
    "status": "avoided_shortage",
    "en_comments": "avoided shortage",
    "en_drug_brand_name": "ASAPHEN E.C. 80 MG",
    "en_drug_common_name": "ASAPHEN",
    "fr_drug_brand_name": "ASAPHEN E.C. 80 MG",
    "fr_drug_common_name": "ASAPHEN",
    "en_ingredients": "ACETYLSALICYLIC ACID",
    "fr_ingredients": "Acide acétylsalicylique",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42096,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20826,
      "drug_code": 82693,
      "updated_date": "2025-05-15T04:15:49-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348232,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02341417",
      "brand_name": "PMS-FENTANYL MTX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302012"
    },
    "created_date": "2018-03-07T15:14:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02341417",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02AB03",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2018-03-30T00:00:00-04:00",
    "actual_start_date": "2018-03-06T00:00:00-05:00",
    "actual_end_date": "2018-03-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-24T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-FENTANYL MTX",
    "en_drug_common_name": "FENTANYL",
    "fr_drug_brand_name": "PMS-FENTANYL MTX",
    "fr_drug_common_name": "FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "100MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42099,
    "drug": {
      "current_status": "DORMANT",
      "id": 4076,
      "drug_code": 19893,
      "updated_date": "2025-05-15T06:55:24-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367033,
          "ingredient": {
            "id": 844,
            "ingredient_code": 10227,
            "en_name": "LITHIUM CARBONATE",
            "fr_name": "Carbonate de lithium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216159",
      "brand_name": "PMS-LITHIUM CARBONATE - CAP 600MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82191",
      "number_of_ais": "1",
      "ai_group_no": "0101163003"
    },
    "created_date": "2018-03-07T15:15:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02216159",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N05AN01",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-06-15T00:00:00-04:00",
    "actual_start_date": "2018-03-07T00:00:00-05:00",
    "actual_end_date": "2018-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-18T19:23:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LITHIUM CARBONATE - CAP 600MG",
    "en_drug_common_name": "LITHIUM CARBONATE",
    "fr_drug_brand_name": "PMS-LITHIUM CARBONATE - CAP 600MG",
    "fr_drug_common_name": "LITHIUM CARBONATE",
    "en_ingredients": "LITHIUM CARBONATE",
    "fr_ingredients": "Carbonate de lithium",
    "drug_strength": "600MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42102,
    "drug": {
      "current_status": "MARKETED",
      "id": 17796,
      "drug_code": 78853,
      "updated_date": "2025-05-15T02:32:04-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256252,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02303205",
      "brand_name": "PMS-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2018-03-07T15:18:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02303205",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-06-20T00:00:00-04:00",
    "actual_start_date": "2018-03-01T00:00:00-05:00",
    "actual_end_date": "2018-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-29T13:54:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "PMS-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42106,
    "drug": {
      "current_status": "MARKETED",
      "id": 22086,
      "drug_code": 84461,
      "updated_date": "2025-05-15T02:32:51-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257912,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359618",
      "brand_name": "PMS-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121002"
    },
    "created_date": "2018-03-07T15:20:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359618",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2018-04-25T00:00:00-04:00",
    "actual_start_date": "2018-04-20T00:00:00-04:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-04T17:47:27-04:00",
    "status": "avoided_shortage",
    "en_comments": "avoided shortage",
    "fr_comments": "Pénurie évitée",
    "en_drug_brand_name": "PMS-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "PMS-PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42109,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15028,
      "drug_code": 75464,
      "updated_date": "2025-12-03T01:23:44-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8341405,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02269260",
      "brand_name": "PMS-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415004"
    },
    "created_date": "2018-03-07T15:20:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02269260",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C10AA01",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2018-03-06T00:00:00-05:00",
    "actual_end_date": "2020-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-08T20:35:00-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued. Transitioned to phama-SIMVASTATIN DIN (02469987)",
    "fr_comments": "Product to be discontinued. Transitioned to phama-SIMVASTATIN DIN (02469987)",
    "en_drug_brand_name": "PMS-SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN",
    "fr_drug_brand_name": "PMS-SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42112,
    "drug": {
      "current_status": "MARKETED",
      "id": 23226,
      "drug_code": 85801,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258389,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258388,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02372908",
      "brand_name": "IRBESARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086003"
    },
    "created_date": "2018-03-07T16:00:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02372908",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09DA04",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2018-03-12T00:00:00-04:00",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_start_date": "2018-03-12T00:00:00-04:00",
    "actual_end_date": "2018-04-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-04-13T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "Delay in availability of replenishment batch",
    "fr_comments": "Retard dans la disponibilité du lot de réapprovisionnement",
    "en_drug_brand_name": "IRBESARTAN/HCTZ",
    "en_drug_common_name": "IRBESARTAN/HCTZ",
    "fr_drug_brand_name": "IRBESARTAN/HCTZ",
    "fr_drug_common_name": "IRBESARTAN/HCTZ COMPRIMES",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "25MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42157,
    "drug": {
      "current_status": "MARKETED",
      "id": 21286,
      "drug_code": 83683,
      "updated_date": "2025-05-15T02:32:42-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8257540,
          "ingredient": {
            "id": 1648,
            "ingredient_code": 11114,
            "en_name": "VALACYCLOVIR",
            "fr_name": "Valaciclovir (Chlorhydrate de valacyclovir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02351579",
      "brand_name": "MYLAN-VALACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128626001"
    },
    "created_date": "2018-03-07T19:16:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02351579",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J05AB11",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2018-04-27T00:00:00-04:00",
    "actual_start_date": "2018-04-20T00:00:00-04:00",
    "actual_end_date": "2018-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-04-28T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-VALACYCLOVIR",
    "en_drug_common_name": "VALACYCLOVIR",
    "fr_drug_brand_name": "MYLAN-VALACYCLOVIR",
    "fr_drug_common_name": "VALACYCLOVIR",
    "en_ingredients": "VALACYCLOVIR",
    "fr_ingredients": "VALACYCLOVIR",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42162,
    "drug": {
      "current_status": "MARKETED",
      "id": 19528,
      "drug_code": 80856,
      "updated_date": "2025-05-15T02:32:20-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256823,
          "ingredient": {
            "id": 3534,
            "ingredient_code": 20438,
            "en_name": "EPLERENONE",
            "fr_name": "Éplérénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02323060",
      "brand_name": "INSPRA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152537002"
    },
    "created_date": "2018-03-07T20:17:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02323060",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "C03DA04",
    "atc_description": "POTASSIUM-SPARING AGENTS",
    "anticipated_start_date": "2018-03-30T00:00:00-04:00",
    "actual_end_date": "2018-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-04-18T13:19:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "INSPRA",
    "en_drug_common_name": "Inspra",
    "fr_drug_brand_name": "INSPRA",
    "fr_drug_common_name": "Inspra",
    "en_ingredients": "EPLERENONE",
    "fr_ingredients": "Éplérénone",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3 x 10 tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42165,
    "drug": {
      "current_status": "MARKETED",
      "id": 2482,
      "drug_code": 15909,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252070,
          "ingredient": {
            "id": 1178,
            "ingredient_code": 9954,
            "en_name": "LIOTHYRONINE",
            "fr_name": "Liothyronine (Liothyronine sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01919458",
      "brand_name": "CYTOMEL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77672",
      "number_of_ais": "1",
      "ai_group_no": "0102421003"
    },
    "created_date": "2018-03-07T20:24:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01919458",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "H03AA02",
    "atc_description": "THYROID PREPARATIONS",
    "actual_start_date": "2018-05-07T00:00:00-04:00",
    "actual_end_date": "2019-01-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-01-09T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CYTOMEL",
    "en_drug_common_name": "Cytomel",
    "fr_drug_brand_name": "CYTOMEL",
    "fr_drug_common_name": "Cytomel",
    "en_ingredients": "LIOTHYRONINE",
    "fr_ingredients": "Liothyronine",
    "drug_strength": "5MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42172,
    "drug": {
      "current_status": "MARKETED",
      "id": 2480,
      "drug_code": 15908,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252069,
          "ingredient": {
            "id": 1178,
            "ingredient_code": 9954,
            "en_name": "LIOTHYRONINE",
            "fr_name": "Liothyronine (Liothyronine sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01919466",
      "brand_name": "CYTOMEL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77671",
      "number_of_ais": "1",
      "ai_group_no": "0102421004"
    },
    "created_date": "2018-03-07T20:27:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01919466",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "H03AA02",
    "atc_description": "THYROID PREPARATIONS",
    "estimated_end_date": "2019-07-05T00:00:00-04:00",
    "actual_start_date": "2018-11-30T00:00:00-05:00",
    "actual_end_date": "2019-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-06-27T12:55:39-04:00",
    "status": "resolved",
    "en_comments": "Other presentation available: 5mcg",
    "fr_comments": "Autre présentation disponible: 5mcg",
    "en_drug_brand_name": "CYTOMEL",
    "en_drug_common_name": "Cytomel",
    "fr_drug_brand_name": "CYTOMEL",
    "fr_drug_common_name": "Cytomel",
    "en_ingredients": "LIOTHYRONINE",
    "fr_ingredients": "LIOTHYRONINE",
    "drug_strength": "25MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42174,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12100,
      "drug_code": 70098,
      "updated_date": "2025-05-15T04:05:04-04:00",
      "company": {
        "id": 30,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 3574,
        "mfr_code": "ALL07",
        "name": "ALLERGAN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "300",
        "street_name": "1380 RODICK ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MARKHAM",
        "postal_code": "L3R 4G5",
        "post_office_box": "",
        "contact_information": "Company contact information;\r\nTelephone number: 800-668-6424\r\nEmail address: MR-GENERAL_INQUIRY@allergan.com\r\nWebsite address: allergan.ca\r\nPostal address:  500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5"
      },
      "drug_ingredients": [
        {
          "id": 8336540,
          "ingredient": {
            "id": 2508,
            "ingredient_code": 7485,
            "en_name": "TESTOSTERONE",
            "fr_name": "Testostérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02245972",
      "brand_name": "ANDRODERM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106405009"
    },
    "created_date": "2018-03-07T20:28:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245972",
    "company_name": "ALLERGAN PHARMA CO.",
    "atc_number": "G03BA03",
    "atc_description": "ANDROGENS",
    "anticipated_start_date": "2018-04-06T00:00:00-04:00",
    "estimated_end_date": "2018-05-18T00:00:00-04:00",
    "actual_end_date": "2018-06-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-09-25T17:41:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ANDRODERM",
    "en_drug_common_name": "Androderm",
    "fr_drug_brand_name": "Androderm",
    "fr_drug_common_name": "Androderm",
    "en_ingredients": "TESTOSTERONE",
    "fr_ingredients": "Testostérone",
    "drug_strength": "24.3MG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "Patches",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42178,
    "drug": {
      "current_status": "MARKETED",
      "id": 4268,
      "drug_code": 20162,
      "updated_date": "2025-12-03T00:30:34-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252679,
          "ingredient": {
            "id": 748,
            "ingredient_code": 7500,
            "en_name": "NORETHINDRONE",
            "fr_name": "Noréthindrone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252678,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.035",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02187086",
      "brand_name": "BREVICON 0.5/35 TABLETS (21-DAY PACK)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82465",
      "number_of_ais": "2",
      "ai_group_no": "0210010001"
    },
    "created_date": "2018-03-07T20:31:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02187086",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "G03AA05",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "actual_start_date": "2018-04-02T00:00:00-04:00",
    "actual_end_date": "2018-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-24T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BREVICON 0.5/35 TABLETS (21-DAY PACK)",
    "en_drug_common_name": "Brevicon",
    "fr_drug_brand_name": "BREVICON 0.5/35 COMPRIMES (21)",
    "fr_drug_common_name": "Brevicon",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nNORETHINDRONE",
    "fr_ingredients": "Éthinylestradiol\r\nNoréthindrone",
    "drug_strength": "0.035MG\r\n0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "21's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42193,
    "drug": {
      "current_status": "MARKETED",
      "id": 28694,
      "drug_code": 90822,
      "updated_date": "2025-05-15T02:34:17-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260411,
          "ingredient": {
            "id": 3198,
            "ingredient_code": 13585,
            "en_name": "ESCITALOPRAM",
            "fr_name": "Escitalopram (Oxalate d'escitalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02423502",
      "brand_name": "MAR-ESCITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150435004"
    },
    "created_date": "2018-03-07T20:44:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423502",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06AB10",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2018-07-16T00:00:00-04:00",
    "actual_start_date": "2018-07-16T00:00:00-04:00",
    "actual_end_date": "2019-09-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-09-10T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-ESCITALOPRAM",
    "en_drug_common_name": "Mar-Escitalopram",
    "fr_drug_brand_name": "MAR-ESCITALOPRAM",
    "fr_drug_common_name": "Mar-Escitalopram",
    "en_ingredients": "ESCITALOPRAM",
    "fr_ingredients": "Escitalopram",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42266,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 26256,
      "drug_code": 88625,
      "updated_date": "2025-05-15T04:20:58-04:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352730,
          "ingredient": {
            "id": 3006,
            "ingredient_code": 11241,
            "en_name": "PIPERACILLIN",
            "fr_name": "Pipéracilline (Pipéracilline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8352729,
          "ingredient": {
            "id": 3416,
            "ingredient_code": 11242,
            "en_name": "TAZOBACTAM",
            "fr_name": "Tazobactam (Tazobactam sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02401339",
      "brand_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
      "brand_name_fr": "PIPÉRACILLINE-TAZOBACTAM POUR INJECTION",
      "descriptor": "SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0225919006"
    },
    "created_date": "2018-03-08T14:55:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02401339",
    "company_name": "TELIGENT OU",
    "atc_number": "J01CR05",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2018-06-15T00:00:00-04:00",
    "actual_start_date": "2018-03-01T00:00:00-05:00",
    "actual_end_date": "2018-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-06-13T13:34:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
    "en_drug_common_name": "Piperacillin and Tazobactam for Injection",
    "fr_drug_brand_name": "PIPÉRACILLINE-TAZOBACTAM POUR INJECTION",
    "fr_drug_common_name": "PIPÉRACILLINE-TAZOBACTAM POUR INJECTION",
    "en_ingredients": "PIPERACILLIN\r\nTAZOBACTAM",
    "fr_ingredients": "PIPÉRACILLINE (PIPÉRACILLINE SODIQUE)\r\nTAZOBACTAM (TAZOBACTAM SODIQUE)",
    "drug_strength": "4G\r\n0.5G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "4.5 G/VIAL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 42273,
    "drug": {
      "current_status": "MARKETED",
      "id": 30000,
      "drug_code": 92056,
      "updated_date": "2025-12-03T00:32:43-05:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260920,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8260919,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.01",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02436221",
      "brand_name": "LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP",
      "brand_name_fr": "INJECTION DE CHLORHYDRATE DE LIDOCAÏNE ET D'ÉPINÉPHRINE USP",
      "descriptor": "MULTIDOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0201284005"
    },
    "created_date": "2018-03-08T15:01:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02436221",
    "company_name": "TELIGENT OU",
    "atc_number": "N01BB02",
    "atc_description": "ANESTHETICS, LOCAL",
    "estimated_end_date": "2018-05-11T00:00:00-04:00",
    "actual_start_date": "2018-03-07T00:00:00-05:00",
    "actual_end_date": "2018-05-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-05-16T17:37:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LIDOCAINE 2% AND EPINEPHRINE 1:100,000 INJECTION",
    "en_drug_common_name": "LIDOCAINE AND EPINEPHRINE INJECTION",
    "fr_drug_brand_name": "LIDOCAÏNE À 2% ET ÉPINÉPHRINE À 1:100 000 POUR INJECTION",
    "fr_drug_common_name": "LIDOCAÎNE ET ÉPINÉPHRINE POUR INJECTION",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE\r\nEPINEPHRINE",
    "fr_ingredients": "Chlorhydrate de lidocaïne\r\nÉpinéphrine",
    "drug_strength": "20MG\r\n0.01MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "50 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42282,
    "drug": {
      "current_status": "MARKETED",
      "id": 12662,
      "drug_code": 71450,
      "updated_date": "2025-12-03T00:30:53-05:00",
      "company": {
        "id": 1028,
        "created_date": "2017-03-09T13:23:38-05:00",
        "updated_date": "2025-05-15T02:30:19-04:00",
        "company_code": 14639,
        "mfr_code": "",
        "name": "VALNEVA SWEDEN AB",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "GUNNAR ASPLUNDS ALLÉ 16",
        "province": "--",
        "country": "SWEDEN",
        "city": "STOCKHOLM",
        "postal_code": "10521",
        "post_office_box": "SE-10521"
      },
      "drug_ingredients": [
        {
          "id": 8254634,
          "ingredient": {
            "id": 3026,
            "ingredient_code": 12358,
            "en_name": "VIBRIO CHOLERAE INABA 48 CLASSICAL BIOTYPE, HEAT INACTIVATED",
            "fr_name": "Biotype classique inaba 48 de vibrio cholerae, inactivé à la chaleur"
          },
          "ingredient_supplied_ind": "I",
          "strength": "31250000000",
          "strength_unit": "CELLS",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8254633,
          "ingredient": {
            "id": 3032,
            "ingredient_code": 12361,
            "en_name": "RECOMBINANT CHOLERA TOXIN B SUBUNIT",
            "fr_name": "Sous-unité b recombinée de la toxine cholérique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8254632,
          "ingredient": {
            "id": 3024,
            "ingredient_code": 12357,
            "en_name": "VIBRIO CHOLERAE INABA 6973 EL TOR BIOTYPE, FORMALIN INACTIVATED",
            "fr_name": "Biotype el tor inaba 6973 de vibrio cholerae, inactivé au formol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "31250000000",
          "strength_unit": "CELLS",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8254631,
          "ingredient": {
            "id": 3030,
            "ingredient_code": 12360,
            "en_name": "VIBRIO CHOLERAE OGAWA 50 CLASSICAL BIOTYPE, FORMALIN INACTIVATED",
            "fr_name": "Biotype classique ogawa 50 de vibrio cholerae, inactivé au formol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "31250000000",
          "strength_unit": "CELLS",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8254630,
          "ingredient": {
            "id": 3028,
            "ingredient_code": 12359,
            "en_name": "VIBRIO CHOLERAE OGAWA 50 CLASSICAL BIOTYPE, HEAT INACTIVATED",
            "fr_name": "Biotype classique ogawa 50 de vibrio cholerae, inactivé à la chaleur"
          },
          "ingredient_supplied_ind": "I",
          "strength": "31250000000",
          "strength_unit": "CELLS",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02247208",
      "brand_name": "DUKORAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "5",
      "ai_group_no": "0548981004"
    },
    "created_date": "2018-03-08T15:32:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247208",
    "company_name": "VALNEVA SWEDEN AB",
    "atc_number": "J07AE01",
    "atc_description": "BACTERIAL VACCINES",
    "anticipated_start_date": "2018-03-07T00:00:00-05:00",
    "estimated_end_date": "2018-03-23T00:00:00-04:00",
    "actual_start_date": "2018-03-08T00:00:00-05:00",
    "actual_end_date": "2018-03-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-03-27T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DUKORAL",
    "en_drug_common_name": "Oral, Inactivated Cholera and ETEC Diarrhea Vaccine",
    "fr_drug_brand_name": "Dukoral",
    "fr_drug_common_name": "Oral, Inactivated Cholera and ETEC Diarrhea Vaccine",
    "en_ingredients": "VIBRIO CHOLERAE INABA 6973 E1 TOR BIOTYPE, FORMALIN INACTIVATED\r\nVIBRIO CHOLERAE INABA 48 CLASSICAL BIOTYPE, HEAT INACTIVATED\r\nVIBRIO CHOLERAE OGAWA 50 CLASSICAL BIOTYPE, HEAT INACTIVATED\r\nVIBRIO CHOLERAE OGAWA 50 CLASSICAL BIOTYPE, FORMALIN INACTIVATED\r\nRECOMBINANT CHOLERA TOXIN B SUBUNIT",
    "fr_ingredients": "Biotype e1 tor inaba 6973 de vibrio cholerae, inactivé au formol\r\nBiotype classique inaba 48 de vibrio cholerae, inactivé à la chaleur\r\nBiotype classique ogawa 50 de vibrio cholerae, inactivé à la chaleur\r\nBiotype classique ogawa 50 de vibrio cholerae, inactivé au formol\r\nSous-unité b recombinée de la toxine cholérique",
    "drug_strength": "25000000000UNIT\r\n25000000000UNIT\r\n25000000000UNIT\r\n25000000000UNIT\r\n1MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Box of 1 single-dose vial of vaccine and 1 sachet (5.6 g) sodium hydrogen carbonate",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42298,
    "drug": {
      "current_status": "MARKETED",
      "id": 55363,
      "drug_code": 94425,
      "updated_date": "2025-05-15T02:35:34-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8262096,
          "ingredient": {
            "id": 2870,
            "ingredient_code": 1893,
            "en_name": "PROPAFENONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propafénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457172",
      "brand_name": "MYLAN-PROPAFENONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116258001"
    },
    "created_date": "2018-03-08T18:20:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457172",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C01BC03",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "anticipated_start_date": "2019-03-12T00:00:00-04:00",
    "estimated_end_date": "2019-03-15T00:00:00-04:00",
    "actual_end_date": "2019-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-03-16T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-PROPAFENONE",
    "en_drug_common_name": "PROPAFENONE",
    "fr_drug_brand_name": "MYLAN-PROPAFENONE",
    "fr_drug_common_name": "PROPAFENONE",
    "en_ingredients": "PROPAFENONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propafénone",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42301,
    "drug": {
      "current_status": "MARKETED",
      "id": 55361,
      "drug_code": 94424,
      "updated_date": "2025-05-15T02:35:34-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8262095,
          "ingredient": {
            "id": 2870,
            "ingredient_code": 1893,
            "en_name": "PROPAFENONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propafénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457164",
      "brand_name": "MYLAN-PROPAFENONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116258002"
    },
    "created_date": "2018-03-08T18:22:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457164",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C01BC03",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "actual_start_date": "2018-05-31T00:00:00-04:00",
    "actual_end_date": "2019-01-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-01-22T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-PROPAFENONE",
    "en_drug_common_name": "PROPAFENONE",
    "fr_drug_brand_name": "MYLAN-PROPAFENONE",
    "fr_drug_common_name": "PROPAFENONE",
    "en_ingredients": "PROPAFENONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propafénone",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42304,
    "drug": {
      "current_status": "MARKETED",
      "id": 24204,
      "drug_code": 86829,
      "updated_date": "2025-05-15T02:33:19-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258710,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382458",
      "brand_name": "MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823003"
    },
    "created_date": "2018-03-08T18:39:31-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02382458",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "R03DC03",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "discontinuation_date": "2018-04-06T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Launch of a new packaging size between March 30th and April 6th 2018, depending on the province.",
    "fr_supply_disruption_mitigation": "Lancement d'un nouveau format d'emballage entre le 30 mars et le 6 avril 2018 dépendamment de la province.",
    "en_discontinuation_comments": "This discontinued packaging size (30) is replaced by a new packaging size (100)",
    "fr_discontinuation_comments": "Ce format d'emballage discontinué (30) est remplacé par un nouveau format (100)",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-04-10T02:44:45-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MONTELUKAST",
    "en_drug_common_name": "MONTELUKAST",
    "fr_drug_brand_name": "MONTELUKAST",
    "fr_drug_common_name": "MONTELUKAST",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "MONTELUKAST",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42307,
    "drug": {
      "current_status": "MARKETED",
      "id": 24206,
      "drug_code": 86830,
      "updated_date": "2025-05-15T02:33:19-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258711,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382466",
      "brand_name": "MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823001"
    },
    "created_date": "2018-03-08T18:42:45-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02382466",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "R03DC03",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "discontinuation_date": "2018-04-06T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Launch of a new packaging size between March 30th and April 6th 2018, depending on the province.",
    "fr_supply_disruption_mitigation": "Lancement d'un nouveau format d'emballage entre le 30 mars et le 6 avril 2018, dépendamment de la province.",
    "en_discontinuation_comments": "This discontinued packaging size (30) is replaced by a new packaging size (100)",
    "fr_discontinuation_comments": "Ce format d'emballage discontinué (30) est remplacé par un nouveau format (100)",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-04-10T02:45:40-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MONTELUKAST",
    "en_drug_common_name": "MONTELUKAST",
    "fr_drug_brand_name": "MONTELUKAST",
    "fr_drug_common_name": "MONTELUKAST",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "MONTELUKAST",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42310,
    "drug": {
      "current_status": "MARKETED",
      "id": 24208,
      "drug_code": 86831,
      "updated_date": "2025-05-15T02:33:19-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258712,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382474",
      "brand_name": "MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823002"
    },
    "created_date": "2018-03-08T18:45:03-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02382474",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "R03DC03",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "discontinuation_date": "2018-04-06T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Launch of a new packaging size between March 30th and April 6th 2018, depending on the province.",
    "fr_supply_disruption_mitigation": "Lancement d'un nouveau format d'emballage entre le 30 mars et le 6 avril 2018, dépendamment de la province.",
    "en_discontinuation_comments": "This discontinued packaging size (30) is replaced by a new packaging size (100)",
    "fr_discontinuation_comments": "Ce format d'emballage discontinué (30) est remplacé par un nouveau format (100)",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-04-10T02:45:15-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MONTELUKAST",
    "en_drug_common_name": "MONTELUKAST",
    "fr_drug_brand_name": "MONTELUKAST",
    "fr_drug_common_name": "MONTELUKAST",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "MONTELUKAST",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42315,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23758,
      "drug_code": 86416,
      "updated_date": "2025-05-15T04:19:48-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8351136,
          "ingredient": {
            "id": 1596,
            "ingredient_code": 8541,
            "en_name": "VANCOMYCIN",
            "fr_name": "Vancomycine (Chlorhydrate de vancomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02378345",
      "brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
      "brand_name_fr": "CHLORHYDRATE DE VANCOMYCINE POUR INJECTION, USP",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131315008"
    },
    "created_date": "2018-03-08T21:08:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378345",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "J01XA01",
    "atc_description": "OTHER ANTIBACTERIALS",
    "actual_start_date": "2018-05-25T00:00:00-04:00",
    "actual_end_date": "2019-07-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-30T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "en_drug_common_name": "VANCOMYCIN",
    "fr_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE POUR INJECTION, USP",
    "fr_drug_common_name": "VANCOMYCIN",
    "en_ingredients": "VANCOMYCIN",
    "fr_ingredients": "VANCOMYCIN",
    "drug_strength": "10G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1x10g GVL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42319,
    "drug": {
      "current_status": "MARKETED",
      "id": 4356,
      "drug_code": 20353,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252727,
          "ingredient": {
            "id": 1658,
            "ingredient_code": 7335,
            "en_name": "ALPROSTADIL",
            "fr_name": "Alprostadil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02215756",
      "brand_name": "CAVERJECT STERILE POWDER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82663",
      "number_of_ais": "1",
      "ai_group_no": "0115288006"
    },
    "created_date": "2018-03-08T21:50:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02215756",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "G04BE01",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "actual_start_date": "2018-04-20T00:00:00-04:00",
    "actual_end_date": "2018-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-04T12:52:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CAVERJECT STERILE POWDER - KIT 23.2MCG/VIAL",
    "en_drug_common_name": "Caverject",
    "fr_drug_brand_name": "CAVERJECT STERILE POWDER - KIT 23.2MCG/VIAL",
    "fr_drug_common_name": "Caverject",
    "en_ingredients": "WATER\r\nALPROSTADIL",
    "fr_ingredients": "Eau\r\nAlprostadil",
    "drug_strength": "99.1%\r\n23.2MCG",
    "drug_dosage_form": "KIT\r\nLIQUID\r\nPOWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Trousse\r\nLiquide\r\nPoudre pour solution",
    "drug_route": "INTRACAVERNOSAL",
    "drug_route_fr": "Intracaverneuse",
    "drug_package_quantity": "5 x 20MCG",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42337,
    "drug": {
      "current_status": "MARKETED",
      "id": 7294,
      "drug_code": 49290,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253268,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02230420",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238005"
    },
    "created_date": "2018-03-09T14:36:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230420",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC01",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2018-05-04T00:00:00-04:00",
    "actual_start_date": "2018-04-10T00:00:00-04:00",
    "actual_end_date": "2018-04-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-04-27T17:04:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX NASAL SPRAY",
    "en_drug_common_name": "Sumatriptan nasal spray",
    "fr_drug_brand_name": "IMITREX NASAL SPRAY",
    "fr_drug_common_name": "vaporisation nasale de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "Sumatriptan",
    "drug_strength": "20MG",
    "drug_dosage_form": "SPRAY",
    "drug_dosage_form_fr": "Pulvérisation",
    "drug_route": "NASAL",
    "drug_route_fr": "Nasale",
    "drug_package_quantity": "2's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42340,
    "drug": {
      "current_status": "MARKETED",
      "id": 2414,
      "drug_code": 15704,
      "updated_date": "2025-12-03T00:30:32-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252053,
          "ingredient": {
            "id": 258,
            "ingredient_code": 12708,
            "en_name": "CONJUGATED ESTROGENS",
            "fr_name": "Oestrogènes conjugués"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.625",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "02043440",
      "brand_name": "PREMARIN VAGINAL CREAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77452",
      "number_of_ais": "1",
      "ai_group_no": "0106442005"
    },
    "created_date": "2018-03-09T16:31:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02043440",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "G03CA57",
    "atc_description": "ESTROGENS",
    "anticipated_start_date": "2018-05-15T00:00:00-04:00",
    "actual_end_date": "2018-05-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-05-17T13:43:30-04:00",
    "status": "resolved",
    "en_comments": "New 30 gram tube presentation is fully available.",
    "fr_comments": "Le nouveau tube de 30 grammes est maintenant disponible pour la vente.",
    "en_drug_brand_name": "PREMARIN VAGINAL CREAM",
    "en_drug_common_name": "Premarin vaginal cream",
    "fr_drug_brand_name": "PREMARIN VAGINAL CREAM",
    "fr_drug_common_name": "Premarin vaginal cream",
    "en_ingredients": "CONJUGATED ESTROGENS",
    "fr_ingredients": "Oestrogènes conjugués",
    "drug_strength": "0.625MG",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "VAGINAL",
    "drug_route_fr": "Vaginale",
    "drug_package_quantity": "14G",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42342,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 50298,
      "drug_code": 94693,
      "updated_date": "2025-05-15T04:24:50-04:00",
      "company": {
        "id": 1188,
        "created_date": "2017-03-09T13:23:54-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 8482,
        "mfr_code": "",
        "name": "BIOGEN CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3300 BLOOR STREET WEST, WEST TOWER, SUITE 1200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M8X 2X2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8357025,
          "ingredient": {
            "id": 6507,
            "ingredient_code": 22834,
            "en_name": "DACLIZUMAB BETA",
            "fr_name": "daclizumab bêta"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02459620",
      "brand_name": "ZINBRYTA",
      "brand_name_fr": "",
      "descriptor": "PRE-FILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0158650001"
    },
    "created_date": "2018-03-09T16:31:38-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02459620",
    "company_name": "BIOGEN CANADA INC",
    "atc_number": "L04AC01",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "anticipated_discontinuation_date": "2018-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Given the nature and complexity of adverse events being reported globally, characterizing the benefit/risk profile of ZINBRYTA will not be possible going forward given the limited number of patients being treated. Therefore, the company believes it is in the best interest of patients to voluntarily withdraw worldwide marketing authorizations for ZINBRYTA.",
    "fr_discontinuation_comments": "Étant donné la nature et la complexité des effets indésirables signalés à travers le monde, et vu le nombre limité de patients utilisant le produit, il n'est plus possible de caractériser le profil avantages-risques de ZINBRYTA. Par conséquent, l'entreprise juge que, dans l'intérêt des patients, il convient de retirer volontairement les autorisations de mise en marché de ZINBRYTA à travers le monde.",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-03-09T18:53:21-05:00",
    "status": "to_be_discontinued",
    "en_drug_brand_name": "ZINBRYTA",
    "en_drug_common_name": "daclizumab beta",
    "fr_drug_brand_name": "ZINBRYTA",
    "fr_drug_common_name": "Daclizumab bêta",
    "en_ingredients": "DACLIZUMAB BETA",
    "fr_ingredients": "Daclizumab bêta",
    "drug_strength": "150MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "One prefilled syringe for injection",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": true,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42370,
    "drug": {
      "current_status": "MARKETED",
      "id": 27112,
      "drug_code": 89366,
      "updated_date": "2025-05-15T02:33:59-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259776,
          "ingredient": {
            "id": 2616,
            "ingredient_code": 11795,
            "en_name": "CLOPIDOGREL",
            "fr_name": "Clopidogrel (Bisulfate de clopidogrel)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02408910",
      "brand_name": "MINT-CLOPIDOGREL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134440001"
    },
    "created_date": "2018-03-09T19:17:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02408910",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "B01AC04",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2019-02-04T00:00:00-05:00",
    "actual_start_date": "2019-03-09T00:00:00-05:00",
    "actual_end_date": "2019-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-12-05T19:04:39-05:00",
    "status": "resolved",
    "en_comments": "Discontinued.",
    "en_drug_brand_name": "MINT-CLOPIDOGREL",
    "en_drug_common_name": "Clopidogrel",
    "fr_drug_brand_name": "Mint- Clopidogrel",
    "fr_drug_common_name": "Clopidogrel",
    "en_ingredients": "CLOPIDOGREL",
    "fr_ingredients": "Clopidogrel",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42395,
    "drug": {
      "current_status": "MARKETED",
      "id": 5800,
      "drug_code": 3883,
      "updated_date": "2025-12-03T00:30:21-05:00",
      "company": {
        "id": 620,
        "created_date": "2017-03-09T13:22:58-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 15460,
        "mfr_code": "",
        "name": "MYLAN SPECIALTY LP",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3711 COLLINS FERRY ROAD",
        "province": "WEST VIRGINIA",
        "country": "UNITED STATES",
        "city": "MORGANTOWN",
        "postal_code": "26505",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250573,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.3",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00509558",
      "brand_name": "EPIPEN",
      "brand_name_fr": "",
      "descriptor": "0.3MG/0.3ML AUTO-INJECTOR",
      "pediatric_flag": false,
      "accession_number": "55851",
      "number_of_ais": "1",
      "ai_group_no": "0104871002"
    },
    "created_date": "2018-03-09T19:50:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00509558",
    "company_name": "MYLAN SPECIALTY LP",
    "atc_number": "C01CA24",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "hc_updated_date": "2018-08-03T16:48:24-04:00",
    "anticipated_start_date": "2018-04-09T00:00:00-04:00",
    "actual_start_date": "2018-04-09T00:00:00-04:00",
    "actual_end_date": "2019-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-20T06:00:03-05:00",
    "status": "resolved",
    "hc_en_comments": "http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67330a-eng.php",
    "hc_fr_comments": "http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67330a-fra.php",
    "en_drug_brand_name": "EPIPEN",
    "en_drug_common_name": "EPIPEN",
    "fr_drug_brand_name": "EPIPEN",
    "fr_drug_common_name": "EPIPEN",
    "en_ingredients": "EPINEPHRINE",
    "fr_ingredients": "Épinéphrine",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "Each (0.3MG/0.3ML AUTO-INJECTOR)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42408,
    "drug": {
      "current_status": "DORMANT",
      "id": 24436,
      "drug_code": 87070,
      "updated_date": "2025-05-15T06:55:45-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368775,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02385031",
      "brand_name": "JAMP-ALENDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2018-03-09T20:15:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02385031",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "M05BA04",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "actual_start_date": "2018-03-08T00:00:00-05:00",
    "actual_end_date": "2018-05-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-19T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-ALENDRONATE",
    "en_drug_common_name": "Alendronate",
    "fr_drug_brand_name": "Jamp-Alendronate",
    "fr_drug_common_name": "Jamp-Alendronate",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "Alendronate",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42426,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19716,
      "drug_code": 81074,
      "updated_date": "2025-05-15T04:14:37-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8346999,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "360",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02325349",
      "brand_name": "DILTIAZEM TZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863009"
    },
    "created_date": "2018-03-09T20:30:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02325349",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C08DB01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "hc_updated_date": "2021-08-06T19:04:56-04:00",
    "actual_start_date": "2018-03-09T00:00:00-05:00",
    "actual_end_date": "2021-07-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-08-06T19:05:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DILTIAZEM TZ",
    "en_drug_common_name": "DILTIAZEM TZ",
    "fr_drug_brand_name": "DILTIAZEM TZ",
    "fr_drug_common_name": "DILTIAZEM TZ",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "360MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42474,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9664,
      "drug_code": 63424,
      "updated_date": "2025-05-15T03:58:58-04:00",
      "company": {
        "id": 334,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4763,
        "mfr_code": "NNA08",
        "name": "NOVO NORDISK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "101-2476 ARGENTIA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 6M1",
        "post_office_box": "",
        "contact_information": "1 800 465 4334"
      },
      "drug_ingredients": [
        {
          "id": 8328721,
          "ingredient": {
            "id": 2678,
            "ingredient_code": 11860,
            "en_name": "REPAGLINIDE",
            "fr_name": "Répaglinide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239924",
      "brand_name": "GLUCONORM 0.5MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137035001"
    },
    "created_date": "2018-03-12T14:42:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239924",
    "company_name": "NOVO NORDISK CANADA INC",
    "atc_number": "A10BX02",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2018-03-12T00:00:00-04:00",
    "estimated_end_date": "2018-05-14T00:00:00-04:00",
    "actual_start_date": "2018-03-12T00:00:00-04:00",
    "actual_end_date": "2018-05-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-05-03T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "GLUCONORM 0.5MG",
    "en_drug_common_name": "REPAGLINIDE",
    "fr_drug_brand_name": "GLUCONORM 0.5 MG 100 TABLETTES",
    "fr_drug_common_name": "Répaglinide",
    "en_ingredients": "REPAGLINIDE",
    "fr_ingredients": "Répaglinide",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 x 100 tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42542,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21190,
      "drug_code": 83568,
      "updated_date": "2025-05-15T04:16:56-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348816,
          "ingredient": {
            "id": 2374,
            "ingredient_code": 11368,
            "en_name": "TERAZOSIN",
            "fr_name": "Térazosine (Chlorhydrate de térazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02350475",
      "brand_name": "TERAZOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136978001"
    },
    "created_date": "2018-03-13T12:00:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02350475",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "G04CA03",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_start_date": "2018-03-19T00:00:00-04:00",
    "estimated_end_date": "2018-04-13T00:00:00-04:00",
    "actual_start_date": "2018-03-19T00:00:00-04:00",
    "actual_end_date": "2018-04-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-04-12T05:00:07-04:00",
    "status": "resolved",
    "en_comments": "Delay in release of replenishment batch",
    "fr_comments": "Retard dans la libération du lot de réapprovisionnement",
    "en_drug_brand_name": "TERAZOSIN",
    "en_drug_common_name": "TERAZOSIN",
    "fr_drug_brand_name": "TERAZOSIN",
    "fr_drug_common_name": "TERAZOSIN COMPRIMES",
    "en_ingredients": "TERAZOSIN",
    "fr_ingredients": "TERAZOSIN",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42549,
    "drug": {
      "current_status": "MARKETED",
      "id": 26214,
      "drug_code": 88546,
      "updated_date": "2025-05-15T02:33:47-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259443,
          "ingredient": {
            "id": 1070,
            "ingredient_code": 1810,
            "en_name": "ENALAPRIL MALEATE",
            "fr_name": "Maléate d'énalapril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02400685",
      "brand_name": "ENALAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0117649002"
    },
    "created_date": "2018-03-13T12:03:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02400685",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09AA02",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2018-05-25T00:00:00-04:00",
    "actual_start_date": "2018-03-16T00:00:00-04:00",
    "actual_end_date": "2018-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-05-23T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Delay in availability of replenishment batch",
    "fr_comments": "Retard dans la disponibilité du lot de réapprovisionnement",
    "en_drug_brand_name": "ENALAPRIL",
    "en_drug_common_name": "ENALAPRIL TAB",
    "fr_drug_brand_name": "ENALAPRIL",
    "fr_drug_common_name": "ENALAPRIL COMPRIMES",
    "en_ingredients": "ENALAPRIL SODIUM",
    "fr_ingredients": "Énalapril sodique",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42553,
    "drug": {
      "current_status": "MARKETED",
      "id": 24176,
      "drug_code": 86797,
      "updated_date": "2025-05-15T02:33:19-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258702,
          "ingredient": {
            "id": 3156,
            "ingredient_code": 13346,
            "en_name": "ELETRIPTAN",
            "fr_name": "Élétriptan (Bromhydrate d'élétriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382105",
      "brand_name": "TEVA-ELETRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150241002"
    },
    "created_date": "2018-03-13T12:07:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382105",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02CC06",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2018-03-19T00:00:00-04:00",
    "actual_start_date": "2018-03-01T00:00:00-05:00",
    "actual_end_date": "2018-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-11T19:04:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ELETRIPTAN",
    "en_drug_common_name": "ELETRIPTAN",
    "fr_drug_brand_name": "TEVA-ELETRIPTAN",
    "fr_drug_common_name": "ELETRIPTAN",
    "en_ingredients": "ELETRIPTAN",
    "fr_ingredients": "Eletriptan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 42562,
    "drug": {
      "current_status": "MARKETED",
      "id": 19116,
      "drug_code": 80371,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256697,
          "ingredient": {
            "id": 3198,
            "ingredient_code": 13585,
            "en_name": "ESCITALOPRAM",
            "fr_name": "Escitalopram (Oxalate d'escitalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02318202",
      "brand_name": "TEVA-ESCITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150435004"
    },
    "created_date": "2018-03-13T12:20:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02318202",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AB10",
    "atc_description": "ANTIDEPRESSANTS",
    "hc_updated_date": "2018-12-07T15:12:56-05:00",
    "estimated_end_date": "2018-04-20T00:00:00-04:00",
    "actual_start_date": "2018-03-07T00:00:00-05:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-12-07T15:12:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ESCITALOPRAM",
    "en_drug_common_name": "ESCITALOPRAM",
    "fr_drug_brand_name": "TEVA-ESCITALOPRAM",
    "fr_drug_common_name": "ESCITALOPRAM",
    "en_ingredients": "ESCITALOPRAM",
    "fr_ingredients": "Escitalopram",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42565,
    "drug": {
      "current_status": "MARKETED",
      "id": 12528,
      "drug_code": 71243,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254602,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247010",
      "brand_name": "TEVA-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2018-03-13T12:22:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247010",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA03",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2018-04-15T00:00:00-04:00",
    "actual_start_date": "2018-03-07T00:00:00-05:00",
    "actual_end_date": "2018-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:20:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "TEVA-PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42570,
    "drug": {
      "current_status": "MARKETED",
      "id": 11466,
      "drug_code": 6813,
      "updated_date": "2025-05-15T02:30:37-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250951,
          "ingredient": {
            "id": 2866,
            "ingredient_code": 1996,
            "en_name": "PIROXICAM",
            "fr_name": "Piroxicam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00695718",
      "brand_name": "TEVA-PIROXICAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "64132",
      "number_of_ais": "1",
      "ai_group_no": "0114612002"
    },
    "created_date": "2018-03-13T12:45:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00695718",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AC01",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2018-03-21T00:00:00-04:00",
    "actual_start_date": "2018-03-07T00:00:00-05:00",
    "actual_end_date": "2018-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-11T19:05:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PIROXICAM",
    "en_drug_common_name": "PIROXICAM",
    "fr_drug_brand_name": "TEVA-PIROXICAM",
    "fr_drug_common_name": "PIROXICAM",
    "en_ingredients": "PIROXICAM",
    "fr_ingredients": "Piroxicam",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42573,
    "drug": {
      "current_status": "MARKETED",
      "id": 22218,
      "drug_code": 84624,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257952,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02361183",
      "brand_name": "TEVA-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121003"
    },
    "created_date": "2018-03-13T12:47:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02361183",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-03-21T00:00:00-04:00",
    "actual_start_date": "2018-03-13T00:00:00-04:00",
    "actual_end_date": "2018-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-11T19:06:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "TEVA-PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42576,
    "drug": {
      "current_status": "MARKETED",
      "id": 3202,
      "drug_code": 18190,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252259,
          "ingredient": {
            "id": 946,
            "ingredient_code": 1939,
            "en_name": "TRAZODONE HYDROCHLORIDE",
            "fr_name": "Chlohydrate de trazodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02144271",
      "brand_name": "TEVA-TRAZODONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80412",
      "number_of_ais": "1",
      "ai_group_no": "0115713002"
    },
    "created_date": "2018-03-13T12:51:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02144271",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX05",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-06-15T00:00:00-04:00",
    "actual_start_date": "2018-03-13T00:00:00-04:00",
    "actual_end_date": "2018-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-07-30T18:11:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TRAZODONE",
    "en_drug_common_name": "TRAZODONE",
    "fr_drug_brand_name": "TEVA-TRAZODONE",
    "fr_drug_common_name": "TRAZODONE",
    "en_ingredients": "TRAZODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlohydrate de trazodone",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42579,
    "drug": {
      "current_status": "MARKETED",
      "id": 3202,
      "drug_code": 18190,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252259,
          "ingredient": {
            "id": 946,
            "ingredient_code": 1939,
            "en_name": "TRAZODONE HYDROCHLORIDE",
            "fr_name": "Chlohydrate de trazodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02144271",
      "brand_name": "TEVA-TRAZODONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80412",
      "number_of_ais": "1",
      "ai_group_no": "0115713002"
    },
    "created_date": "2018-03-13T12:54:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02144271",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX05",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-06-15T00:00:00-04:00",
    "actual_start_date": "2018-03-13T00:00:00-04:00",
    "actual_end_date": "2018-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-30T18:16:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TRAZODONE",
    "en_drug_common_name": "TRAZODONE",
    "fr_drug_brand_name": "TEVA-TRAZODONE",
    "fr_drug_common_name": "TRAZODONE",
    "en_ingredients": "TRAZODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlohydrate de trazodone",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42582,
    "drug": {
      "current_status": "MARKETED",
      "id": 20188,
      "drug_code": 81625,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257160,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257159,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02330520",
      "brand_name": "TEVA-IRBESARTAN HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086002"
    },
    "created_date": "2018-03-13T12:55:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330520",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09DA04",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2018-03-23T00:00:00-04:00",
    "actual_start_date": "2018-03-10T00:00:00-05:00",
    "actual_end_date": "2018-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T18:50:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RATIO-IRBESARTAN HCTZ",
    "en_drug_common_name": "IRBESARTAN/HCTZ",
    "fr_drug_brand_name": "TEVA-IRBESARTAN/HCTZ",
    "fr_drug_common_name": "IRBESARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "12.5MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42585,
    "drug": {
      "current_status": "MARKETED",
      "id": 14886,
      "drug_code": 75289,
      "updated_date": "2025-05-15T02:31:40-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255333,
          "ingredient": {
            "id": 3044,
            "ingredient_code": 1218,
            "en_name": "BISOPROLOL FUMARATE",
            "fr_name": "Fumarate de bisoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02267489",
      "brand_name": "TEVA-BISOPROLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122418002"
    },
    "created_date": "2018-03-13T13:00:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02267489",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AB07",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2018-04-20T00:00:00-04:00",
    "actual_start_date": "2018-03-10T00:00:00-05:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-30T18:35:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-BISOPROLOL",
    "en_drug_common_name": "BISOPROLOL",
    "fr_drug_brand_name": "TEVA-BISOPROLOL",
    "fr_drug_common_name": "BISOPROLOL",
    "en_ingredients": "BISOPROLOL FUMARATE",
    "fr_ingredients": "Fumarate de bisoprolol",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42588,
    "drug": {
      "current_status": "MARKETED",
      "id": 11566,
      "drug_code": 68490,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254312,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244513",
      "brand_name": "TEVA-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "100MG",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929001"
    },
    "created_date": "2018-03-13T13:02:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244513",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-04-15T00:00:00-04:00",
    "actual_start_date": "2018-03-13T00:00:00-04:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-30T18:53:42-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "TEVA-GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42591,
    "drug": {
      "current_status": "MARKETED",
      "id": 3170,
      "drug_code": 18071,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252248,
          "ingredient": {
            "id": 1092,
            "ingredient_code": 2251,
            "en_name": "LOPERAMIDE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lopéramide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02132591",
      "brand_name": "TEVA-LOPERAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80285",
      "number_of_ais": "1",
      "ai_group_no": "0111332001"
    },
    "created_date": "2018-03-13T13:04:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02132591",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A07DA03",
    "atc_description": "ANTIPROPULSIVES",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_start_date": "2018-03-01T00:00:00-05:00",
    "actual_end_date": "2018-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:16:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-LOPERAMIDE",
    "en_drug_common_name": "LOPERAMIDE",
    "fr_drug_brand_name": "TEVA-LOPERAMIDE",
    "fr_drug_common_name": "LOPERAMIDE",
    "en_ingredients": "LOPERAMIDE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lopéramide",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 42594,
    "drug": {
      "current_status": "MARKETED",
      "id": 3170,
      "drug_code": 18071,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252248,
          "ingredient": {
            "id": 1092,
            "ingredient_code": 2251,
            "en_name": "LOPERAMIDE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lopéramide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02132591",
      "brand_name": "TEVA-LOPERAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80285",
      "number_of_ais": "1",
      "ai_group_no": "0111332001"
    },
    "created_date": "2018-03-13T13:06:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02132591",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A07DA03",
    "atc_description": "ANTIPROPULSIVES",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_start_date": "2018-03-01T00:00:00-05:00",
    "actual_end_date": "2018-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:16:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-LOPERAMIDE",
    "en_drug_common_name": "LOPERAMIDE",
    "fr_drug_brand_name": "TEVA-LOPERAMIDE",
    "fr_drug_common_name": "LOPERAMIDE",
    "en_ingredients": "LOPERAMIDE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lopéramide",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 42597,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9594,
      "drug_code": 6323,
      "updated_date": "2025-12-03T01:01:49-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8280187,
          "ingredient": {
            "id": 102,
            "ingredient_code": 2609,
            "en_name": "IBUPROFEN",
            "fr_name": "Ibuprofène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00629359",
      "brand_name": "TEVA-PROFEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62797",
      "number_of_ais": "1",
      "ai_group_no": "0108883003"
    },
    "created_date": "2018-03-13T13:08:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00629359",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AE01",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2018-03-23T00:00:00-04:00",
    "actual_start_date": "2018-03-07T00:00:00-05:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:21:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PROFEN",
    "en_drug_common_name": "PROFEN",
    "fr_drug_brand_name": "TEVA-PROFEN",
    "fr_drug_common_name": "PROFEN",
    "en_ingredients": "IBUPROFEN",
    "fr_ingredients": "Ibuprofène",
    "drug_strength": "600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42601,
    "drug": {
      "id": 14666,
      "drug_code": 74963,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255275,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02264196",
      "brand_name": "TEVA-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332003"
    },
    "created_date": "2018-03-13T13:14:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02264196",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AX08",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-04-15T00:00:00-04:00",
    "actual_start_date": "2018-03-10T00:00:00-05:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:24:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "TEVA-RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "1.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42604,
    "drug": {
      "current_status": "MARKETED",
      "id": 8276,
      "drug_code": 5646,
      "updated_date": "2025-05-15T02:30:34-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250793,
          "ingredient": {
            "id": 1010,
            "ingredient_code": 7408,
            "en_name": "SPIRONOLACTONE",
            "fr_name": "Spironolactone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00613215",
      "brand_name": "TEVA-SPIRONOLACTONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61191",
      "number_of_ais": "1",
      "ai_group_no": "0106462001"
    },
    "created_date": "2018-03-13T13:16:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00613215",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03DA01",
    "atc_description": "POTASSIUM-SPARING AGENTS",
    "estimated_end_date": "2018-04-15T00:00:00-04:00",
    "actual_start_date": "2018-03-07T00:00:00-05:00",
    "actual_end_date": "2018-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:26:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SPIRONOLACTONE",
    "en_drug_common_name": "SPIRONOLACTONE",
    "fr_drug_brand_name": "TEVA-SPIRONOLACTONE",
    "fr_drug_common_name": "SPIRONOLACTONE",
    "en_ingredients": "SPIRONOLACTONE",
    "fr_ingredients": "Spironolactone",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 UD",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42607,
    "drug": {
      "current_status": "MARKETED",
      "id": 17048,
      "drug_code": 78071,
      "updated_date": "2025-05-15T02:31:56-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256014,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295407",
      "brand_name": "TEVA-OMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643003"
    },
    "created_date": "2018-03-13T13:20:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295407",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BC01",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2018-04-20T00:00:00-04:00",
    "actual_start_date": "2018-03-07T00:00:00-05:00",
    "actual_end_date": "2018-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:19:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OMEPRAZOLE",
    "en_drug_common_name": "OMEPRAZOLE",
    "fr_drug_brand_name": "TEVA-OMEPRAZOLE",
    "fr_drug_common_name": "OMEPRAZOLE",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42610,
    "drug": {
      "current_status": "DORMANT",
      "id": 140,
      "drug_code": 10394,
      "updated_date": "2025-05-15T06:55:23-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366572,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00862924",
      "brand_name": "TEVA-DILTIAZEM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70219",
      "number_of_ais": "1",
      "ai_group_no": "0115863001"
    },
    "created_date": "2018-03-13T13:21:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00862924",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08DB01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "actual_start_date": "2018-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:08:17-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "TEVA-DILTIAZEM",
    "en_drug_common_name": "DILTIAZEM",
    "fr_drug_brand_name": "TEVA-DILTIAZEM",
    "fr_drug_common_name": "DILTIAZEM",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 42613,
    "drug": {
      "current_status": "MARKETED",
      "id": 2948,
      "drug_code": 17230,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252195,
          "ingredient": {
            "id": 960,
            "ingredient_code": 1904,
            "en_name": "GEMFIBROZIL",
            "fr_name": "Gemfibrozil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02142074",
      "brand_name": "TEVA-GEMFIBROZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79383",
      "number_of_ais": "1",
      "ai_group_no": "0116135002"
    },
    "created_date": "2018-03-13T13:23:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02142074",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AB04",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_start_date": "2018-03-07T00:00:00-05:00",
    "actual_end_date": "2018-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:14:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-GEMFIBROZIL",
    "en_drug_common_name": "GEMFIBROZIL",
    "fr_drug_brand_name": "TEVA-GEMFIBROZIL",
    "fr_drug_common_name": "GEFIBROZIL",
    "en_ingredients": "GEMFIBROZIL",
    "fr_ingredients": "Gemfibrozil",
    "drug_strength": "600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42616,
    "drug": {
      "current_status": "MARKETED",
      "id": 22218,
      "drug_code": 84624,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257952,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02361183",
      "brand_name": "TEVA-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121003"
    },
    "created_date": "2018-03-13T13:24:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02361183",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_start_date": "2018-03-13T00:00:00-04:00",
    "actual_end_date": "2018-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:21:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "TEVA-PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42619,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19806,
      "drug_code": 81140,
      "updated_date": "2025-05-15T04:14:41-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8347025,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02326051",
      "brand_name": "TEVA-AMITRIPTYLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101524002"
    },
    "created_date": "2018-03-13T13:26:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02326051",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AA09",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-03-29T00:00:00-04:00",
    "actual_start_date": "2018-03-01T00:00:00-05:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T18:56:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-AMITRIPTYLINE",
    "en_drug_common_name": "AMITRIPTYLINE",
    "fr_drug_brand_name": "TEVA-AMITRIPTYLINE",
    "fr_drug_common_name": "AMITRIPTYLINE",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 42622,
    "drug": {
      "current_status": "MARKETED",
      "id": 6838,
      "drug_code": 4522,
      "updated_date": "2025-12-03T00:30:22-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250646,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00535435",
      "brand_name": "TEVA-ECTOSONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57940",
      "number_of_ais": "1",
      "ai_group_no": "0106299001"
    },
    "created_date": "2018-03-13T13:28:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00535435",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AC01",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "actual_start_date": "2018-03-01T00:00:00-05:00",
    "actual_end_date": "2018-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-11T17:20:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RATIO-ECTOSONE REGULAR CREAM 0.1%",
    "en_drug_common_name": "ECTOSONE",
    "fr_drug_brand_name": "RATIO-ECTOSONE REGULAR CREAM 0.1%",
    "fr_drug_common_name": "ECTOSONE",
    "en_ingredients": "BETAMETHASONE",
    "fr_ingredients": "Bétaméthasone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "450G",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 42626,
    "drug": {
      "current_status": "MARKETED",
      "id": 28154,
      "drug_code": 90301,
      "updated_date": "2025-05-15T02:34:11-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260230,
          "ingredient": {
            "id": 3336,
            "ingredient_code": 19840,
            "en_name": "RASAGILINE",
            "fr_name": "Rasagiline (Mésylate de rasagiline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02418444",
      "brand_name": "TEVA-RASAGILINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151662002"
    },
    "created_date": "2018-03-13T13:30:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02418444",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N04BD02",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2018-05-30T00:00:00-04:00",
    "actual_start_date": "2018-03-13T00:00:00-04:00",
    "actual_end_date": "2018-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-31T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-RASAGILINE",
    "en_drug_common_name": "RASAGILINE",
    "fr_drug_brand_name": "TEVA-RASAGILINE",
    "fr_drug_common_name": "RASAGILINE",
    "en_ingredients": "RASAGILINE",
    "fr_ingredients": "Rasagiline",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42629,
    "drug": {
      "current_status": "MARKETED",
      "id": 20804,
      "drug_code": 82619,
      "updated_date": "2025-05-15T02:32:34-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257359,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02340615",
      "brand_name": "TEVA-DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548002"
    },
    "created_date": "2018-03-13T13:31:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02340615",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06DA02",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2018-05-20T00:00:00-04:00",
    "actual_start_date": "2018-03-07T00:00:00-05:00",
    "actual_end_date": "2018-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:08:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DONEPEZIL",
    "en_drug_common_name": "DONEPEZIL",
    "fr_drug_brand_name": "TEVA-DONEPEZIL",
    "fr_drug_common_name": "DONEPEZIL",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42632,
    "drug": {
      "current_status": "MARKETED",
      "id": 10774,
      "drug_code": 66536,
      "updated_date": "2025-05-15T02:31:12-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254074,
          "ingredient": {
            "id": 608,
            "ingredient_code": 11258,
            "en_name": "DOXAZOSIN",
            "fr_name": "Doxazosine (Mésylate de doxazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02242729",
      "brand_name": "TEVA-DOXAZOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131431003"
    },
    "created_date": "2018-03-13T13:32:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242729",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C02CA04",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_start_date": "2018-03-13T00:00:00-04:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:09:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DOXAZOSIN",
    "en_drug_common_name": "DOXAZOSIN",
    "fr_drug_brand_name": "TEVA-DOXAZOSIN",
    "fr_drug_common_name": "DOXAZOSIN",
    "en_ingredients": "DOXAZOSIN",
    "fr_ingredients": "Doxazosin",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42635,
    "drug": {
      "current_status": "MARKETED",
      "id": 10776,
      "drug_code": 66537,
      "updated_date": "2025-05-15T02:31:12-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254075,
          "ingredient": {
            "id": 608,
            "ingredient_code": 11258,
            "en_name": "DOXAZOSIN",
            "fr_name": "Doxazosine (Mésylate de doxazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242730",
      "brand_name": "TEVA-DOXAZOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131431002"
    },
    "created_date": "2018-03-13T13:33:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242730",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C02CA04",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_start_date": "2018-03-13T00:00:00-04:00",
    "actual_end_date": "2018-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:10:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DOXAZOSIN",
    "en_drug_common_name": "DOXAZOSIN",
    "fr_drug_brand_name": "TEVA-DOXAZOSIN",
    "fr_drug_common_name": "DOXAZOSIN",
    "en_ingredients": "DOXAZOSIN",
    "fr_ingredients": "Doxazosin",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42638,
    "drug": {
      "current_status": "MARKETED",
      "id": 27026,
      "drug_code": 89271,
      "updated_date": "2025-05-15T02:33:59-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259730,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02408015",
      "brand_name": "FENTORA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302017"
    },
    "created_date": "2018-03-13T13:37:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02408015",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AB03",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2018-06-08T00:00:00-04:00",
    "actual_start_date": "2018-03-01T00:00:00-05:00",
    "actual_end_date": "2018-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-30T19:09:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FENTORA",
    "en_drug_common_name": "FENTANYL",
    "fr_drug_brand_name": "FENTORA",
    "fr_drug_common_name": "FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "200MCG",
    "drug_dosage_form": "TABLET (EFFERVESCENT)",
    "drug_dosage_form_fr": "Comprimé (effervescent)",
    "drug_route": "BUCCAL\r\nSUBLINGUAL",
    "drug_route_fr": "Buccale\r\nSublinguale",
    "drug_package_quantity": "28",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 42644,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9588,
      "drug_code": 6322,
      "updated_date": "2025-05-15T03:29:44-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8280186,
          "ingredient": {
            "id": 102,
            "ingredient_code": 2609,
            "en_name": "IBUPROFEN",
            "fr_name": "Ibuprofène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00629340",
      "brand_name": "NOVO-PROFEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62796",
      "number_of_ais": "1",
      "ai_group_no": "0108883002"
    },
    "created_date": "2018-03-13T13:43:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00629340",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AE01",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2018-03-30T00:00:00-04:00",
    "actual_start_date": "2018-03-07T00:00:00-05:00",
    "actual_end_date": "2018-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T18:46:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NOVO-PROFEN",
    "en_drug_common_name": "PROFEN",
    "fr_drug_brand_name": "TEVA-PROFEN",
    "fr_drug_common_name": "PROFEN",
    "en_ingredients": "IBUPROFEN",
    "fr_ingredients": "Ibuprofène",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42651,
    "drug": {
      "current_status": "MARKETED",
      "id": 4692,
      "drug_code": 2447,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250414,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00337749",
      "brand_name": "TEVA-FUROSEMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "49660",
      "number_of_ais": "1",
      "ai_group_no": "0101944001"
    },
    "created_date": "2018-03-13T13:48:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00337749",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03CA01",
    "atc_description": "HIGH-CEILING DIURETICS",
    "estimated_end_date": "2018-03-30T00:00:00-04:00",
    "actual_start_date": "2018-03-13T00:00:00-04:00",
    "actual_end_date": "2018-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:12:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FUROSEMIDE",
    "en_drug_common_name": "FUROSEMIDE",
    "fr_drug_brand_name": "TEVA-FUROSEMIDE",
    "fr_drug_common_name": "FUROSEMIDE",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42658,
    "drug": {
      "current_status": "MARKETED",
      "id": 9880,
      "drug_code": 64051,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253775,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240481",
      "brand_name": "TEVA-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417002"
    },
    "created_date": "2018-03-13T13:49:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240481",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AB06",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-04-15T00:00:00-04:00",
    "actual_start_date": "2018-03-13T00:00:00-04:00",
    "actual_end_date": "2018-04-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:26:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "TEVA-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42669,
    "drug": {
      "current_status": "MARKETED",
      "id": 15346,
      "drug_code": 75886,
      "updated_date": "2025-05-15T02:31:42-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255493,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02273373",
      "brand_name": "APO-AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131437002"
    },
    "created_date": "2018-03-13T14:19:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02273373",
    "company_name": "APOTEX INC",
    "atc_number": "C08CA01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "estimated_end_date": "2018-05-31T00:00:00-04:00",
    "actual_start_date": "2018-03-12T00:00:00-04:00",
    "actual_end_date": "2018-04-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-19T13:28:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMLODIPINE",
    "en_drug_common_name": "AMLODIPINE",
    "fr_drug_brand_name": "APO-AMLODIPINE",
    "fr_drug_common_name": "AMLODIPINE",
    "en_ingredients": "AMLODIPINE",
    "fr_ingredients": "AMLODIPINE",
    "drug_strength": "5.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42672,
    "drug": {
      "current_status": "MARKETED",
      "id": 19102,
      "drug_code": 80357,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256692,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02318067",
      "brand_name": "APO-ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434005"
    },
    "created_date": "2018-03-13T14:22:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02318067",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA09",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2018-07-13T00:00:00-04:00",
    "actual_start_date": "2018-03-05T00:00:00-05:00",
    "actual_end_date": "2018-07-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-18T14:13:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "APO-ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 42675,
    "drug": {
      "current_status": "DORMANT",
      "id": 16704,
      "drug_code": 77651,
      "updated_date": "2025-05-15T06:55:35-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368041,
          "ingredient": {
            "id": 958,
            "ingredient_code": 951,
            "en_name": "CILAZAPRIL",
            "fr_name": "Cilazapril (Monohydrate de Cilazapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02291134",
      "brand_name": "APO-CILAZAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122806001"
    },
    "created_date": "2018-03-13T14:24:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02291134",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA08",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2018-05-31T00:00:00-04:00",
    "actual_start_date": "2018-03-12T00:00:00-04:00",
    "actual_end_date": "2018-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-24T01:16:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CILAZAPRIL",
    "en_drug_common_name": "CILAZAPRIL",
    "fr_drug_brand_name": "APO-CILAZAPRIL",
    "fr_drug_common_name": "CILAZAPRIL",
    "en_ingredients": "CILAZAPRIL",
    "fr_ingredients": "Cilazapril",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42681,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11784,
      "drug_code": 69248,
      "updated_date": "2025-12-03T01:20:43-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8335903,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245233",
      "brand_name": "APO-CLINDAMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830003"
    },
    "created_date": "2018-03-13T14:37:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245233",
    "company_name": "APOTEX INC",
    "atc_number": "J01FF01",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2018-06-08T00:00:00-04:00",
    "actual_start_date": "2018-03-12T00:00:00-04:00",
    "actual_end_date": "2018-05-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-12T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CLINDAMYCIN",
    "en_drug_common_name": "CLINDAMYCIN",
    "fr_drug_brand_name": "APO-CLINDAMYCIN",
    "fr_drug_common_name": "CLINDAMYCIN",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "CLINDAMYCIN",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42686,
    "drug": {
      "current_status": "MARKETED",
      "id": 6608,
      "drug_code": 43813,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253111,
          "ingredient": {
            "id": 824,
            "ingredient_code": 1840,
            "en_name": "DOMPERIDONE",
            "fr_name": "Dompéridone (Maléate de dompéridone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02103613",
      "brand_name": "APO-DOMPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "S9806",
      "number_of_ais": "1",
      "ai_group_no": "0116957001"
    },
    "created_date": "2018-03-13T14:42:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02103613",
    "company_name": "APOTEX INC",
    "atc_number": "A03FA03",
    "atc_description": "PROPULSIVES",
    "estimated_end_date": "2018-05-04T00:00:00-04:00",
    "actual_start_date": "2018-03-12T00:00:00-04:00",
    "actual_end_date": "2018-04-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-16T22:37:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DOMPERIDONE - TAB 10MG",
    "en_drug_common_name": "DOMPERIDONE",
    "fr_drug_brand_name": "APO-DOMPERIDONE - TAB 10MG",
    "fr_drug_common_name": "DOMPERIDONE",
    "en_ingredients": "DOMPERIDONE",
    "fr_ingredients": "DOMPERIDONE",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42691,
    "drug": {
      "current_status": "MARKETED",
      "id": 4132,
      "drug_code": 19961,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252586,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216361",
      "brand_name": "APO-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82260",
      "number_of_ais": "1",
      "ai_group_no": "0116847001"
    },
    "created_date": "2018-03-13T14:48:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02216361",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB03",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-05-16T00:00:00-04:00",
    "actual_start_date": "2018-03-12T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FLUOXETINE",
    "en_drug_common_name": "FLUOXETINE",
    "fr_drug_brand_name": "APO-FLUOXETINE",
    "fr_drug_common_name": "FLUOXETINE",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "FLUOXETINE",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42694,
    "drug": {
      "current_status": "MARKETED",
      "id": 8456,
      "drug_code": 5917,
      "updated_date": "2025-05-15T02:30:35-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250847,
          "ingredient": {
            "id": 102,
            "ingredient_code": 2609,
            "en_name": "IBUPROFEN",
            "fr_name": "Ibuprofène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00585114",
      "brand_name": "APO-IBUPROFEN TAB 600MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61771",
      "number_of_ais": "1",
      "ai_group_no": "0108883003"
    },
    "created_date": "2018-03-13T14:53:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00585114",
    "company_name": "APOTEX INC",
    "atc_number": "M01AE01",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2018-06-08T00:00:00-04:00",
    "actual_start_date": "2018-03-12T00:00:00-04:00",
    "actual_end_date": "2018-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-09T12:08:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO IBUPROFEN TAB 600MG",
    "en_drug_common_name": "IBUPROFEN",
    "fr_drug_brand_name": "APO IBUPROFEN TAB 600MG",
    "fr_drug_common_name": "IBUPROFEN",
    "en_ingredients": "IBUPROFEN",
    "fr_ingredients": "Ibuprofène",
    "drug_strength": "600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42697,
    "drug": {
      "current_status": "MARKETED",
      "id": 16536,
      "drug_code": 77363,
      "updated_date": "2025-05-15T02:31:51-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255879,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02288192",
      "brand_name": "APO-ONDANSETRON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131120001"
    },
    "created_date": "2018-03-13T14:58:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02288192",
    "company_name": "APOTEX INC",
    "atc_number": "A04AA01",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "estimated_end_date": "2018-10-01T00:00:00-04:00",
    "actual_start_date": "2018-03-12T00:00:00-04:00",
    "actual_end_date": "2018-09-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-29T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ONDANSETRON",
    "en_drug_common_name": "ONDANSETRON",
    "fr_drug_brand_name": "APO-ONDANSETRON",
    "fr_drug_common_name": "ONDANSETRON",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "10 BLS & 30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42700,
    "drug": {
      "current_status": "MARKETED",
      "id": 312,
      "drug_code": 10830,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251402,
          "ingredient": {
            "id": 236,
            "ingredient_code": 11108,
            "en_name": "PRAZOSIN",
            "fr_name": "Prazosine (Chlorhydrate de prazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00882836",
      "brand_name": "APO-PRAZO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70923",
      "number_of_ais": "1",
      "ai_group_no": "0111527003"
    },
    "created_date": "2018-03-13T15:09:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00882836",
    "company_name": "APOTEX INC",
    "atc_number": "C02CA01",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "estimated_end_date": "2018-07-09T00:00:00-04:00",
    "actual_start_date": "2018-03-12T00:00:00-04:00",
    "actual_end_date": "2018-06-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-12T12:57:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRAZO TAB 5MG",
    "en_drug_common_name": "PRAZOSIN",
    "fr_drug_brand_name": "APO-PRAZO TAB 5MG",
    "fr_drug_common_name": "PRAZOSIN",
    "en_ingredients": "PRAZOSIN",
    "fr_ingredients": "PRAZOSIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42705,
    "drug": {
      "current_status": "MARKETED",
      "id": 13136,
      "drug_code": 72539,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254780,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02248203",
      "brand_name": "APO-SILDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261003"
    },
    "created_date": "2018-03-13T15:13:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248203",
    "company_name": "APOTEX INC",
    "atc_number": "G04BE03",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2018-07-31T00:00:00-04:00",
    "actual_start_date": "2018-03-12T00:00:00-04:00",
    "actual_end_date": "2018-06-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-03T10:34:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SILDENAFIL",
    "en_drug_common_name": "SILDENAFIL",
    "fr_drug_brand_name": "APO-SILDENAFIL",
    "fr_drug_common_name": "SILDENAFIL",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "SILDENAFIL",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42708,
    "drug": {
      "current_status": "MARKETED",
      "id": 3152,
      "drug_code": 18040,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252242,
          "ingredient": {
            "id": 946,
            "ingredient_code": 1939,
            "en_name": "TRAZODONE HYDROCHLORIDE",
            "fr_name": "Chlohydrate de trazodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02147653",
      "brand_name": "APO-TRAZODONE D TABLETS 150MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80254",
      "number_of_ais": "1",
      "ai_group_no": "0115713003"
    },
    "created_date": "2018-03-13T15:14:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02147653",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX05",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-12-21T00:00:00-05:00",
    "actual_start_date": "2018-03-12T00:00:00-04:00",
    "actual_end_date": "2018-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-12-18T23:22:25-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TRAZODONE D TABLETS 150MG",
    "en_drug_common_name": "TRAZODONE",
    "fr_drug_brand_name": "APO-TRAZODONE D TABLETS 150MG",
    "fr_drug_common_name": "TRAZODONE",
    "en_ingredients": "TRAZODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlohydrate de trazodone",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42711,
    "drug": {
      "current_status": "MARKETED",
      "id": 30154,
      "drug_code": 92202,
      "updated_date": "2025-05-15T02:34:41-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261013,
          "ingredient": {
            "id": 502,
            "ingredient_code": 7588,
            "en_name": "TRIAMCINOLONE ACETONIDE",
            "fr_name": "Acétonide  de triamcinolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "55",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02437635",
      "brand_name": "APO-TRIAMCINOLONE AQ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106310010"
    },
    "created_date": "2018-03-13T15:16:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02437635",
    "company_name": "APOTEX INC",
    "atc_number": "R01AD11",
    "atc_description": "DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",
    "actual_start_date": "2018-03-12T00:00:00-04:00",
    "actual_end_date": "2018-11-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-11-09T15:27:09-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TRIAMCINOLONE AQ",
    "en_drug_common_name": "TRIAMCINOLONE",
    "fr_drug_brand_name": "APO-TRIAMCINOLONE AQ",
    "fr_drug_common_name": "TRIAMCINOLONE",
    "en_ingredients": "TRIAMCINOLONE ACETONIDE",
    "fr_ingredients": "Acétonide  de triamcinolone",
    "drug_strength": "55MCG",
    "drug_dosage_form": "SPRAY, METERED DOSE",
    "drug_dosage_form_fr": "Pulvérisation, à dose mesurée",
    "drug_route": "NASAL",
    "drug_route_fr": "Nasale",
    "drug_package_quantity": "120 MS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42714,
    "drug": {
      "current_status": "MARKETED",
      "id": 32210,
      "drug_code": 9940,
      "updated_date": "2025-12-03T00:30:29-05:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251250,
          "ingredient": {
            "id": 38,
            "ingredient_code": 10110,
            "en_name": "VERAPAMIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de vérapamil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00782491",
      "brand_name": "AA-VERAP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69445",
      "number_of_ais": "1",
      "ai_group_no": "0113846001"
    },
    "created_date": "2018-03-13T15:17:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00782491",
    "company_name": "APOTEX INC",
    "atc_number": "C08DA01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "actual_start_date": "2018-03-12T00:00:00-04:00",
    "actual_end_date": "2018-07-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-12T13:16:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-VERAP TABLET 120MG",
    "en_drug_common_name": "VERAPAMIL",
    "fr_drug_brand_name": "APO-VERAP TABLET 120MG",
    "fr_drug_common_name": "VERAPAMIL",
    "en_ingredients": "VERAPAMIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de vérapamil",
    "drug_strength": "120MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42717,
    "drug": {
      "current_status": "MARKETED",
      "id": 51287,
      "drug_code": 94919,
      "updated_date": "2025-05-15T02:35:45-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262353,
          "ingredient": {
            "id": 3356,
            "ingredient_code": 20022,
            "en_name": "DEFERASIROX",
            "fr_name": "Déférasirox"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461552",
      "brand_name": "APO-DEFERASIROX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151733002"
    },
    "created_date": "2018-03-13T15:18:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461552",
    "company_name": "APOTEX INC",
    "atc_number": "V03AC03",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2018-07-05T00:00:00-04:00",
    "actual_start_date": "2018-03-12T00:00:00-04:00",
    "actual_end_date": "2018-06-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-03T10:46:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DEFERASIROX",
    "en_drug_common_name": "DEFERASIROX",
    "fr_drug_brand_name": "APO-DEFERASIROX",
    "fr_drug_common_name": "DEFERASIROX",
    "en_ingredients": "DEFERASIROX",
    "fr_ingredients": "Déférasirox",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET FOR SUSPENSION",
    "drug_dosage_form_fr": "Comprimé pour suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42738,
    "drug": {
      "current_status": "MARKETED",
      "id": 29848,
      "drug_code": 91888,
      "updated_date": "2025-05-15T02:34:35-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8260822,
          "ingredient": {
            "id": 3162,
            "ingredient_code": 13352,
            "en_name": "CINACALCET",
            "fr_name": "Cinacalcet (Chlorhydrate de cinacalcet)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "90",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02434555",
      "brand_name": "MYLAN-CINACALCET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150282003"
    },
    "created_date": "2018-03-13T15:54:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02434555",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "H05BX01",
    "atc_description": "ANTI-PARATHYROID HORMONES",
    "anticipated_start_date": "2018-04-05T00:00:00-04:00",
    "estimated_end_date": "2018-12-07T00:00:00-05:00",
    "actual_start_date": "2018-04-06T00:00:00-04:00",
    "actual_end_date": "2018-12-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-12-06T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-CINACALCET",
    "en_drug_common_name": "CINACALCET",
    "fr_drug_brand_name": "Mylan-Cinacalcet",
    "fr_drug_common_name": "Cinacalcet",
    "en_ingredients": "CINACALCET",
    "fr_ingredients": "Cinacalcet",
    "drug_strength": "90MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42756,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22230,
      "drug_code": 84644,
      "updated_date": "2025-05-15T04:17:50-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8349749,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8349748,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02361361",
      "brand_name": "OXYCODONE/ACET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0215596001"
    },
    "created_date": "2018-03-13T17:53:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02361361",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N02AJ17",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2018-03-16T00:00:00-04:00",
    "estimated_end_date": "2018-05-11T00:00:00-04:00",
    "actual_start_date": "2018-03-13T00:00:00-04:00",
    "actual_end_date": "2018-05-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-05-03T05:00:09-04:00",
    "status": "resolved",
    "en_comments": "Delay in release of replenishment batch",
    "fr_comments": "Retard dans la libération du lot de réapprovisionnement",
    "en_drug_brand_name": "OXYCODONE/ACET",
    "en_drug_common_name": "OXYCODONE/ACET TAB",
    "fr_drug_brand_name": "OXYCODONE/ACET",
    "fr_drug_common_name": "OXYCODONE/ACET COMPRIMES",
    "en_ingredients": "ACETAMINOPHEN\r\nOXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Acétaminophène\r\nChlorhydrate d'oxycodone",
    "drug_strength": "325MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42769,
    "drug": {
      "current_status": "MARKETED",
      "id": 23126,
      "drug_code": 85701,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258354,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02371898",
      "brand_name": "MAR-CITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243001"
    },
    "created_date": "2018-03-13T18:01:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02371898",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06AB04",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2018-03-13T00:00:00-04:00",
    "estimated_end_date": "2018-08-15T00:00:00-04:00",
    "actual_start_date": "2018-03-13T00:00:00-04:00",
    "actual_end_date": "2018-04-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-04-03T05:00:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-CITALOPRAM",
    "en_drug_common_name": "Mar-Citalopram",
    "fr_drug_brand_name": "MAR-CITALOPRAM",
    "fr_drug_common_name": "MAR-Citalopram",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "Citalopram",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42773,
    "drug": {
      "current_status": "MARKETED",
      "id": 19092,
      "drug_code": 80351,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8256687,
          "ingredient": {
            "id": 3280,
            "ingredient_code": 12477,
            "en_name": "TRAVOPROST",
            "fr_name": "Travoprost"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.004",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02318008",
      "brand_name": "TRAVATAN Z",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145801001"
    },
    "created_date": "2018-03-13T19:34:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02318008",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01EE04",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2018-04-24T00:00:00-04:00",
    "actual_start_date": "2018-03-19T00:00:00-04:00",
    "actual_end_date": "2018-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-04-25T21:31:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TRAVATAN Z",
    "en_drug_common_name": "TRAVATAN Z SOLUTION 5ML",
    "fr_drug_brand_name": "TRAVATAN Z",
    "fr_drug_common_name": "TRAVATAN Z SOLUTION 5ML",
    "en_ingredients": "TRAVOPROST",
    "fr_ingredients": "Travoprost",
    "drug_strength": "0.004%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42825,
    "drug": {
      "current_status": "MARKETED",
      "id": 3454,
      "drug_code": 18742,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252365,
          "ingredient": {
            "id": 1132,
            "ingredient_code": 4179,
            "en_name": "CYCLOPENTOLATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de cyclopentolate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02148382",
      "brand_name": "MINIMS CYCLOPENTOLATE HYDROCHLORIDE",
      "brand_name_fr": "MINIMS CHLORHYDRATE DE CYCLOPENTOLATE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81016",
      "number_of_ais": "1",
      "ai_group_no": "0108675001"
    },
    "created_date": "2018-03-14T12:30:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148382",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "S01FA04",
    "atc_description": "MYDRIATICSAND CYCLOPLEGICS",
    "actual_start_date": "2018-02-14T00:00:00-05:00",
    "actual_end_date": "2018-03-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-03-14T12:30:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINIMS CYCLOPENTOLATE HYDROCHLORIDE 1%",
    "en_drug_common_name": "MINIMS CYCLOPENTOLATE HYDROCHLORIDE 1%",
    "fr_drug_brand_name": "CYCLOPENTOLATE",
    "fr_drug_common_name": "CYCLOPENTOLATE",
    "en_ingredients": "CYCLOPENTOLATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de cyclopentolate",
    "drug_strength": "1%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "NA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 42830,
    "drug": {
      "current_status": "MARKETED",
      "id": 3476,
      "drug_code": 18759,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252376,
          "ingredient": {
            "id": 78,
            "ingredient_code": 10258,
            "en_name": "PHENYLEPHRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de phényléphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02148455",
      "brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
      "brand_name_fr": "MINIMS CHLORHYDRATE DE PHÉNYLÉPHRINE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81033",
      "number_of_ais": "1",
      "ai_group_no": "0100662005"
    },
    "created_date": "2018-03-14T12:31:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148455",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "S01FB01",
    "atc_description": "MYDRIATICSAND CYCLOPLEGICS",
    "actual_start_date": "2018-03-02T00:00:00-05:00",
    "actual_end_date": "2018-03-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-03-17T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE 10%",
    "en_drug_common_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE 10%",
    "fr_drug_brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE 10%",
    "fr_drug_common_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE 10%",
    "en_ingredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de phényléphrine",
    "drug_strength": "10%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "NA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 42850,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 182,
      "drug_code": 10488,
      "updated_date": "2025-05-15T03:37:09-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8286773,
          "ingredient": {
            "id": 146,
            "ingredient_code": 8007,
            "en_name": "FLUPHENAZINE DECANOATE",
            "fr_name": "Décanoate de fluphénazine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00755575",
      "brand_name": "MODECATE CONCENTRATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70394",
      "number_of_ais": "1",
      "ai_group_no": "0110769002"
    },
    "created_date": "2018-03-14T14:50:30-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00755575",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "N05AB02",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2018-12-28T00:00:00-05:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Stock will be available until Dec. 31st, 2018.",
    "fr_supply_disruption_mitigation": "Le produit sera disponible jusqu’au 31 déc. 2018.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-01-02T19:46:10-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MODECATE CONCENTRATE",
    "en_drug_common_name": "Fluphenazine Decanoate",
    "fr_drug_brand_name": "MODECATE CONCENTRÉ",
    "fr_drug_common_name": "Décanoate de fluphénazine",
    "en_ingredients": "FLUPHENAZINE DECANOATE",
    "fr_ingredients": "Décanoate de fluphénazine",
    "drug_strength": "100MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAMUSCULAR\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nSous-cutanée",
    "drug_package_quantity": "5 amp x 1 ml",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42860,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1264,
      "drug_code": 12818,
      "updated_date": "2025-05-15T03:39:03-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8290530,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01918311",
      "brand_name": "COUMADIN TAB 1MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74038",
      "number_of_ais": "1",
      "ai_group_no": "0104597002"
    },
    "created_date": "2018-03-14T16:17:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01918311",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "B01AA03",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2018-05-31T00:00:00-04:00",
    "estimated_end_date": "2018-06-08T00:00:00-04:00",
    "actual_start_date": "2018-06-04T00:00:00-04:00",
    "actual_end_date": "2018-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-06-09T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Due to delays in supply and increased demand we will be allocating orders until the new lot arrives.",
    "fr_comments": "Les stocks seront alloué pour éviter un rupture de stocks.",
    "en_drug_brand_name": "COUMADIN TAB 1MG",
    "en_drug_common_name": "Warfarin",
    "fr_drug_brand_name": "Coumadin 1mg",
    "fr_drug_common_name": "Warfarine",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 BTL x 100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42873,
    "drug": {
      "current_status": "MARKETED",
      "id": 28684,
      "drug_code": 90814,
      "updated_date": "2025-05-15T02:34:17-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8260408,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02423413",
      "brand_name": "MYLAN-RIVASTIGMINE PATCH 5",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521007"
    },
    "created_date": "2018-03-14T16:47:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423413",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06DA03",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2018-04-02T00:00:00-04:00",
    "estimated_end_date": "2018-04-10T00:00:00-04:00",
    "actual_start_date": "2018-04-02T00:00:00-04:00",
    "actual_end_date": "2018-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-04-05T11:55:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-RIVASTIGMINE PATCH 5",
    "en_drug_common_name": "RIVASTIGMINE",
    "fr_drug_brand_name": "MYLAN-RIVASTIGMINE PATCH 5",
    "fr_drug_common_name": "RIVASTIGMINE",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine",
    "drug_strength": "9MG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "30 Patches",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42913,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27842,
      "drug_code": 90044,
      "updated_date": "2025-05-15T04:21:52-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8353938,
          "ingredient": {
            "id": 2632,
            "ingredient_code": 11811,
            "en_name": "RALOXIFENE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de raloxifène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415852",
      "brand_name": "RALOXIFENE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151607001"
    },
    "created_date": "2018-03-14T19:18:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02415852",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "G03XC01",
    "atc_description": "OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM",
    "actual_start_date": "2018-03-14T00:00:00-04:00",
    "actual_end_date": "2018-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-05-31T05:00:06-04:00",
    "status": "resolved",
    "en_comments": "Discontinued as of April 26, 2018",
    "fr_comments": "Discontinué depuis le 26 avril 2018",
    "en_drug_brand_name": "RALOXIFENE",
    "en_drug_common_name": "RALOXIFENE",
    "fr_drug_brand_name": "RALOXIFENE",
    "fr_drug_common_name": "RALOXIFENE",
    "en_ingredients": "RALOXIFENE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de raloxifène",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30-100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42916,
    "drug": {
      "current_status": "MARKETED",
      "id": 1710,
      "drug_code": 13686,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251798,
          "ingredient": {
            "id": 268,
            "ingredient_code": 2072,
            "en_name": "ALPRAZOLAM",
            "fr_name": "Alprazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00813958",
      "brand_name": "XANAX TS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75123",
      "number_of_ais": "1",
      "ai_group_no": "0115008004"
    },
    "created_date": "2018-03-14T19:19:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00813958",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "N05BA12",
    "atc_description": "ANXIOLYTICS",
    "actual_start_date": "2018-04-20T00:00:00-04:00",
    "actual_end_date": "2018-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-01T14:16:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "XANAX TS",
    "en_drug_common_name": "Xanax",
    "fr_drug_brand_name": "XANAX TS",
    "fr_drug_common_name": "Xanax",
    "en_ingredients": "ALPRAZOLAM",
    "fr_ingredients": "Alprazolam",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42938,
    "drug": {
      "current_status": "MARKETED",
      "id": 19252,
      "drug_code": 80509,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8256732,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256731,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02319624",
      "brand_name": "OLMETEC PLUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252502002"
    },
    "created_date": "2018-03-14T20:20:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02319624",
    "company_name": "MERCK CANADA INC",
    "atc_number": "C09DA08",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2018-03-16T00:00:00-04:00",
    "estimated_end_date": "2018-05-04T00:00:00-04:00",
    "actual_start_date": "2018-03-15T00:00:00-04:00",
    "actual_end_date": "2018-05-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-05-04T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "Reason for shortage: shortage of other manufactures.",
    "fr_comments": "Raison: Pénurie d'autres fabricants",
    "en_drug_brand_name": "OLMETEC PLUS",
    "en_drug_common_name": "Olmesartan medoxomil and hydrochlorothiazide tablets",
    "fr_drug_brand_name": "OLMETEC PLUS",
    "fr_drug_common_name": "comprimés d'olmésartan médoxomil et hydrochlorothiazide",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nOLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "12.5MG\r\n40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42990,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 936,
      "drug_code": 12216,
      "updated_date": "2025-05-15T03:38:40-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8289474,
          "ingredient": {
            "id": 562,
            "ingredient_code": 6044,
            "en_name": "PHENYLTOLOXAMINE",
            "fr_name": "Phényltoloxamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8289473,
          "ingredient": {
            "id": 560,
            "ingredient_code": 20386,
            "en_name": "HYDROCODONE",
            "fr_name": "Hydrocodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01916971",
      "brand_name": "TUSSIONEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73264",
      "number_of_ais": "2",
      "ai_group_no": "0252486002"
    },
    "created_date": "2018-03-15T15:28:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01916971",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "R05DA20",
    "atc_description": "COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS",
    "anticipated_start_date": "2018-05-01T00:00:00-04:00",
    "estimated_end_date": "2018-08-15T00:00:00-04:00",
    "actual_start_date": "2018-05-01T00:00:00-04:00",
    "actual_end_date": "2018-07-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-07-26T12:47:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TUSSIONEX",
    "en_drug_common_name": "Tussionex Suspension",
    "fr_drug_brand_name": "Tusssionex",
    "fr_drug_common_name": "Tussionex Suspension",
    "en_ingredients": "HYDROCODONE\r\nPHENYLTOLOXAMINE",
    "fr_ingredients": "Hydrocodone\r\nPhényltoloxamine",
    "drug_strength": "5MG\r\n10MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 42995,
    "drug": {
      "current_status": "MARKETED",
      "id": 49646,
      "drug_code": 92881,
      "updated_date": "2025-12-03T00:32:52-05:00",
      "company": {
        "id": 1964,
        "created_date": "2017-03-09T20:00:09-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 16391,
        "mfr_code": "",
        "name": "LINEPHARMA INTERNATIONAL LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16 UPPER WOBURN PLACE",
        "province": "GREATER LONDON",
        "country": "UNITED KINGDOM",
        "city": "LONDON",
        "postal_code": "WC1H0BS",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261359,
          "ingredient": {
            "id": 930,
            "ingredient_code": 1859,
            "en_name": "MISOPROSTOL",
            "fr_name": "Misoprostol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261358,
          "ingredient": {
            "id": 6186,
            "ingredient_code": 22628,
            "en_name": "MIFEPRISTONE",
            "fr_name": "MIFÉPRISTONE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02444038",
      "brand_name": "MIFEGYMISO",
      "brand_name_fr": "MIFÉGYMISO",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0257170001"
    },
    "created_date": "2018-03-15T15:39:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02444038",
    "company_name": "LINEPHARMA INTERNATIONAL LIMITED",
    "atc_number": "G03XB51",
    "atc_description": "OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM",
    "anticipated_start_date": "2018-03-12T00:00:00-04:00",
    "estimated_end_date": "2018-03-28T00:00:00-04:00",
    "actual_start_date": "2018-03-12T00:00:00-04:00",
    "actual_end_date": "2018-04-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-04-03T15:44:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIFEGYMISO",
    "en_drug_common_name": "Mifepristone / Misoprostol",
    "fr_drug_brand_name": "MIFEGYMISO",
    "fr_drug_common_name": "Mifepristone / Misoprostol",
    "en_ingredients": "MISOPROSTOL\r\nMIFEPRISTONE",
    "fr_ingredients": "Mifepristone\r\nMisoprostol",
    "drug_strength": "200MCG\r\n200MG",
    "drug_dosage_form": "KIT\r\nTABLET",
    "drug_dosage_form_fr": "Trousse\r\nComprimé",
    "drug_route": "BUCCAL\r\nORAL",
    "drug_route_fr": "Buccale\r\nOrale",
    "drug_package_quantity": "Combipack (1 box of 1 tablet of mifepristone + 1 box of 4 tablets of misoprostol)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43037,
    "drug": {
      "current_status": "MARKETED",
      "id": 6170,
      "drug_code": 42910,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253002,
          "ingredient": {
            "id": 2112,
            "ingredient_code": 20260,
            "en_name": "ESMOLOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'esmolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02188880",
      "brand_name": "BREVIBLOC INJECTION 10MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9097",
      "number_of_ais": "1",
      "ai_group_no": "0123418003"
    },
    "created_date": "2018-03-15T20:05:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02188880",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "C07AB09",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2018-03-09T00:00:00-05:00",
    "estimated_end_date": "2018-05-09T00:00:00-04:00",
    "actual_start_date": "2018-03-27T00:00:00-04:00",
    "actual_end_date": "2018-05-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-16T17:27:19-04:00",
    "status": "resolved",
    "en_comments": "For further questions regarding this product, please contact Baxter Customer Service at 1-888-719-9955 or Medical Information at 1-855-584-1368.",
    "fr_comments": "Pour toute autre questions concernant ce produit, veuillez contacter le service à la clientèle de Baxter au 1-888-719-9955 ou l'information médicale au 1-855-584-1368.",
    "en_drug_brand_name": "BREVIBLOC INJECTION 10MG/ML",
    "en_drug_common_name": "Brevibloc Injection",
    "fr_drug_brand_name": "Brevibloc Injection",
    "fr_drug_common_name": "Brevibloc Injection",
    "en_ingredients": "ESMOLOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'esmolol",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10mL vials",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43053,
    "drug": {
      "current_status": "MARKETED",
      "id": 30290,
      "drug_code": 92351,
      "updated_date": "2025-12-03T00:32:46-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261063,
          "ingredient": {
            "id": 4068,
            "ingredient_code": 22591,
            "en_name": "BROMFENAC",
            "fr_name": "Bromfénac (Bromfénac sodique sesquihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.07",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02439123",
      "brand_name": "PROLENSA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0156750001"
    },
    "created_date": "2018-03-16T12:59:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439123",
    "company_name": "BAUSCH & LOMB INC",
    "atc_number": "S01BC11",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "actual_start_date": "2018-05-10T00:00:00-04:00",
    "actual_end_date": "2018-06-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-06-20T17:48:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PROLENSA",
    "en_drug_common_name": "PROLENSA",
    "fr_drug_brand_name": "PROLENSA",
    "fr_drug_common_name": "PROLENSA",
    "en_ingredients": "Bromfenac",
    "fr_ingredients": "Bromfenac sodium  sesquihydrate",
    "drug_strength": "0.07%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "3ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43056,
    "drug": {
      "current_status": "MARKETED",
      "id": 6774,
      "drug_code": 44257,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8253176,
          "ingredient": {
            "id": 202,
            "ingredient_code": 7358,
            "en_name": "CHORIONIC GONADOTROPIN",
            "fr_name": "Ganodotrophine chorionique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02182904",
      "brand_name": "PREGNYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9981",
      "number_of_ais": "1",
      "ai_group_no": "0106481003"
    },
    "created_date": "2018-03-16T13:28:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02182904",
    "company_name": "MERCK CANADA INC",
    "atc_number": "G03GA01",
    "atc_description": "GONADOTROPHINS AND OTHER OVULATION STIMULANTS",
    "anticipated_start_date": "2018-03-16T00:00:00-04:00",
    "estimated_end_date": "2018-03-30T00:00:00-04:00",
    "actual_start_date": "2018-03-16T00:00:00-04:00",
    "actual_end_date": "2018-03-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-03-28T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Limited quantities available",
    "fr_comments": "Quantité limitée disponible",
    "en_drug_brand_name": "PREGNYL",
    "en_drug_common_name": "chorionic gonadotropin for injection",
    "fr_drug_brand_name": "PREGNYL",
    "fr_drug_common_name": "gonadotrophine chorionique pour injection",
    "en_ingredients": "CHORIONIC GONADOTROPIN\r\nWATER",
    "fr_ingredients": "Ganodotrophine chorionique\r\nEau",
    "drug_strength": "10000UNIT\r\n10ML",
    "drug_dosage_form": "KIT\r\nLIQUID\r\nPOWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Trousse\r\nLiquide\r\nPoudre pour solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "10000U VIAL & 10ML SOLVENT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43073,
    "drug": {
      "current_status": "MARKETED",
      "id": 2932,
      "drug_code": 17201,
      "updated_date": "2025-12-03T00:30:32-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8252190,
          "ingredient": {
            "id": 1318,
            "ingredient_code": 238,
            "en_name": "LAMOTRIGINE",
            "fr_name": "Lamotrigine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02142104",
      "brand_name": "LAMICTAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79352",
      "number_of_ais": "1",
      "ai_group_no": "0127134001"
    },
    "created_date": "2018-03-16T14:09:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02142104",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N03AX09",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-06-08T00:00:00-04:00",
    "actual_start_date": "2018-05-11T00:00:00-04:00",
    "actual_end_date": "2018-05-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-05-26T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LAMICTAL",
    "en_drug_common_name": "Lamotrigine tablets",
    "fr_drug_brand_name": "LAMICTAL",
    "fr_drug_common_name": "Comprimés de lamotrigine",
    "en_ingredients": "LAMOTRIGINE",
    "fr_ingredients": "Lamotrigine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43076,
    "drug": {
      "current_status": "MARKETED",
      "id": 52979,
      "drug_code": 2390,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250406,
          "ingredient": {
            "id": 558,
            "ingredient_code": 8970,
            "en_name": "ATROPINE SULFATE",
            "fr_name": "Sulfate d'atropine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "10",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00328154",
      "brand_name": "ATROPINE SULFATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "10ML PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "49353",
      "number_of_ais": "1",
      "ai_group_no": "0104748003"
    },
    "created_date": "2018-03-16T14:59:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00328154",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "A03BA01",
    "atc_description": "BELLADONNAAND DERIVATIVES, PLAIN",
    "actual_start_date": "2018-05-25T00:00:00-04:00",
    "actual_end_date": "2018-07-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-07-16T13:07:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ATROPINE SULFATE INJECTION USP",
    "en_drug_common_name": "ATROPINE SULFATE LIFESHIELD",
    "fr_drug_brand_name": "ATROPINE SULFATE INJECTION USP",
    "fr_drug_common_name": "ATROPINE SULFATE LIFESHIELD",
    "en_ingredients": "ATROPINE SULFATE",
    "fr_ingredients": "Sulfate d'atropine",
    "drug_strength": "0.1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10 x 10mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43080,
    "drug": {
      "current_status": "MARKETED",
      "id": 21142,
      "drug_code": 8351,
      "updated_date": "2025-12-03T00:30:25-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8251079,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00436208",
      "brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "66765",
      "number_of_ais": "1",
      "ai_group_no": "0101280001"
    },
    "created_date": "2018-03-16T15:04:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00436208",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "C01BB01",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "anticipated_start_date": "2018-04-13T00:00:00-04:00",
    "estimated_end_date": "2018-07-13T00:00:00-04:00",
    "actual_end_date": "2018-07-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-03T13:19:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "2% LIDOCAINE HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "LIDOCAINE HYDROCHLORIDE LIFESHIELD",
    "fr_drug_brand_name": "2% LIDOCAINE HYDROCHLORIDE INJECTION USP",
    "fr_drug_common_name": "LIDOCAINE HYDROCHLORIDE LIFESHIELD",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lidocaïne",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 x 5mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43083,
    "drug": {
      "current_status": "MARKETED",
      "id": 1138,
      "drug_code": 12645,
      "updated_date": "2025-12-03T00:30:30-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8251648,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00884154",
      "brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "73810",
      "number_of_ais": "1",
      "ai_group_no": "0101280004"
    },
    "created_date": "2018-03-16T15:08:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00884154",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB02",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2018-06-29T00:00:00-04:00",
    "actual_end_date": "2019-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-03-28T14:02:45-04:00",
    "status": "resolved",
    "en_comments": "Produit est discontinué",
    "fr_comments": "Product is discontinued.",
    "en_drug_brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP 1%",
    "en_drug_common_name": "LIDOCAINE HYDROCHLORIDE",
    "fr_drug_brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP 1%",
    "fr_drug_common_name": "LIDOCAINE HYDROCHLORIDE",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lidocaïne",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "5 x 5mL AMP",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43086,
    "drug": {
      "current_status": "MARKETED",
      "id": 1138,
      "drug_code": 12645,
      "updated_date": "2025-12-03T00:30:30-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8251648,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00884154",
      "brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "73810",
      "number_of_ais": "1",
      "ai_group_no": "0101280004"
    },
    "created_date": "2018-03-16T15:10:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00884154",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB02",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2018-04-06T00:00:00-04:00",
    "actual_end_date": "2018-04-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-14T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP 1%",
    "en_drug_common_name": "LIDOCAINE HYDROCHLORIDE",
    "fr_drug_brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP 1%",
    "fr_drug_common_name": "LIDOCAINE HYDROCHLORIDE",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lidocaïne",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "25 x 20mL PVL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43092,
    "drug": {
      "current_status": "MARKETED",
      "id": 5792,
      "drug_code": 3837,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250571,
          "ingredient": {
            "id": 800,
            "ingredient_code": 9197,
            "en_name": "SODIUM BICARBONATE",
            "fr_name": "Bicarbonate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00038083",
      "brand_name": "SODIUM BICARBONATE INJECTION USP",
      "brand_name_fr": "BICARBONATE DE SODIUM INJECTABLE USP",
      "descriptor": "SINGLE-USE SYRINGE",
      "pediatric_flag": false,
      "accession_number": "55654",
      "number_of_ais": "1",
      "ai_group_no": "0104153004"
    },
    "created_date": "2018-03-16T15:16:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00038083",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "B05XA02",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2018-05-04T00:00:00-04:00",
    "actual_end_date": "2018-05-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-17T13:15:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SODIUM BICARBONATE INJECTION USP",
    "en_drug_common_name": "SODIUM BICARBONATE LIFESHIELD",
    "fr_drug_brand_name": "SODIUM BICARBONATE INJECTION USP",
    "fr_drug_common_name": "SODIUM BICARBONATE LIFESHIELD",
    "en_ingredients": "SODIUM BICARBONATE",
    "fr_ingredients": "Bicarbonate de sodium",
    "drug_strength": "75MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 x 50mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43095,
    "drug": {
      "current_status": "MARKETED",
      "id": 2998,
      "drug_code": 1740,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250302,
          "ingredient": {
            "id": 162,
            "ingredient_code": 9547,
            "en_name": "MANNITOL",
            "fr_name": "Mannitol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00038016",
      "brand_name": "MANNITOL INJECTION USP",
      "brand_name_fr": "MANNITOL INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "43667",
      "number_of_ais": "1",
      "ai_group_no": "0103277003"
    },
    "created_date": "2018-03-16T15:27:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00038016",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "B05BC01",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2018-03-27T00:00:00-04:00",
    "estimated_end_date": "2018-04-20T00:00:00-04:00",
    "actual_end_date": "2018-03-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-23T12:07:44-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MANNITOL INJECTION USP",
    "en_drug_common_name": "Mannitol 20% injection USP",
    "fr_drug_brand_name": "20 % mannitol injectable USP",
    "fr_drug_common_name": "20 % mannitol injectable USP",
    "en_ingredients": "MANNITOL",
    "fr_ingredients": "Mannitol",
    "drug_strength": "200MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "500 ML",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43116,
    "drug": {
      "current_status": "MARKETED",
      "id": 14444,
      "drug_code": 74709,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255202,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02261715",
      "brand_name": "TEVA-ALENDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2018-03-16T17:27:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02261715",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M05BA04",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2018-08-10T00:00:00-04:00",
    "actual_start_date": "2018-03-01T00:00:00-05:00",
    "actual_end_date": "2018-09-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-10-11T17:21:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ALENDRONATE",
    "en_drug_common_name": "ALENDRONATE",
    "fr_drug_brand_name": "TEVA-ALENDRONATE",
    "fr_drug_common_name": "ALENDRONATE",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "Alendronate",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 43119,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30102,
      "drug_code": 92140,
      "updated_date": "2025-05-15T04:23:33-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8355577,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02437090",
      "brand_name": "DULOXETINE DR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350002"
    },
    "created_date": "2018-03-16T17:31:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02437090",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX21",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-10-30T00:00:00-04:00",
    "actual_start_date": "2018-03-01T00:00:00-05:00",
    "actual_end_date": "2018-10-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-11-08T16:24:58-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DULOXETINE DR",
    "en_drug_common_name": "DULOXETINE",
    "fr_drug_brand_name": "TEVA-DULOXETINE",
    "fr_drug_common_name": "DULOXETINE",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 43122,
    "drug": {
      "current_status": "MARKETED",
      "id": 8962,
      "drug_code": 6135,
      "updated_date": "2025-05-15T02:30:36-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250865,
          "ingredient": {
            "id": 1210,
            "ingredient_code": 2300,
            "en_name": "LORAZEPAM",
            "fr_name": "Lorazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00637742",
      "brand_name": "TEVA-LORAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62377",
      "number_of_ais": "1",
      "ai_group_no": "0110731001"
    },
    "created_date": "2018-03-16T17:35:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00637742",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05BA06",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2018-10-30T00:00:00-04:00",
    "actual_start_date": "2018-03-15T00:00:00-04:00",
    "actual_end_date": "2018-07-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-30T19:13:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-LORAZEPAM",
    "en_drug_common_name": "LORAZEPAM",
    "fr_drug_brand_name": "TEVA-LORAZEPAM",
    "fr_drug_common_name": "LORAZEPAM",
    "en_ingredients": "LORAZEPAM",
    "fr_ingredients": "Lorazépam",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43126,
    "drug": {
      "current_status": "MARKETED",
      "id": 6078,
      "drug_code": 4255,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250614,
          "ingredient": {
            "id": 1222,
            "ingredient_code": 10127,
            "en_name": "PROPRANOLOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propranolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00496499",
      "brand_name": "TEVA-PROPRANOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57111",
      "number_of_ais": "1",
      "ai_group_no": "0101831004"
    },
    "created_date": "2018-03-16T17:38:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00496499",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AA05",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2018-04-03T00:00:00-04:00",
    "actual_start_date": "2018-03-15T00:00:00-04:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:22:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PROPRANOLOL",
    "en_drug_common_name": "PROPRANOLOL",
    "fr_drug_brand_name": "TEVA-PROPRANOLOL",
    "fr_drug_common_name": "PROPRANOLOL",
    "en_ingredients": "PROPRANOLOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propanolol",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43129,
    "drug": {
      "current_status": "MARKETED",
      "id": 16870,
      "drug_code": 77858,
      "updated_date": "2025-05-15T02:31:55-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255957,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02293218",
      "brand_name": "TEVA-CITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243001"
    },
    "created_date": "2018-03-16T17:40:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02293218",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AB04",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_start_date": "2018-03-15T00:00:00-04:00",
    "actual_end_date": "2018-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:06:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CITALOPRAM",
    "en_drug_common_name": "CITALOPRAM",
    "fr_drug_brand_name": "TEVA-CITALOPRAM",
    "fr_drug_common_name": "CITALOPRAM",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "Citalopram",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43132,
    "drug": {
      "current_status": "MARKETED",
      "id": 12558,
      "drug_code": 7128,
      "updated_date": "2025-05-15T02:30:38-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250983,
          "ingredient": {
            "id": 26,
            "ingredient_code": 10146,
            "en_name": "HALOPERIDOL",
            "fr_name": "Halopéridol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00363685",
      "brand_name": "TEVA-HALOPERIDOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "64741",
      "number_of_ais": "1",
      "ai_group_no": "0101774002"
    },
    "created_date": "2018-03-16T17:43:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00363685",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AD01",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-07-30T00:00:00-04:00",
    "actual_start_date": "2018-03-01T00:00:00-05:00",
    "actual_end_date": "2018-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-11T17:21:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-HALOPERIDOL",
    "en_drug_common_name": "HALOPERIDOL",
    "fr_drug_brand_name": "TEVA-HALOPERIDOL",
    "fr_drug_common_name": "HALOPERIDOL",
    "en_ingredients": "HALOPERIDOL",
    "fr_ingredients": "Halopéridol",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 43135,
    "drug": {
      "current_status": "MARKETED",
      "id": 12572,
      "drug_code": 7130,
      "updated_date": "2025-05-15T02:30:38-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250985,
          "ingredient": {
            "id": 26,
            "ingredient_code": 10146,
            "en_name": "HALOPERIDOL",
            "fr_name": "Halopéridol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00363669",
      "brand_name": "TEVA-HALOPERIDOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "64743",
      "number_of_ais": "1",
      "ai_group_no": "0101774004"
    },
    "created_date": "2018-03-16T17:45:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00363669",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AD01",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-06-06T00:00:00-04:00",
    "actual_start_date": "2018-03-01T00:00:00-05:00",
    "actual_end_date": "2018-07-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-30T19:15:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-HALOPERIDOL",
    "en_drug_common_name": "HALOPERIDOL",
    "fr_drug_brand_name": "TEVA-HALOPERIDOL",
    "fr_drug_common_name": "HALOPERIDOL",
    "en_ingredients": "HALOPERIDOL",
    "fr_ingredients": "Halopéridol",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 43138,
    "drug": {
      "current_status": "MARKETED",
      "id": 17322,
      "drug_code": 78369,
      "updated_date": "2025-05-15T02:31:58-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256100,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "35",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02298392",
      "brand_name": "TEVA-RISEDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301003"
    },
    "created_date": "2018-03-16T17:47:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02298392",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M05BA07",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2018-06-15T00:00:00-04:00",
    "actual_start_date": "2018-03-15T00:00:00-04:00",
    "actual_end_date": "2018-07-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-30T19:18:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-RISEDRONATE",
    "en_drug_common_name": "RISEDRONATE",
    "fr_drug_brand_name": "TEVA-RISEDRONATE",
    "fr_drug_common_name": "RISEDRONATE",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique",
    "drug_strength": "35MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43141,
    "drug": {
      "current_status": "MARKETED",
      "id": 30346,
      "drug_code": 9240,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251135,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00765953",
      "brand_name": "TEVA-FUROSEMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68167",
      "number_of_ais": "1",
      "ai_group_no": "0101944004"
    },
    "created_date": "2018-03-16T17:54:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00765953",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03CA01",
    "atc_description": "HIGH-CEILING DIURETICS",
    "estimated_end_date": "2018-04-05T00:00:00-04:00",
    "actual_start_date": "2018-03-16T00:00:00-04:00",
    "actual_end_date": "2018-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:12:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FUROSEMIDE",
    "en_drug_common_name": "FUROSEMIDE",
    "fr_drug_brand_name": "TEVA-FUROSEMIDE",
    "fr_drug_common_name": "FUROSEMIDE",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43152,
    "drug": {
      "current_status": "MARKETED",
      "id": 11568,
      "drug_code": 68491,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254313,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244514",
      "brand_name": "TEVA-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "300MG",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929003"
    },
    "created_date": "2018-03-16T18:00:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244514",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-06-20T00:00:00-04:00",
    "actual_start_date": "2018-03-15T00:00:00-04:00",
    "actual_end_date": "2018-07-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-30T19:21:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "TEVA-GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43155,
    "drug": {
      "current_status": "MARKETED",
      "id": 5776,
      "drug_code": 3822,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250567,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00498785",
      "brand_name": "STERILE WATER FOR IRRIGATION USP",
      "brand_name_fr": "EAU STÉRILE POUR IRRIGATION USP",
      "descriptor": "SINGLE-DOSE",
      "pediatric_flag": false,
      "accession_number": "55619",
      "number_of_ais": "1",
      "ai_group_no": "0105143002"
    },
    "created_date": "2018-03-16T18:06:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00498785",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2018-04-01T00:00:00-04:00",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_end_date": "2018-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-23T13:46:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "STERILE WATER FOR IRRIGATION USP",
    "en_drug_common_name": "Sterile Water for Irrigation USP",
    "fr_drug_brand_name": "Eau stérile pour irrigation USP",
    "fr_drug_common_name": "Eau stérile pour irrigation USP",
    "en_ingredients": "WATER",
    "fr_ingredients": "Eau",
    "drug_strength": "100%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAPERITONEAL\r\nIRRIGATION",
    "drug_route_fr": "Intrapéritonéale\r\nIrrigation",
    "drug_package_quantity": "1000ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43168,
    "drug": {
      "current_status": "MARKETED",
      "id": 25644,
      "drug_code": 88053,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259262,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395444",
      "brand_name": "TEVA-QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858006"
    },
    "created_date": "2018-03-16T18:12:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395444",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH04",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-04-07T00:00:00-04:00",
    "actual_start_date": "2018-03-16T00:00:00-04:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:22:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE XR",
    "fr_drug_brand_name": "TEVA-QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE XR",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43171,
    "drug": {
      "current_status": "MARKETED",
      "id": 296,
      "drug_code": 10791,
      "updated_date": "2025-12-03T00:30:30-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251392,
          "ingredient": {
            "id": 194,
            "ingredient_code": 11164,
            "en_name": "TAMOXIFEN",
            "fr_name": "Tamoxifène (Citrate de tamoxifène)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "00851973",
      "brand_name": "TEVA-TAMOXIFEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70838",
      "number_of_ais": "1",
      "ai_group_no": "0131293002"
    },
    "created_date": "2018-03-16T18:18:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00851973",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L02BA01",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2018-04-09T00:00:00-04:00",
    "actual_start_date": "2018-03-15T00:00:00-04:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:27:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TAMOXIFEN",
    "en_drug_common_name": "TAMOXIFEN",
    "fr_drug_brand_name": "TEVA-TAMOXIFEN",
    "fr_drug_common_name": "TAMOXIFEN",
    "en_ingredients": "TAMOXIFEN",
    "fr_ingredients": "Tamoxifen",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43174,
    "drug": {
      "current_status": "MARKETED",
      "id": 296,
      "drug_code": 10791,
      "updated_date": "2025-12-03T00:30:30-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251392,
          "ingredient": {
            "id": 194,
            "ingredient_code": 11164,
            "en_name": "TAMOXIFEN",
            "fr_name": "Tamoxifène (Citrate de tamoxifène)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "00851973",
      "brand_name": "TEVA-TAMOXIFEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70838",
      "number_of_ais": "1",
      "ai_group_no": "0131293002"
    },
    "created_date": "2018-03-16T18:26:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00851973",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L02BA01",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2018-04-09T00:00:00-04:00",
    "actual_start_date": "2018-03-15T00:00:00-04:00",
    "actual_end_date": "2018-04-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-30T19:27:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TAMOXIFEN",
    "en_drug_common_name": "TAMOXIFEN",
    "fr_drug_brand_name": "TEVA-TAMOXIFEN",
    "fr_drug_common_name": "TAMOXIFEN",
    "en_ingredients": "TAMOXIFEN",
    "fr_ingredients": "TAMOXIFEN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43179,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15564,
      "drug_code": 76238,
      "updated_date": "2025-05-15T04:11:02-04:00",
      "company": {
        "id": 88,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T03:21:46-04:00",
        "company_code": 11902,
        "mfr_code": "",
        "name": "VALEANT CANADA LP / VALEANT CANADA S.E.C.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8342306,
          "ingredient": {
            "id": 78,
            "ingredient_code": 10258,
            "en_name": "PHENYLEPHRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de phényléphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8342305,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02276704",
      "brand_name": "EXTRA STRENGTH CONTAC COLD & SORE THROAT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0217793003"
    },
    "created_date": "2018-03-16T19:12:57-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02276704",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "N02BE51",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "discontinuation_date": "2017-07-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-03-16T19:26:16-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "EXTRA STRENGTH CONTAC COLD & SORE THROAT",
    "en_drug_common_name": "EXTRA STRENGTH CONTAC COLD & SORE THROAT",
    "fr_drug_brand_name": "EXTRA STRENGTH CONTAC COLD & SORE THROAT",
    "fr_drug_common_name": "EXTRA STRENGTH CONTAC COLD & SORE THROAT",
    "en_ingredients": "PHENYLEPHRINE HYDROCHLORIDE\r\nACETAMINOPHEN",
    "fr_ingredients": "Chlorhydrate de phényléphrine\r\nAcétaminophène",
    "drug_strength": "5MG\r\n500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "n/a",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 43186,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15548,
      "drug_code": 76189,
      "updated_date": "2025-05-15T04:10:56-04:00",
      "company": {
        "id": 88,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T03:21:46-04:00",
        "company_code": 11902,
        "mfr_code": "",
        "name": "VALEANT CANADA LP / VALEANT CANADA S.E.C.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8342197,
          "ingredient": {
            "id": 78,
            "ingredient_code": 10258,
            "en_name": "PHENYLEPHRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de phényléphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8342196,
          "ingredient": {
            "id": 50,
            "ingredient_code": 10247,
            "en_name": "DEXTROMETHORPHAN HYDROBROMIDE",
            "fr_name": "Bromhydrate de dextrométhorphane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8342195,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02276224",
      "brand_name": "EXTRA STRENGTH CONTAC COMPLETE COUGH, COLD & FLU",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "3",
      "ai_group_no": "0351264002"
    },
    "created_date": "2018-03-16T19:27:54-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02276224",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "N02BE51",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "discontinuation_date": "2017-07-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-03-16T19:28:18-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "EXTRA STRENGTH CONTAC COMPLETE COUGH, COLD & FLU",
    "en_drug_common_name": "EXTRA STRENGTH CONTAC COMPLETE COUGH, COLD & FLU",
    "fr_drug_brand_name": "EXTRA STRENGTH CONTAC COMPLETE COUGH, COLD & FLU",
    "fr_drug_common_name": "EXTRA STRENGTH CONTAC COMPLETE COUGH, COLD & FLU",
    "en_ingredients": "DEXTROMETHORPHAN HYDROBROMIDE\r\nPHENYLEPHRINE HYDROCHLORIDE\r\nACETAMINOPHEN",
    "fr_ingredients": "Bromhydrate de dextrométhorphane\r\nChlorhydrate de phényléphrine\r\nAcétaminophène",
    "drug_strength": "15MG\r\n5MG\r\n500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "n/a",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 43191,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15546,
      "drug_code": 76188,
      "updated_date": "2025-05-15T04:10:56-04:00",
      "company": {
        "id": 88,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T03:21:46-04:00",
        "company_code": 11902,
        "mfr_code": "",
        "name": "VALEANT CANADA LP / VALEANT CANADA S.E.C.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8342194,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8342193,
          "ingredient": {
            "id": 574,
            "ingredient_code": 10259,
            "en_name": "CHLORPHENIRAMINE MALEATE",
            "fr_name": "Maléate de chlorphéniramine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8342192,
          "ingredient": {
            "id": 78,
            "ingredient_code": 10258,
            "en_name": "PHENYLEPHRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de phényléphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02276216",
      "brand_name": "NIGHTTIME EXTRA STRENGTH CONTAC COLD & SORE THROAT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "3",
      "ai_group_no": "0316099001"
    },
    "created_date": "2018-03-16T19:45:19-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02276216",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "N02BE51",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "discontinuation_date": "2017-07-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-03-16T19:45:56-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "NIGHTTIME EXTRA STRENGTH CONTAC COLD & SORE THROAT",
    "en_drug_common_name": "NIGHTTIME EXTRA STRENGTH CONTAC COLD & SORE THROAT",
    "fr_drug_brand_name": "NIGHTTIME EXTRA STRENGTH CONTAC COLD & SORE THROAT",
    "fr_drug_common_name": "NIGHTTIME EXTRA STRENGTH CONTAC COLD & SORE THROAT",
    "en_ingredients": "PHENYLEPHRINE HYDROCHLORIDE\r\nCHLORPHENIRAMINE MALEATE\r\nACETAMINOPHEN",
    "fr_ingredients": "Chlorhydrate de phényléphrine\r\nMaléate de chlorphéniramine\r\nAcétaminophène",
    "drug_strength": "5MG\r\n2MG\r\n500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "n/a",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 43194,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15550,
      "drug_code": 76190,
      "updated_date": "2025-05-15T04:10:56-04:00",
      "company": {
        "id": 88,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T03:21:46-04:00",
        "company_code": 11902,
        "mfr_code": "",
        "name": "VALEANT CANADA LP / VALEANT CANADA S.E.C.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8342201,
          "ingredient": {
            "id": 50,
            "ingredient_code": 10247,
            "en_name": "DEXTROMETHORPHAN HYDROBROMIDE",
            "fr_name": "Bromhydrate de dextrométhorphane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8342200,
          "ingredient": {
            "id": 78,
            "ingredient_code": 10258,
            "en_name": "PHENYLEPHRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de phényléphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8342199,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8342198,
          "ingredient": {
            "id": 574,
            "ingredient_code": 10259,
            "en_name": "CHLORPHENIRAMINE MALEATE",
            "fr_name": "Maléate de chlorphéniramine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02276232",
      "brand_name": "NIGHTTIME EXTRA STRENGTH CONTAC COMPLETE COUGH, COLD & FLU",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "4",
      "ai_group_no": "0451565003"
    },
    "created_date": "2018-03-16T19:47:03-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02276232",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "N02BE51",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "discontinuation_date": "2017-07-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-03-16T19:47:18-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "NIGHTTIME EXTRA STRENGTH CONTAC COMPLETE COUGH, COLD & FLU",
    "en_drug_common_name": "NIGHTTIME EXTRA STRENGTH CONTAC COMPLETE COUGH, COLD & FLU",
    "fr_drug_brand_name": "NIGHTTIME EXTRA STRENGTH CONTAC COMPLETE COUGH, COLD & FLU",
    "fr_drug_common_name": "NIGHTTIME EXTRA STRENGTH CONTAC COMPLETE COUGH, COLD & FLU",
    "en_ingredients": "DEXTROMETHORPHAN HYDROBROMIDE\r\nPHENYLEPHRINE HYDROCHLORIDE\r\nCHLORPHENIRAMINE MALEATE\r\nACETAMINOPHEN",
    "fr_ingredients": "Bromhydrate de dextrométhorphane\r\nChlorhydrate de phényléphrine\r\nMaléate de chlorphéniramine\r\nAcétaminophène",
    "drug_strength": "15MG\r\n5MG\r\n2MG\r\n500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "n/a",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 43248,
    "drug": {
      "current_status": "MARKETED",
      "id": 12792,
      "drug_code": 71771,
      "updated_date": "2025-05-15T02:31:25-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8254671,
          "ingredient": {
            "id": 3046,
            "ingredient_code": 12754,
            "en_name": "EZETIMIBE",
            "fr_name": "Ézétimibe"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247521",
      "brand_name": "EZETROL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149164001"
    },
    "created_date": "2018-03-19T13:13:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247521",
    "company_name": "MERCK CANADA INC",
    "atc_number": "C10AX09",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2018-04-09T00:00:00-04:00",
    "estimated_end_date": "2018-06-01T00:00:00-04:00",
    "actual_start_date": "2018-03-29T00:00:00-04:00",
    "actual_end_date": "2018-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-25T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "EZETROL",
    "en_drug_common_name": "ezetimibe tablets",
    "fr_drug_brand_name": "EZETROL",
    "fr_drug_common_name": "comprimés d’ézétimibe",
    "en_ingredients": "EZETIMIBE",
    "fr_ingredients": "Ézétimibe",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 tab",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43251,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8662,
      "drug_code": 60465,
      "updated_date": "2025-05-15T03:56:18-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8324762,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237147",
      "brand_name": "MIRAPEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169004"
    },
    "created_date": "2018-03-19T13:17:09-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02237147",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "N04BC05",
    "atc_description": "DOPAMINERGIC AGENTS",
    "discontinuation_date": "2018-04-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-04-02T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MIRAPEX",
    "en_drug_common_name": "Mirapex 1.5 mg",
    "fr_drug_brand_name": "Mirapex",
    "fr_drug_common_name": "Mirapex 1.5mg",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "1.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90s",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43254,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10266,
      "drug_code": 65251,
      "updated_date": "2025-05-15T04:01:03-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8331497,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02241594",
      "brand_name": "MIRAPEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169002"
    },
    "created_date": "2018-03-19T13:19:58-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02241594",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "N04BC05",
    "atc_description": "DOPAMINERGIC AGENTS",
    "discontinuation_date": "2018-04-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2018-04-02T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MIRAPEX",
    "en_drug_common_name": "Mirapex 0.5mg",
    "fr_drug_brand_name": "Mirapex",
    "fr_drug_common_name": "Mirapex 0.5mg",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90s",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43257,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8660,
      "drug_code": 60464,
      "updated_date": "2025-05-15T03:56:18-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8324761,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237146",
      "brand_name": "MIRAPEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169003"
    },
    "created_date": "2018-03-19T13:22:17-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02237146",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "N04BC05",
    "atc_description": "DOPAMINERGIC AGENTS",
    "discontinuation_date": "2018-04-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2018-04-02T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MIRAPEX",
    "en_drug_common_name": "Mirapex 1mg",
    "fr_drug_brand_name": "Mirapex",
    "fr_drug_common_name": "Mirapex 1mg",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "1.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90s",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43284,
    "drug": {
      "current_status": "MARKETED",
      "id": 11222,
      "drug_code": 67606,
      "updated_date": "2025-12-03T00:30:48-05:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8254211,
          "ingredient": {
            "id": 486,
            "ingredient_code": 7746,
            "en_name": "HEPATITIS B SURFACE ANTIGEN",
            "fr_name": "Antigène de surface du virus de l'hépatite b (recombiné)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02243676",
      "brand_name": "RECOMBIVAX HB",
      "brand_name_fr": "",
      "descriptor": "PRESERVATIVE-FREE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119570001"
    },
    "created_date": "2018-03-19T15:22:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243676",
    "company_name": "MERCK CANADA INC",
    "atc_number": "J07BC01",
    "atc_description": "VIRAL VACCINES",
    "anticipated_start_date": "2018-03-21T00:00:00-04:00",
    "estimated_end_date": "2020-12-31T00:00:00-05:00",
    "actual_start_date": "2018-03-19T00:00:00-04:00",
    "actual_end_date": "2020-09-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-11T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Remaining doses are reserved for the public immunization program. /Les doses restantes sont réservées au programme public de vaccination.",
    "fr_comments": "Remaining doses are reserved for the public immunization program. /Les doses restantes sont réservées au programme public de vaccination.",
    "en_drug_brand_name": "RECOMBIVAX HB     -(PRESERVATIVE FREE)",
    "en_drug_common_name": "(hepatitis B vaccine [recombinant])",
    "fr_drug_brand_name": "RECOMBIVAX hb",
    "fr_drug_common_name": "vaccin contre l’hépatite B [ADN recombiné]",
    "en_ingredients": "HEPATITIS B SURFACE ANTIGEN",
    "fr_ingredients": "ADN recombiné",
    "drug_strength": "10MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "5MCG/0.5ML 1DOSE VIAL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43286,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 5646,
      "drug_code": 37357,
      "updated_date": "2025-05-15T03:47:55-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8309951,
          "ingredient": {
            "id": 240,
            "ingredient_code": 4007,
            "en_name": "GLYBURIDE",
            "fr_name": "Glyburide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02224569",
      "brand_name": "DIABETA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4884",
      "number_of_ais": "1",
      "ai_group_no": "0108708001"
    },
    "created_date": "2018-03-19T15:24:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02224569",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A10BB01",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2018-04-16T00:00:00-04:00",
    "estimated_end_date": "2018-05-31T00:00:00-04:00",
    "actual_start_date": "2018-04-02T00:00:00-04:00",
    "actual_end_date": "2018-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-05-01T14:59:00-04:00",
    "status": "resolved",
    "en_comments": "Delay in production",
    "fr_comments": "Délai de production",
    "en_drug_brand_name": "DIABETA",
    "en_drug_common_name": "Diabeta 5mg 30's",
    "fr_drug_brand_name": "Diabeta",
    "fr_drug_common_name": "Diabeta 5mg",
    "en_ingredients": "GLYBURIDE",
    "fr_ingredients": "Glyburide",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43342,
    "drug": {
      "current_status": "MARKETED",
      "id": 19342,
      "drug_code": 80614,
      "updated_date": "2025-12-03T00:31:24-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256759,
          "ingredient": {
            "id": 2182,
            "ingredient_code": 27,
            "en_name": "ANASTROZOLE",
            "fr_name": "Anastrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02320738",
      "brand_name": "PMS-ANASTROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128681001"
    },
    "created_date": "2018-03-19T17:40:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02320738",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "L02BG03",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2018-06-25T00:00:00-04:00",
    "actual_start_date": "2018-03-19T00:00:00-04:00",
    "actual_end_date": "2018-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-29T13:16:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ANASTROZOLE",
    "en_drug_common_name": "ANASTROZOLE",
    "fr_drug_brand_name": "PMS-ANASTROZOLE",
    "fr_drug_common_name": "ANASTROZOLE",
    "en_ingredients": "ANASTROZOLE",
    "fr_ingredients": "Anastrozole",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43345,
    "drug": {
      "current_status": "MARKETED",
      "id": 7446,
      "drug_code": 50067,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253314,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230803",
      "brand_name": "PMS-METOPROLOL-L",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111923002"
    },
    "created_date": "2018-03-19T17:42:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230803",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C07AB02",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2018-04-27T00:00:00-04:00",
    "actual_start_date": "2018-03-14T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-METOPROLOL-L",
    "en_drug_common_name": "METOPROLOL",
    "fr_drug_brand_name": "PMS-METOPROLOL-L",
    "fr_drug_common_name": "METOPROLO",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43348,
    "drug": {
      "current_status": "MARKETED",
      "id": 23330,
      "drug_code": 85916,
      "updated_date": "2025-05-15T02:33:03-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258411,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02373947",
      "brand_name": "PMS-MONTELUKAST FC",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823002"
    },
    "created_date": "2018-03-19T17:46:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02373947",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "R03DC03",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "estimated_end_date": "2018-04-18T00:00:00-04:00",
    "actual_start_date": "2018-03-19T00:00:00-04:00",
    "actual_end_date": "2018-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-19T14:00:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-MONTELUKAST FC",
    "en_drug_common_name": "MONTELUKAST",
    "fr_drug_brand_name": "PMS-MONTELUKAST FC",
    "fr_drug_common_name": "MONTELUKAST",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "MONTELUKAST",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43351,
    "drug": {
      "current_status": "DORMANT",
      "id": 55325,
      "drug_code": 85233,
      "updated_date": "2025-05-15T06:55:43-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368625,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02367483",
      "brand_name": "PMS-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783006"
    },
    "created_date": "2018-03-19T17:49:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02367483",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2018-03-19T00:00:00-04:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-10T12:38:40-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued.",
    "fr_comments": "Product to be discontinued.",
    "en_drug_brand_name": "PMS-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "PMS-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43354,
    "drug": {
      "current_status": "MARKETED",
      "id": 17798,
      "drug_code": 78854,
      "updated_date": "2025-05-15T02:32:04-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256253,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02303213",
      "brand_name": "PMS-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783005"
    },
    "created_date": "2018-03-19T17:52:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02303213",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2018-04-12T00:00:00-04:00",
    "estimated_end_date": "2018-06-15T00:00:00-04:00",
    "actual_start_date": "2018-04-17T00:00:00-04:00",
    "actual_end_date": "2018-06-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-07T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "PMS-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43357,
    "drug": {
      "current_status": "MARKETED",
      "id": 25942,
      "drug_code": 88302,
      "updated_date": "2025-05-15T02:33:44-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259359,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "225",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02398079",
      "brand_name": "PMS-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121007"
    },
    "created_date": "2018-03-19T17:55:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02398079",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AX16",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2018-06-01T00:00:00-04:00",
    "actual_end_date": "2018-06-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-29T14:06:53-04:00",
    "status": "resolved",
    "en_comments": "AVOIDED SHORTAGE",
    "fr_comments": "Pénurie évitée",
    "en_drug_brand_name": "PMS-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "PMS-PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "225MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43360,
    "drug": {
      "current_status": "MARKETED",
      "id": 11538,
      "drug_code": 68347,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254302,
          "ingredient": {
            "id": 1076,
            "ingredient_code": 8209,
            "en_name": "PROPOFOL",
            "fr_name": "Propofol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02244379",
      "brand_name": "PROPOFOL INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121833001"
    },
    "created_date": "2018-03-19T18:06:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244379",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N01AX10",
    "atc_description": "ANESTHETICS, GENERAL",
    "actual_start_date": "2018-03-19T00:00:00-04:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-06-10T12:51:10-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued.",
    "fr_comments": "Product to be discontinued.",
    "en_drug_brand_name": "PMS-PROPOFOL",
    "en_drug_common_name": "PROPOFOL",
    "fr_drug_brand_name": "PMS-PROPOFOL",
    "fr_drug_common_name": "PROPOFOL",
    "en_ingredients": "PROPOFOL",
    "fr_ingredients": "Propofol",
    "drug_strength": "10MG",
    "drug_dosage_form": "EMULSION",
    "drug_dosage_form_fr": "Émulsion",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "100ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43366,
    "drug": {
      "current_status": "MARKETED",
      "id": 9072,
      "drug_code": 61730,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253569,
          "ingredient": {
            "id": 1478,
            "ingredient_code": 2048,
            "en_name": "SOTALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sotalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238327",
      "brand_name": "PMS-SOTALOL - 160 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113778001"
    },
    "created_date": "2018-03-19T18:32:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238327",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C07AA07",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2018-04-19T00:00:00-04:00",
    "estimated_end_date": "2018-05-30T00:00:00-04:00",
    "actual_start_date": "2018-04-19T00:00:00-04:00",
    "actual_end_date": "2018-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-18T19:37:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-SOTALOL - 160 MG",
    "en_drug_common_name": "SOTALOL",
    "fr_drug_brand_name": "PMS-SOTALOL - 160 MG",
    "fr_drug_common_name": "SOTALOL",
    "en_ingredients": "SOTALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sotalol",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43458,
    "drug": {
      "current_status": "MARKETED",
      "id": 23030,
      "drug_code": 85622,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8258327,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258326,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02371022",
      "brand_name": "TWYNSTA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252947001"
    },
    "created_date": "2018-03-20T12:53:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02371022",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "C09DB04",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2018-03-23T00:00:00-04:00",
    "estimated_end_date": "2018-04-18T00:00:00-04:00",
    "actual_end_date": "2018-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-20T13:22:42-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TWYNSTA",
    "en_drug_common_name": "TWYNSTA 40 + 5 MG",
    "fr_drug_brand_name": "TWYNSTA",
    "fr_drug_common_name": "TWYNSTA 40 + 5 MG",
    "en_ingredients": "AMLODIPINE\r\nTELMISARTAN",
    "fr_ingredients": "Telmisartan",
    "drug_strength": "5MG\r\n40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4 x 7",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43498,
    "drug": {
      "current_status": "MARKETED",
      "id": 13454,
      "drug_code": 73131,
      "updated_date": "2025-05-15T02:31:32-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254876,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8254875,
          "ingredient": {
            "id": 1356,
            "ingredient_code": 10135,
            "en_name": "CHLORTHALIDONE",
            "fr_name": "Chlorthalidone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248763",
      "brand_name": "AA-ATENIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0216877002"
    },
    "created_date": "2018-03-20T13:18:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248763",
    "company_name": "APOTEX INC",
    "atc_number": "C07CB03",
    "atc_description": "BETA BLOCKING AGENTS AND OTHER DIURETICS",
    "estimated_end_date": "2018-08-13T00:00:00-04:00",
    "actual_start_date": "2018-03-19T00:00:00-04:00",
    "actual_end_date": "2018-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-24T01:31:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ATENIDONE",
    "en_drug_common_name": "ATENIDONE",
    "fr_drug_brand_name": "APO-ATENIDONE",
    "fr_drug_common_name": "ATENIDONE",
    "en_ingredients": "CHLORTHALIDONE\r\nATENOLOL",
    "fr_ingredients": "Chlorthalidone\r\nAténolol",
    "drug_strength": "25MG\r\n50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43501,
    "drug": {
      "current_status": "MARKETED",
      "id": 9248,
      "drug_code": 62232,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253610,
          "ingredient": {
            "id": 1492,
            "ingredient_code": 7567,
            "en_name": "BECLOMETHASONE DIPROPIONATE",
            "fr_name": "Dipropionate de béclométhasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02238796",
      "brand_name": "APO-BECLOMETHASONE NASAL SPRAY",
      "brand_name_fr": "",
      "descriptor": "METERED DOSE SPRAY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106320002"
    },
    "created_date": "2018-03-20T13:20:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238796",
    "company_name": "APOTEX INC",
    "atc_number": "R01AD01",
    "atc_description": "DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",
    "estimated_end_date": "2018-11-23T00:00:00-05:00",
    "actual_start_date": "2018-03-19T00:00:00-04:00",
    "actual_end_date": "2018-11-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-11-22T22:55:17-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-BECLOMETHASONE NASAL SPRAY",
    "en_drug_common_name": "BECLOMETHASONE",
    "fr_drug_brand_name": "APO-BECLOMETHASONE NASAL SPRAY",
    "fr_drug_common_name": "BECLOMETHASONE",
    "en_ingredients": "BECLOMETHASONE DIPROPIONATE",
    "fr_ingredients": "Dipropionate de béclométhasone",
    "drug_strength": "50MCG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "NASAL",
    "drug_route_fr": "Nasale",
    "drug_package_quantity": "200 doses",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43505,
    "drug": {
      "current_status": "MARKETED",
      "id": 7992,
      "drug_code": 5196,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250717,
          "ingredient": {
            "id": 2194,
            "ingredient_code": 2165,
            "en_name": "CIMETIDINE",
            "fr_name": "Cimétidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00487872",
      "brand_name": "CIMETIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59900",
      "number_of_ais": "1",
      "ai_group_no": "0111925001"
    },
    "created_date": "2018-03-20T13:49:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00487872",
    "company_name": "APOTEX INC",
    "atc_number": "A02BA01",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2018-06-22T00:00:00-04:00",
    "actual_start_date": "2018-03-19T00:00:00-04:00",
    "actual_end_date": "2018-06-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-03T10:04:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO CIMETIDINE TAB 300MG",
    "en_drug_common_name": "CIMETIDINE",
    "fr_drug_brand_name": "APO CIMETIDINE TAB 300MG",
    "fr_drug_common_name": "CIMETIDINE",
    "en_ingredients": "CIMETIDINE",
    "fr_ingredients": "Cimétidine",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43508,
    "drug": {
      "current_status": "MARKETED",
      "id": 30438,
      "drug_code": 92480,
      "updated_date": "2025-05-15T02:34:45-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261117,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02440431",
      "brand_name": "APO-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350002"
    },
    "created_date": "2018-03-20T13:51:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02440431",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX21",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-06-01T00:00:00-04:00",
    "actual_start_date": "2018-03-19T00:00:00-04:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-23T12:15:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DULOXETINE",
    "en_drug_common_name": "DULOXETINE",
    "fr_drug_brand_name": "APO-DULOXETINE",
    "fr_drug_common_name": "DULOXETINE",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43511,
    "drug": {
      "current_status": "MARKETED",
      "id": 9480,
      "drug_code": 6296,
      "updated_date": "2025-05-15T02:30:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250872,
          "ingredient": {
            "id": 1210,
            "ingredient_code": 2300,
            "en_name": "LORAZEPAM",
            "fr_name": "Lorazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00655759",
      "brand_name": "APO-LORAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62759",
      "number_of_ais": "1",
      "ai_group_no": "0110731001"
    },
    "created_date": "2018-03-20T13:52:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00655759",
    "company_name": "APOTEX INC",
    "atc_number": "N05BA06",
    "atc_description": "ANXIOLYTICS",
    "anticipated_start_date": "2018-04-13T00:00:00-04:00",
    "estimated_end_date": "2018-07-13T00:00:00-04:00",
    "actual_start_date": "2018-04-02T00:00:00-04:00",
    "actual_end_date": "2018-06-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-12T12:55:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LORAZEPAM TAB 1MG",
    "en_drug_common_name": "LORAZEPAM",
    "fr_drug_brand_name": "APO-LORAZEPAM TAB 1MG",
    "fr_drug_common_name": "LORAZEPAM",
    "en_ingredients": "LORAZEPAM",
    "fr_ingredients": "Lorazépam",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43516,
    "drug": {
      "current_status": "MARKETED",
      "id": 5334,
      "drug_code": 3465,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250518,
          "ingredient": {
            "id": 1948,
            "ingredient_code": 9956,
            "en_name": "OXAZEPAM",
            "fr_name": "Oxazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00402745",
      "brand_name": "APO-OXAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54422",
      "number_of_ais": "1",
      "ai_group_no": "0102420002"
    },
    "created_date": "2018-03-20T13:54:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00402745",
    "company_name": "APOTEX INC",
    "atc_number": "N05BA04",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2018-08-31T00:00:00-04:00",
    "actual_start_date": "2018-03-19T00:00:00-04:00",
    "actual_end_date": "2018-06-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-03T10:28:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO OXAZEPAM TAB 15MG",
    "en_drug_common_name": "OXAZEPAM",
    "fr_drug_brand_name": "APO OXAZEPAM TAB 15MG",
    "fr_drug_common_name": "OXAZEPAM",
    "en_ingredients": "OXAZEPAM",
    "fr_ingredients": "Oxazépam",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43519,
    "drug": {
      "current_status": "MARKETED",
      "id": 21598,
      "drug_code": 83987,
      "updated_date": "2025-05-15T02:32:47-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257722,
          "ingredient": {
            "id": 1648,
            "ingredient_code": 11114,
            "en_name": "VALACYCLOVIR",
            "fr_name": "Valaciclovir (Chlorhydrate de valacyclovir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02354705",
      "brand_name": "APO-VALACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128626003"
    },
    "created_date": "2018-03-20T13:56:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02354705",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB11",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2019-01-25T00:00:00-05:00",
    "actual_start_date": "2018-03-19T00:00:00-04:00",
    "actual_end_date": "2019-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-01-18T16:50:36-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-VALACYCLOVIR",
    "en_drug_common_name": "VALACYCLOVIR",
    "fr_drug_brand_name": "APO-VALACYCLOVIR",
    "fr_drug_common_name": "VALACYCLOVIR",
    "en_ingredients": "VALACYCLOVIR",
    "fr_ingredients": "VALACYCLOVIR",
    "drug_strength": "1000MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "21 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43530,
    "drug": {
      "current_status": "MARKETED",
      "id": 4748,
      "drug_code": 254,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 16,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 3594,
        "mfr_code": "ALC08",
        "name": "ALCON CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2665 MEADOWPINE BLVD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 8C7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250136,
          "ingredient": {
            "id": 558,
            "ingredient_code": 8970,
            "en_name": "ATROPINE SULFATE",
            "fr_name": "Sulfate d'atropine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "00035017",
      "brand_name": "ALCON ATROPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "09922",
      "number_of_ais": "1",
      "ai_group_no": "0104748001"
    },
    "created_date": "2018-03-20T17:43:39-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00035017",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01FA01",
    "atc_description": "MYDRIATICSAND CYCLOPLEGICS",
    "discontinuation_date": "2018-03-13T00:00:00-04:00",
    "decision_reversal": true,
    "fr_supply_disruption_mitigation": "Produit discontinuer - modification aux normes d'essai de qualité",
    "en_discontinuation_comments": "WILL NOT BE DISCONTINUED.   Product  is now available.    Novartis Pharmaceuticals has moved to a tight and timely management of inventory for continuity of supply of Isopto Atropine throughout Canada",
    "fr_discontinuation_comments": "NOVARTIS NE METTRA PAS FIN A LA PRODUCTION.  L'inventaire d'Isopto est maintenant disponible.  Novartis travaille presentement sur une solution d'approvisionnement durable nous permettant de recontrer l'ensemble de la demande du produit au Canada.",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-08-29T15:52:52-04:00",
    "status": "reversed",
    "en_drug_brand_name": "ISOPTO ATROPINE",
    "en_drug_common_name": "ISOPTO ATROPINE 1% SOLUTION 5ML",
    "fr_drug_brand_name": "ISOPTO ATROPRINE",
    "fr_drug_common_name": "ISOPTO ATROPINE 1% SOLUTION 5ML",
    "en_ingredients": "ATROPINE SULFATE",
    "fr_ingredients": "Sulfate d'atropine",
    "drug_strength": "1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "5ML",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 43543,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19850,
      "drug_code": 81189,
      "updated_date": "2025-05-15T04:14:41-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8347047,
          "ingredient": {
            "id": 1116,
            "ingredient_code": 11247,
            "en_name": "CLAVULANIC ACID",
            "fr_name": "Acide clavulanique (Clavulinate potassique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8347046,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "875",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02326523",
      "brand_name": "AMOXI-CLAV",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0234720005"
    },
    "created_date": "2018-03-20T18:46:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02326523",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "J01CR02",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "actual_start_date": "2018-03-27T00:00:00-04:00",
    "actual_end_date": "2018-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-05-31T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Discontinued as of April 26, 2018",
    "fr_comments": "Discontinué depuis le 26 avril 2018",
    "en_drug_brand_name": "AMOXI-CLAV",
    "en_drug_common_name": "AMOXI-CLAV",
    "fr_drug_brand_name": "AMOXI-CLAV",
    "fr_drug_common_name": "AMOXI-CLAV",
    "en_ingredients": "AMOXICILLIN\r\nCLAVULANIC ACID",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "875MG\r\n125MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43556,
    "drug": {
      "current_status": "MARKETED",
      "id": 30774,
      "drug_code": 92837,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8261336,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02443686",
      "brand_name": "BUPIVACAINE INJECTION BP",
      "brand_name_fr": "BUPIVACAINE INJECTABLE BP",
      "descriptor": "SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108896001"
    },
    "created_date": "2018-03-20T22:42:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443686",
    "company_name": "STERIMAX INC",
    "atc_number": "N01BB01",
    "atc_description": "ANESTHETICS, LOCAL",
    "estimated_end_date": "2018-06-08T00:00:00-04:00",
    "actual_start_date": "2018-03-20T00:00:00-04:00",
    "actual_end_date": "2018-05-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-05-26T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BUPIVACAINE INJECTION BP",
    "en_drug_common_name": "BUPIVACAINE INJECTION BP",
    "fr_drug_brand_name": "BUPIVACAINE INJECTABLE BP",
    "fr_drug_common_name": "BUPIVACAINE INJECTABLE BP",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Bloc/Infiltration\r\nÉpidurale",
    "drug_package_quantity": "10 VIALS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43608,
    "drug": {
      "current_status": "MARKETED",
      "id": 30872,
      "drug_code": 93011,
      "updated_date": "2025-05-15T02:35:05-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261404,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02444887",
      "brand_name": "BIO-CIPROFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123207001"
    },
    "created_date": "2018-03-21T16:16:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02444887",
    "company_name": "BIOMED PHARMA",
    "atc_number": "J01MA02",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "actual_start_date": "2018-01-10T00:00:00-05:00",
    "actual_end_date": "2018-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-09-19T16:51:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BIO-CIPROFLOXACIN",
    "en_drug_common_name": "CIPROFLOXACIN",
    "fr_drug_brand_name": "BIO-CIPROFLOXACIN",
    "fr_drug_common_name": "CIPROFLOXACIN",
    "en_ingredients": "CIPROFLOXACIN",
    "fr_ingredients": "Ciprofloxacine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 43613,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30984,
      "drug_code": 93125,
      "updated_date": "2025-05-15T04:24:13-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8356196,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445980",
      "brand_name": "BIO-LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971002"
    },
    "created_date": "2018-03-21T17:43:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445980",
    "company_name": "BIOMED PHARMA",
    "atc_number": "C09CA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2018-01-10T00:00:00-05:00",
    "actual_end_date": "2018-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-09-19T16:57:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BIO-LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "BIO-LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 43616,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30982,
      "drug_code": 93124,
      "updated_date": "2025-05-15T04:24:13-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8356195,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445972",
      "brand_name": "BIO-LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971003"
    },
    "created_date": "2018-03-21T17:48:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445972",
    "company_name": "BIOMED PHARMA",
    "atc_number": "C09CA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2018-06-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-09-19T16:58:05-04:00",
    "status": "resolved",
    "en_comments": "Commande en cours.",
    "en_drug_brand_name": "BIO-LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "BIO-LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 43619,
    "drug": {
      "current_status": "DORMANT",
      "id": 31112,
      "drug_code": 93279,
      "updated_date": "2025-05-15T06:55:56-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369330,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02447223",
      "brand_name": "BIO-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2018-03-21T18:33:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02447223",
    "company_name": "BIOMED PHARMA",
    "atc_number": "N05AH04",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2018-02-01T00:00:00-05:00",
    "actual_end_date": "2018-10-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-10-06T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Commande en cours.",
    "en_drug_brand_name": "BIO-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "BIO-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 43622,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12382,
      "drug_code": 70833,
      "updated_date": "2025-05-15T04:05:53-04:00",
      "company": {
        "id": 176,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T03:21:45-04:00",
        "company_code": 11642,
        "mfr_code": "",
        "name": "HOSPIRA HEALTHCARE ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / Service à la clientele 1-866-488-6088 option 3"
      },
      "drug_ingredients": [
        {
          "id": 8337318,
          "ingredient": {
            "id": 3006,
            "ingredient_code": 11241,
            "en_name": "PIPERACILLIN",
            "fr_name": "Pipéracilline (Pipéracilline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02246641",
      "brand_name": "PIPERACILLIN FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115403002"
    },
    "created_date": "2018-03-21T18:37:17-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02246641",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "J01CA12",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "discontinuation_date": "2019-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-03-13T19:02:35-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PIPERACILLIN FOR INJECTION",
    "en_drug_common_name": "PIPERACILLIN",
    "fr_drug_brand_name": "PIPERACILLIN FOR INJECTION",
    "fr_drug_common_name": "PIPERACILLIN",
    "en_ingredients": "PIPERACILLIN",
    "fr_ingredients": "PIPERACILLIN",
    "drug_strength": "3G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10 x 3g GVL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43629,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 51237,
      "drug_code": 93649,
      "updated_date": "2025-05-15T04:24:24-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8356482,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02450364",
      "brand_name": "BIO-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843003"
    },
    "created_date": "2018-03-21T19:15:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02450364",
    "company_name": "BIOMED PHARMA",
    "atc_number": "N03AX14",
    "atc_description": "ANTIEPILEPTICS",
    "actual_start_date": "2018-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-08-21T12:46:38-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "BIO-LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM",
    "fr_drug_brand_name": "BIO-LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "120",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43632,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 51233,
      "drug_code": 93647,
      "updated_date": "2025-05-15T04:24:24-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8356480,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02450348",
      "brand_name": "BIO-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843001"
    },
    "created_date": "2018-03-21T19:20:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02450348",
    "company_name": "BIOMED PHARMA",
    "atc_number": "N03AX14",
    "atc_description": "ANTIEPILEPTICS",
    "actual_start_date": "2018-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-08-21T12:46:17-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "BIO-LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM",
    "fr_drug_brand_name": "BIO-LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "120",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43635,
    "drug": {
      "current_status": "MARKETED",
      "id": 4740,
      "drug_code": 2527,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250423,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "149",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037869",
      "brand_name": "POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "50067",
      "number_of_ais": "1",
      "ai_group_no": "0100273006"
    },
    "created_date": "2018-03-21T20:05:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037869",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "B05XA01",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2018-08-06T00:00:00-04:00",
    "actual_end_date": "2018-06-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-07T14:38:03-04:00",
    "status": "avoided_shortage",
    "en_comments": "10mL presentatation remains available. Preventative allocation measures are in place for both.",
    "fr_comments": "La fiole de 10mL demeure disponible. Des mesures d'allocations préventives sont en place pour les deux présentations.",
    "en_drug_brand_name": "POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP",
    "en_drug_common_name": "POTASSIUM CHLORIDE",
    "fr_drug_brand_name": "CHLORURE DE POTASSIUM POUR INJECTION",
    "fr_drug_common_name": "CHLORURE DE POTASSIUM",
    "en_ingredients": "POTASSIUM CHLORIDE",
    "fr_ingredients": "Chlorure de potassium",
    "drug_strength": "149MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "25 X 20mL PVL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43643,
    "drug": {
      "current_status": "MARKETED",
      "id": 6794,
      "drug_code": 44273,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253186,
          "ingredient": {
            "id": 2250,
            "ingredient_code": 20144,
            "en_name": "PENTAMIDINE ISETIONATE",
            "fr_name": "Isétionate de pentamidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02183080",
      "brand_name": "PENTAMIDINE ISETIONATE FOR INJECTION BP",
      "brand_name_fr": "ISÉTIONATE DE PENTAMIDINE POUR INJECTION BP",
      "descriptor": "SINGLE-USE",
      "pediatric_flag": false,
      "accession_number": "T9997",
      "number_of_ais": "1",
      "ai_group_no": "0152223001"
    },
    "created_date": "2018-03-21T20:17:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02183080",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "P01CX01",
    "atc_description": "AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS",
    "anticipated_start_date": "2018-03-26T00:00:00-04:00",
    "actual_end_date": "2018-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-20T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PENTAMIDINE ISETIONATE FOR INJECTION BP",
    "en_drug_common_name": "PENTAMIDINE ISETIONATE",
    "fr_drug_brand_name": "ISÉTIONATE DE PENTAMIDINE",
    "fr_drug_common_name": "ISÉTIONATE DE PENTAMIDINE",
    "en_ingredients": "PENTAMIDINE ISETIONATE",
    "fr_ingredients": "Isétionate de pentamidine",
    "drug_strength": "300MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "5 x 300mg GVL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43646,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28722,
      "drug_code": 90846,
      "updated_date": "2025-05-15T04:22:24-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8354578,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02423766",
      "brand_name": "MIDAZOLAM INJECTION",
      "brand_name_fr": "",
      "descriptor": "5MG/ML; 15MG/3ML; 50MG/10ML SINGLE USE AMPOULES",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2018-03-21T20:25:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423766",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "N05CD08",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2018-05-25T00:00:00-04:00",
    "actual_end_date": "2018-10-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-11-02T12:50:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "MIDAZOLAM",
    "fr_drug_brand_name": "MIDAZOLAM",
    "fr_drug_common_name": "MIDAZOLAM",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "5 x 3mL PVL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43668,
    "drug": {
      "current_status": "MARKETED",
      "id": 30186,
      "drug_code": 92234,
      "updated_date": "2025-05-15T02:34:41-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261026,
          "ingredient": {
            "id": 3272,
            "ingredient_code": 18175,
            "en_name": "SOLIFENACIN SUCCINATE",
            "fr_name": "Succinate de solifénacine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02437988",
      "brand_name": "TARO-SOLIFENACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151584001"
    },
    "created_date": "2018-03-22T13:54:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02437988",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "G04BD08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2018-03-22T00:00:00-04:00",
    "actual_start_date": "2018-03-22T00:00:00-04:00",
    "actual_end_date": "2018-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T21:48:04-05:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "en_drug_brand_name": "RAN-SOLIFENACIN",
    "en_drug_common_name": "RAN-SOLIFENACIN",
    "fr_drug_brand_name": "RAN-SOLIFENACIN",
    "fr_drug_common_name": "RAN-SOLIFENACIN",
    "en_ingredients": "SOLIFENACIN SUCCINATE",
    "fr_ingredients": "Succinate de solifénacine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43707,
    "drug": {
      "current_status": "MARKETED",
      "id": 25020,
      "drug_code": 87529,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8259056,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389819",
      "brand_name": "ACH-TEMOZOLOMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781002"
    },
    "created_date": "2018-03-22T18:59:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389819",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "L01AX03",
    "atc_description": "ALKYLATINGAGENTS",
    "estimated_end_date": "2018-04-27T00:00:00-04:00",
    "actual_start_date": "2018-03-09T00:00:00-05:00",
    "actual_end_date": "2018-05-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-24T15:23:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-TEMOZOLOMIDE",
    "en_drug_common_name": "TEMOZOLOMIDE",
    "fr_drug_brand_name": "ACH-TEMOZOLOMIDE",
    "fr_drug_common_name": "TEMOZOLOMIDE",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 CAPSULE/SACHET, 5 SACHETS/BOX  | 1 CAPSULE/SACHET, 5 SACHETS/BOÎTE",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 43728,
    "drug": {
      "current_status": "MARKETED",
      "id": 1882,
      "drug_code": 14017,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251849,
          "ingredient": {
            "id": 1008,
            "ingredient_code": 2402,
            "en_name": "DANTROLENE SODIUM",
            "fr_name": "Dantrolène sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "01997572",
      "brand_name": "DANTRIUM INTRAVENOUS",
      "brand_name_fr": "DANTRIUM INTRAVEINEUX",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75514",
      "number_of_ais": "1",
      "ai_group_no": "0109855003"
    },
    "created_date": "2018-03-22T20:20:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01997572",
    "company_name": "PAR PHARMACEUTICAL COMPANIES",
    "atc_number": "M03CA01",
    "atc_description": "MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS",
    "estimated_end_date": "2018-07-15T00:00:00-04:00",
    "actual_start_date": "2018-03-22T00:00:00-04:00",
    "actual_end_date": "2018-07-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-07-31T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DANTRIUM INTRAVENOUS",
    "en_drug_common_name": "Dantrolene Sodium for Injection",
    "fr_drug_brand_name": "Dantrium IV",
    "fr_drug_common_name": "Dantrolène sodique puor injection",
    "en_ingredients": "DANTROLENE SODIUM",
    "fr_ingredients": "Dantrolène sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "Box containing 6x20mg Vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43730,
    "drug": {
      "current_status": "MARKETED",
      "id": 28542,
      "drug_code": 90664,
      "updated_date": "2025-12-03T00:32:31-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260352,
          "ingredient": {
            "id": 3518,
            "ingredient_code": 20429,
            "en_name": "LOTEPREDNOL ETABONATE",
            "fr_name": "Étabonate de lotéprednol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02421941",
      "brand_name": "LOTEMAX OINTMENT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152508002"
    },
    "created_date": "2018-03-22T20:22:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02421941",
    "company_name": "BAUSCH & LOMB INC",
    "atc_number": "S01BA14",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "actual_start_date": "2018-03-16T00:00:00-04:00",
    "actual_end_date": "2018-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-06-01T20:15:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LOTEMAX OINTMENT",
    "en_drug_common_name": "LOTEMAX OINTMENT",
    "fr_drug_brand_name": "LOTEMAX OINTMENT",
    "fr_drug_common_name": "LOTEMAX OINTMENT",
    "en_ingredients": "LOTEPREDNOL ETABONATE",
    "fr_ingredients": "Étabonate de lotéprednol",
    "drug_strength": "0.5%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "n/a",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43748,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 4120,
      "drug_code": 19939,
      "updated_date": "2025-05-15T03:46:01-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8304438,
          "ingredient": {
            "id": 598,
            "ingredient_code": 11162,
            "en_name": "ACEBUTOLOL",
            "fr_name": "Acébutolol (Chlorhydrate d'acébutolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02164396",
      "brand_name": "ACEBUTOLOL-100",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82238",
      "number_of_ais": "1",
      "ai_group_no": "0131282001"
    },
    "created_date": "2018-03-23T13:46:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02164396",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C07AB04",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2018-03-23T00:00:00-04:00",
    "actual_end_date": "2018-11-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-11-16T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACEBUTOLOL-100-TAB 100MG",
    "en_drug_common_name": "ACEBUTOLOL 100 MG",
    "fr_drug_brand_name": "ACEBUTOLOL 100 MG",
    "fr_drug_common_name": "ACEBUTOLOL 100 MG",
    "en_ingredients": "ACEBUTOLOL",
    "fr_ingredients": "ACEBUTOLOL",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43751,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13682,
      "drug_code": 73527,
      "updated_date": "2025-05-15T04:08:23-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8339758,
          "ingredient": {
            "id": 3124,
            "ingredient_code": 13311,
            "en_name": "VARDENAFIL",
            "fr_name": "Vardénafil (Chlorhydrate de vardénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02250470",
      "brand_name": "LEVITRA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150003002"
    },
    "created_date": "2018-03-23T14:29:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02250470",
    "company_name": "BAYER INC",
    "atc_number": "G04BE09",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2018-05-01T00:00:00-04:00",
    "estimated_end_date": "2018-08-31T00:00:00-04:00",
    "actual_end_date": "2018-08-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-14T18:35:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LEVITRA",
    "en_drug_common_name": "Vardenafil Tablets",
    "fr_drug_brand_name": "LEVITRA",
    "fr_drug_common_name": "Comprimés de vardénafil",
    "en_ingredients": "VARDENAFIL",
    "fr_ingredients": "Vardénafil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43754,
    "drug": {
      "current_status": "MARKETED",
      "id": 7588,
      "drug_code": 50339,
      "updated_date": "2025-12-03T00:30:39-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253352,
          "ingredient": {
            "id": 36161,
            "ingredient_code": 23888,
            "en_name": "HEPATITIS A VIRUS, INACTIVATED",
            "fr_name": "Virus inactivé contre l'hépatite a, inactivé"
          },
          "ingredient_supplied_ind": "I",
          "strength": "720",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02231056",
      "brand_name": "HAVRIX 720 JUNIOR",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0165325001"
    },
    "created_date": "2018-03-23T14:56:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231056",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07BC02",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2018-04-05T00:00:00-04:00",
    "actual_start_date": "2018-03-19T00:00:00-04:00",
    "actual_end_date": "2018-03-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-03-24T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HAVRIX 720 JUNIOR",
    "en_drug_common_name": "hepatitis A vaccine, inactivated",
    "fr_drug_brand_name": "HAVRIX 720 Junior",
    "fr_drug_common_name": "vaccin contre l’hépatite A, inactivé",
    "en_ingredients": "HEPATITIS A VACCINE, INACTIVATED",
    "fr_ingredients": "Vaccin contre l'hépatite a, inactivé",
    "drug_strength": "720UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1's (prefilled syringe)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43761,
    "drug": {
      "current_status": "MARKETED",
      "id": 1878,
      "drug_code": 14007,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8251848,
          "ingredient": {
            "id": 1004,
            "ingredient_code": 11340,
            "en_name": "PAROXETINE",
            "fr_name": "Paroxétine (Chlorhydrate de paroxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "01940481",
      "brand_name": "PAXIL TAB 20MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75504",
      "number_of_ais": "1",
      "ai_group_no": "0123131002"
    },
    "created_date": "2018-03-23T15:07:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01940481",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N06AB05",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-05-31T00:00:00-04:00",
    "actual_start_date": "2018-04-05T00:00:00-04:00",
    "actual_end_date": "2018-05-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-05-10T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PAXIL TAB 20MG",
    "en_drug_common_name": "Paroxetine Tablets",
    "fr_drug_brand_name": "PAXIL",
    "fr_drug_common_name": "Comprimés de paroxétine",
    "en_ingredients": "PAROXETINE",
    "fr_ingredients": "Paroxétine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43772,
    "drug": {
      "current_status": "MARKETED",
      "id": 4418,
      "drug_code": 2138,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250362,
          "ingredient": {
            "id": 22,
            "ingredient_code": 6311,
            "en_name": "FLUOROURACIL",
            "fr_name": "Fluorouracil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00330582",
      "brand_name": "EFUDEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "47716",
      "number_of_ais": "1",
      "ai_group_no": "0107505001"
    },
    "created_date": "2018-03-23T15:27:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00330582",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "L01BC02",
    "atc_description": "ANTIMETABOLITES",
    "actual_start_date": "2018-07-24T00:00:00-04:00",
    "actual_end_date": "2018-08-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-08-07T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "EFUDEX CRM 5%",
    "en_drug_common_name": "EFUDEX CRM 5%",
    "fr_drug_brand_name": "EFUDEX CRM 5%",
    "fr_drug_common_name": "EFUDEX CRM 5%",
    "en_ingredients": "FLUOROURACIL",
    "fr_ingredients": "Fluorouracil",
    "drug_strength": "5%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "n/a",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43777,
    "drug": {
      "current_status": "DORMANT",
      "id": 8006,
      "drug_code": 52048,
      "updated_date": "2025-12-03T02:32:17-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367302,
          "ingredient": {
            "id": 124,
            "ingredient_code": 2585,
            "en_name": "SALBUTAMOL",
            "fr_name": "Salbutamol (Sulfate de salbutamol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02232570",
      "brand_name": "AIROMIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108887003"
    },
    "created_date": "2018-03-23T15:30:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02232570",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "R03AC02",
    "atc_description": "ADRENERGICS, INHALANTS",
    "actual_start_date": "2018-03-21T00:00:00-04:00",
    "actual_end_date": "2018-06-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-06-12T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AIROMIR",
    "en_drug_common_name": "AIROMIR",
    "fr_drug_brand_name": "AIROMIR",
    "fr_drug_common_name": "AIROMIR",
    "en_ingredients": "SALBUTAMOL",
    "fr_ingredients": "Salbutamol",
    "drug_strength": "100MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "n/a",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43782,
    "drug": {
      "current_status": "MARKETED",
      "id": 30882,
      "drug_code": 93019,
      "updated_date": "2025-05-15T02:35:05-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261410,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02444976",
      "brand_name": "BIO-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963001"
    },
    "created_date": "2018-03-23T15:46:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02444976",
    "company_name": "BIOMED PHARMA",
    "atc_number": "C10AA07",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2018-03-22T00:00:00-04:00",
    "actual_end_date": "2018-09-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-09-22T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BIO-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "BIO-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "Rosuvastatin",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43845,
    "drug": {
      "current_status": "DORMANT",
      "id": 10798,
      "drug_code": 66620,
      "updated_date": "2025-05-15T06:55:28-04:00",
      "company": {
        "id": 206,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 6837,
        "mfr_code": "XYG07",
        "name": "LABORATOIRES CONFAB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4355 BOUL. SIR WILFRID LAURIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-HUBERT",
        "postal_code": "J3Y 3X3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367473,
          "ingredient": {
            "id": 686,
            "ingredient_code": 8746,
            "en_name": "ZINC SULFATE",
            "fr_name": "Sulfate de zinc"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8367472,
          "ingredient": {
            "id": 126,
            "ingredient_code": 7531,
            "en_name": "HYDROCORTISONE ACETATE",
            "fr_name": "Acétate d'hydrocortisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8367471,
          "ingredient": {
            "id": 46,
            "ingredient_code": 6343,
            "en_name": "PRAMOXINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de pramoxine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242797",
      "brand_name": "ANUZINC HC PLUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "3",
      "ai_group_no": "0314223002"
    },
    "created_date": "2018-03-23T18:57:40-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02242797",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C05AA51",
    "atc_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
    "discontinuation_date": "2018-03-20T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 2,
      "en_reason": "Raw material availability",
      "fr_reason": "Disponibilité des matières premières",
      "active": true
    },
    "updated_date": "2018-03-23T18:58:48-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ ANUZINC HC PLUS SUPPOSITORIES",
    "en_drug_common_name": "ANUZINC",
    "fr_drug_brand_name": "ANUZINC HC PLUS",
    "fr_drug_common_name": "ANUZINC",
    "en_ingredients": "PRAMOXINE HYDROCHLORIDE\r\nHYDROCORTISONE ACETATE\r\nZINC SULFATE",
    "fr_ingredients": "Chlorhydrate de pramoxime\r\nAcétate d'hydrocortisone\r\nSulfate de zinc",
    "drug_strength": "20MG\r\n10MG\r\n10MG",
    "drug_dosage_form": "SUPPOSITORY",
    "drug_dosage_form_fr": "Suppositoire",
    "drug_route": "RECTAL",
    "drug_route_fr": "Rectale",
    "drug_package_quantity": "12/Box",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43848,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2188,
      "drug_code": 14595,
      "updated_date": "2025-12-03T01:06:42-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8293803,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8293802,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8293801,
          "ingredient": {
            "id": 100,
            "ingredient_code": 9358,
            "en_name": "CAFFEINE",
            "fr_name": "Caféine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02028174",
      "brand_name": "ACETAMINOPHEN, CAFFEINE & CODEINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": true,
      "accession_number": "76249",
      "number_of_ais": "3",
      "ai_group_no": "0311391002"
    },
    "created_date": "2018-03-23T19:23:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02028174",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02AJ06",
    "atc_description": "OPIOIDS",
    "hc_updated_date": "2020-06-09T14:37:12-04:00",
    "actual_start_date": "2018-03-23T00:00:00-04:00",
    "actual_end_date": "2020-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-06-09T14:37:16-04:00",
    "status": "resolved",
    "en_comments": "in process of deactivation\r\nProduct already discontinued DIN cancelled post market.",
    "fr_comments": "en proceessus de desactivation",
    "en_drug_brand_name": "ACETAMINOPHEN, CAFFEINE & CODEINE",
    "en_drug_common_name": "ACET CODEINE",
    "fr_drug_brand_name": "ACETAMINOPHEN, CAFFEINE & CODEINE",
    "fr_drug_common_name": "ACET CODEINE",
    "en_ingredients": "ACETAMINOPHEN\r\nCODEINE PHOSPHATE\r\nCAFFEINE",
    "fr_ingredients": "Acétaminophène\r\nPhosphate de codéine\r\nCaféine",
    "drug_strength": "300MG\r\n8MG\r\n15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43851,
    "drug": {
      "current_status": "MARKETED",
      "id": 9524,
      "drug_code": 63098,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253702,
          "ingredient": {
            "id": 1298,
            "ingredient_code": 1945,
            "en_name": "IPRATROPIUM BROMIDE",
            "fr_name": "Bromure d'ipratropium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "21",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02239627",
      "brand_name": "PMS-IPRATROPIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115643002"
    },
    "created_date": "2018-03-23T19:25:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239627",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "R03BB01",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_start_date": "2018-03-23T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-IPRATROPIUM",
    "en_drug_common_name": "IPRATROPIUM",
    "fr_drug_brand_name": "PMS-IPRATROPIUM",
    "fr_drug_common_name": "IPRATROPIUM",
    "en_ingredients": "IPRATROPIUM BROMIDE",
    "fr_ingredients": "Bromure d'ipratropium",
    "drug_strength": "0.30MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43854,
    "drug": {
      "current_status": "MARKETED",
      "id": 6546,
      "drug_code": 43486,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253088,
          "ingredient": {
            "id": 1092,
            "ingredient_code": 2251,
            "en_name": "LOPERAMIDE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lopéramide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02228351",
      "brand_name": "PMS-LOPERAMIDE - CAPLET 2MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9825",
      "number_of_ais": "1",
      "ai_group_no": "0111332001"
    },
    "created_date": "2018-03-23T19:29:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02228351",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A07DA03",
    "atc_description": "ANTIPROPULSIVES",
    "anticipated_start_date": "2018-06-15T00:00:00-04:00",
    "estimated_end_date": "2019-01-10T00:00:00-05:00",
    "actual_start_date": "2018-05-01T00:00:00-04:00",
    "actual_end_date": "2019-01-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-01-17T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LOPERAMIDE - CAPLET 2MG",
    "en_drug_common_name": "LOPERAMIDE",
    "fr_drug_brand_name": "PMS-LOPERAMIDE - CAPLET 2MG",
    "fr_drug_common_name": "LOPERAMIDE",
    "en_ingredients": "LOPERAMIDE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lopéramide",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43857,
    "drug": {
      "current_status": "MARKETED",
      "id": 11538,
      "drug_code": 68347,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254302,
          "ingredient": {
            "id": 1076,
            "ingredient_code": 8209,
            "en_name": "PROPOFOL",
            "fr_name": "Propofol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02244379",
      "brand_name": "PROPOFOL INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121833001"
    },
    "created_date": "2018-03-23T19:31:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244379",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N01AX10",
    "atc_description": "ANESTHETICS, GENERAL",
    "anticipated_start_date": "2018-04-01T00:00:00-04:00",
    "actual_start_date": "2018-04-05T00:00:00-04:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-10T12:50:34-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued.",
    "fr_comments": "Product to be discontinued.",
    "en_drug_brand_name": "PMS-PROPOFOL",
    "en_drug_common_name": "PROPOFOL",
    "fr_drug_brand_name": "PMS-PROPOFOL",
    "fr_drug_common_name": "PROPOFOL",
    "en_ingredients": "PROPOFOL",
    "fr_ingredients": "Propofol",
    "drug_strength": "10MG",
    "drug_dosage_form": "EMULSION",
    "drug_dosage_form_fr": "Émulsion",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "50ML & 100ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43880,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8454,
      "drug_code": 5907,
      "updated_date": "2025-05-15T03:29:15-04:00",
      "company": {
        "id": 272,
        "created_date": "2017-03-09T13:22:39-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12428,
        "mfr_code": "",
        "name": "SANOFI PASTEUR LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "Customer Service/Service à la clientèle: 1-800-268-4171\r\nVaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146"
      },
      "drug_ingredients": [
        {
          "id": 8279374,
          "ingredient": {
            "id": 2398,
            "ingredient_code": 7935,
            "en_name": "TETANUS TOXOID",
            "fr_name": "Anatoxine tétanique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "LF",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8279373,
          "ingredient": {
            "id": 2384,
            "ingredient_code": 127,
            "en_name": "INACTIVATED POLIOMYELITIS VACCINE",
            "fr_name": "Vaccin antipoliomyélitique de type 3 (D.C.O.) inactivé, souch Saukett"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8279372,
          "ingredient": {
            "id": 2386,
            "ingredient_code": 128,
            "en_name": "INACTIVATED POLIOMYELITIS VACCINE",
            "fr_name": "Vaccin antipoliomyélitique de type 2 (D.C.O.) inactivé, souche MEF1"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8279371,
          "ingredient": {
            "id": 2388,
            "ingredient_code": 129,
            "en_name": "INACTIVATED POLIOMYELITIS VACCINE",
            "fr_name": "Vaccin antipoliomyélitique de type 1 (D.C.O.) inactivé, souche Mahoney"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8279370,
          "ingredient": {
            "id": 2400,
            "ingredient_code": 7941,
            "en_name": "DIPHTHERIA TOXOID",
            "fr_name": "Anatoxine diphtérique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "LF",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00615358",
      "brand_name": "TD POLIO ADSORBED",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61752",
      "number_of_ais": "5",
      "ai_group_no": "0528062002"
    },
    "created_date": "2018-03-24T02:14:53-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00615358",
    "company_name": "SANOFI PASTEUR LIMITED",
    "atc_number": "J07CA01",
    "atc_description": "BACTERIAL AND VIRAL VACCINES, COMBINED",
    "discontinuation_date": "2018-10-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Please be advised that Sanofi Pasteur Limited is discontinuing Td POLIO ADSORBED,\r\nTetanus and Diphtheria Toxoids Adsorbed and Inactivated Poliomyelitis Vaccine",
    "fr_discontinuation_comments": "Veuillez noter que Sanofi Pasteur Limited a mis fin au vaccin antipoliomyélitique\r\nadsorbé et inactivé contre les agents anti-tétanos et diphtériques, Td POLIO ADSORBÉES",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-10-04T16:56:28-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TD POLIO ADSORBED",
    "en_drug_common_name": "Tetanus and Diphtheria Toxoids Adsorbed and Inactivated Poliomyelitis Vaccine",
    "fr_drug_brand_name": "TD POLIO ADSORBED",
    "fr_drug_common_name": "Anatoxines tétanique et diphtérique adsorbées et vaccin antipoliomyélitique inactivé",
    "en_ingredients": "INACTIVATED POLIOMYELITIS VACCINE\r\nINACTIVATED POLIOMYELITIS VACCINE\r\nINACTIVATED POLIOMYELITIS VACCINE\r\nTETANUS TOXOID\r\nDIPHTHERIA TOXOID",
    "fr_ingredients": "Vaccin antipoliomyélitique de type 3 (D.C.O.) inactivé, souch Saukett\r\nVaccin antipoliomyélitique de type 2 (D.C.O.) inactivé, souche MEF1\r\nVaccin antipoliomyélitique de type 1 (D.C.O.) inactivé, souche Mahoney\r\nAnatoxine tétanique\r\nAnatoxine diphtérique",
    "drug_strength": "32UNIT\r\n8UNIT\r\n40UNIT\r\n5LF\r\n2LF",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "5 x 0.5 mL vials",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43911,
    "drug": {
      "current_status": "MARKETED",
      "id": 32054,
      "drug_code": 9575,
      "updated_date": "2025-05-15T02:30:45-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251194,
          "ingredient": {
            "id": 4198,
            "ingredient_code": 2117,
            "en_name": "TRIAZOLAM",
            "fr_name": "Triazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00808571",
      "brand_name": "TRIAZOLAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68773",
      "number_of_ais": "1",
      "ai_group_no": "0112970002"
    },
    "created_date": "2018-03-26T12:48:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00808571",
    "company_name": "AA PHARMA INC",
    "atc_number": "N05CD05",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "estimated_end_date": "2018-07-06T00:00:00-04:00",
    "actual_start_date": "2018-03-26T00:00:00-04:00",
    "actual_end_date": "2018-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-02T05:00:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TRIAZOLAM",
    "en_drug_common_name": "Triazolam",
    "fr_drug_brand_name": "Triazolam",
    "fr_drug_common_name": "Triazolam",
    "en_ingredients": "TRIAZOLAM",
    "fr_ingredients": "Triazolam",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "7x10 BListers",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43918,
    "drug": {
      "current_status": "MARKETED",
      "id": 17622,
      "drug_code": 78666,
      "updated_date": "2025-05-15T02:32:03-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256193,
          "ingredient": {
            "id": 2534,
            "ingredient_code": 11710,
            "en_name": "BRIMONIDINE TARTRATE",
            "fr_name": "Tartrate de brimonidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.15",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02301334",
      "brand_name": "BRIMONIDINE P",
      "brand_name_fr": "BRIMONIDINE P",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131859003"
    },
    "created_date": "2018-03-26T12:59:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02301334",
    "company_name": "AA PHARMA INC",
    "atc_number": "S01EA05",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2018-07-18T00:00:00-04:00",
    "actual_start_date": "2018-03-26T00:00:00-04:00",
    "actual_end_date": "2018-07-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-17T05:00:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BRIMONIDINE P",
    "en_drug_common_name": "BRIMONIDINE P",
    "fr_drug_brand_name": "BRIMONIDINE P",
    "fr_drug_common_name": "BRIMONIDINE P",
    "en_ingredients": "BRIMONIDINE TARTRATE",
    "fr_ingredients": "Tartrate de brimonidine",
    "drug_strength": "0.15%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "5ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43932,
    "drug": {
      "current_status": "MARKETED",
      "id": 20254,
      "drug_code": 817,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250195,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037796",
      "brand_name": "SODIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "CHLORURE DE SODIUM INJECTABLE USP",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "30210",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2018-03-26T14:04:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037796",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "B05XA03",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2018-07-06T00:00:00-04:00",
    "actual_end_date": "2018-07-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-26T13:20:42-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SODIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "SODIUM CHLORIDE",
    "fr_drug_brand_name": "CHLORURE DE SODIUM POUR INJECTION USP",
    "fr_drug_common_name": "CHLORURE DE SODIUM",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAPERITONEAL\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntrapéritonéale\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "25 x 20mL PVL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 43935,
    "drug": {
      "current_status": "MARKETED",
      "id": 5146,
      "drug_code": 31491,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252793,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02142546",
      "brand_name": "STERILE WATER FOR INJECTION USP",
      "brand_name_fr": "EAU STÉRILE POUR PRÉPARATIONS INJECTABLES USP",
      "descriptor": "SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "F8788",
      "number_of_ais": "1",
      "ai_group_no": "0105143002"
    },
    "created_date": "2018-03-26T14:07:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02142546",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "actual_start_date": "2018-03-23T00:00:00-04:00",
    "actual_end_date": "2018-06-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-23T05:00:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "STERILE WATER FOR INJECTION USP",
    "en_drug_common_name": "STERILE WATER",
    "fr_drug_brand_name": "EAU STÉRILE POUR INJECTION USP",
    "fr_drug_common_name": "EAU STÉRILE POUR INJECTION",
    "en_ingredients": "WATER",
    "fr_ingredients": "Eau",
    "drug_strength": "100%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAPERITONEAL\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntrapéritonéale\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "25 x 20mL PVL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44006,
    "drug": {
      "current_status": "MARKETED",
      "id": 18194,
      "drug_code": 79459,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8256383,
          "ingredient": {
            "id": 3460,
            "ingredient_code": 20215,
            "en_name": "NEPAFENAC",
            "fr_name": "Népafénac"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02308983",
      "brand_name": "NEVANAC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152459001"
    },
    "created_date": "2018-03-26T20:36:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02308983",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01BC10",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2018-03-29T00:00:00-04:00",
    "estimated_end_date": "2018-04-10T00:00:00-04:00",
    "actual_start_date": "2018-03-29T00:00:00-04:00",
    "actual_end_date": "2018-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-04-13T20:06:55-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NEVANAC",
    "en_drug_common_name": "NEVANAC SUSPENSION  5ML",
    "fr_drug_brand_name": "NEVANAC",
    "fr_drug_common_name": "NEVANAC SUSPENSION 5ML",
    "en_ingredients": "NEPAFENAC",
    "fr_ingredients": "Népafénac",
    "drug_strength": "0.1%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44012,
    "drug": {
      "current_status": "MARKETED",
      "id": 4674,
      "drug_code": 2423,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8250409,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8250408,
          "ingredient": {
            "id": 56,
            "ingredient_code": 8638,
            "en_name": "NEOMYCIN",
            "fr_name": "Néomycine (Sulfate de néomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8250407,
          "ingredient": {
            "id": 106,
            "ingredient_code": 8519,
            "en_name": "POLYMYXIN B SULFATE",
            "fr_name": "Sulfate de polymyxine b"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "00358177",
      "brand_name": "MAXITROL",
      "brand_name_fr": "",
      "descriptor": "OINTMENT",
      "pediatric_flag": false,
      "accession_number": "49526",
      "number_of_ais": "3",
      "ai_group_no": "0305643001"
    },
    "created_date": "2018-03-26T20:40:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00358177",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01CA01",
    "atc_description": "ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB",
    "anticipated_start_date": "2018-04-03T00:00:00-04:00",
    "estimated_end_date": "2018-04-23T00:00:00-04:00",
    "actual_end_date": "2018-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-04-25T21:33:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAXITROL",
    "en_drug_common_name": "MAXITROL OINT 3.5G",
    "fr_drug_brand_name": "MAXITROL",
    "fr_drug_common_name": "MAXITROL OINT 3.5G",
    "en_ingredients": "DEXAMETHASONE\r\nPOLYMYXIN B SULFATE\r\nNEOMYCIN",
    "fr_ingredients": "Dexaméthasone\r\nSulfate de polymyxine b\r\nNéomycine",
    "drug_strength": "1MG\r\n6000UNIT\r\n3.5MG",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "3.5G",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44015,
    "drug": {
      "current_status": "MARKETED",
      "id": 884,
      "drug_code": 11969,
      "updated_date": "2025-05-15T02:30:52-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8251588,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "01940414",
      "brand_name": "VOLTAREN OPHTHA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72938",
      "number_of_ais": "1",
      "ai_group_no": "0114417004"
    },
    "created_date": "2018-03-26T20:44:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01940414",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01BC03",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2018-04-27T00:00:00-04:00",
    "estimated_end_date": "2018-12-10T00:00:00-05:00",
    "actual_start_date": "2018-05-04T00:00:00-04:00",
    "actual_end_date": "2018-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-12-11T21:27:49-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VOLTAREN OPHTHA",
    "en_drug_common_name": "VOLTAREN OPH 0.1.% SOLN 2x5ML",
    "fr_drug_brand_name": "VOLTAREN",
    "fr_drug_common_name": "VOLTAREN OPH 0.1% SOLN 2 x 5 ML",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "0.1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "2 X 5 ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44018,
    "drug": {
      "current_status": "MARKETED",
      "id": 884,
      "drug_code": 11969,
      "updated_date": "2025-05-15T02:30:52-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8251588,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "01940414",
      "brand_name": "VOLTAREN OPHTHA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72938",
      "number_of_ais": "1",
      "ai_group_no": "0114417004"
    },
    "created_date": "2018-03-26T20:49:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01940414",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01BC03",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2018-04-30T00:00:00-04:00",
    "estimated_end_date": "2018-06-25T00:00:00-04:00",
    "actual_start_date": "2018-05-04T00:00:00-04:00",
    "actual_end_date": "2018-06-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-06-22T14:19:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VOLTAREN OPHTHA",
    "en_drug_common_name": "VOLTAREN oph 0.1% SOLN 5ML",
    "fr_drug_brand_name": "VOLTAREN",
    "fr_drug_common_name": "VOLTAREN OPH 0.1% SOLN 5ML",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "0.1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "5 ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44039,
    "drug": {
      "current_status": "MARKETED",
      "id": 24552,
      "drug_code": 87155,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258872,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02385945",
      "brand_name": "VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294005"
    },
    "created_date": "2018-03-26T21:33:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02385945",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N06AX16",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2018-05-07T00:00:00-04:00",
    "actual_start_date": "2018-05-10T00:00:00-04:00",
    "actual_end_date": "2018-07-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-07-31T16:11:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VENLAFAXINE XR",
    "en_drug_common_name": "VENLAFAXINE XR",
    "fr_drug_brand_name": "VENLAFAXINE XR",
    "fr_drug_common_name": "VENLAFAXINE XR",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "VENLAFAXINE",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44052,
    "drug": {
      "current_status": "MARKETED",
      "id": 28018,
      "drug_code": 90198,
      "updated_date": "2025-12-03T00:32:26-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260189,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417359",
      "brand_name": "QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858006"
    },
    "created_date": "2018-03-26T21:45:42-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02417359",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N05AH04",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2018-03-16T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "New pack size available",
    "fr_discontinuation_comments": "Nouveau format d'emballage disponible",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-03-26T21:46:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE XR",
    "fr_drug_brand_name": "QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE XR",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 44055,
    "drug": {
      "current_status": "MARKETED",
      "id": 28020,
      "drug_code": 90199,
      "updated_date": "2025-12-03T00:32:26-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260190,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417367",
      "brand_name": "QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858004"
    },
    "created_date": "2018-03-26T21:56:13-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02417367",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N05AH04",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2018-03-16T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "New pack size available",
    "fr_discontinuation_comments": "Nouveau format d'emballage disponible",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-03-26T21:56:41-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE XR",
    "fr_drug_brand_name": "QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE XR",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 44058,
    "drug": {
      "current_status": "MARKETED",
      "id": 28024,
      "drug_code": 90200,
      "updated_date": "2025-12-03T00:32:26-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260191,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417375",
      "brand_name": "QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2018-03-26T21:57:15-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02417375",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N05AH04",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2018-03-16T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "New pack size available",
    "fr_discontinuation_comments": "Nouveau format d'emballage disponible",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-03-26T21:57:36-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE XR",
    "fr_drug_brand_name": "QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE XR",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 44061,
    "drug": {
      "current_status": "MARKETED",
      "id": 28026,
      "drug_code": 90201,
      "updated_date": "2025-12-03T00:32:26-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260192,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417383",
      "brand_name": "QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858005"
    },
    "created_date": "2018-03-26T21:58:10-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02417383",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N05AH04",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2018-03-16T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "New pack size available",
    "fr_discontinuation_comments": "Nouveau format d'emballage disponible",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-03-26T21:58:37-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE XR",
    "fr_drug_brand_name": "QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE XR",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 44064,
    "drug": {
      "current_status": "MARKETED",
      "id": 28028,
      "drug_code": 90202,
      "updated_date": "2025-12-03T00:32:26-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260193,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417391",
      "brand_name": "QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858007"
    },
    "created_date": "2018-03-26T21:59:11-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02417391",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N05AH04",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2018-03-16T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "New pack size available",
    "fr_discontinuation_comments": "Nouveau format d'emballage disponible",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-03-26T21:59:37-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE XR",
    "fr_drug_brand_name": "QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE XR",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 44099,
    "drug": {
      "current_status": "MARKETED",
      "id": 8406,
      "drug_code": 5825,
      "updated_date": "2025-05-15T02:30:35-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250839,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00628158",
      "brand_name": "APO-AMOXI",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61603",
      "number_of_ais": "1",
      "ai_group_no": "0131314003"
    },
    "created_date": "2018-03-27T11:48:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00628158",
    "company_name": "APOTEX INC",
    "atc_number": "J01CA04",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2018-04-27T00:00:00-04:00",
    "actual_start_date": "2018-03-26T00:00:00-04:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-24T13:49:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMOXI PWR FOR SUSP 250MG/5ML",
    "en_drug_common_name": "AMOXICILLIN",
    "fr_drug_brand_name": "APO-AMOXI PWR FOR SUSP 250MG/5ML",
    "fr_drug_common_name": "AMOXICILLIN",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "250MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44102,
    "drug": {
      "current_status": "MARKETED",
      "id": 53515,
      "drug_code": 95539,
      "updated_date": "2025-05-15T02:35:58-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262664,
          "ingredient": {
            "id": 3520,
            "ingredient_code": 20430,
            "en_name": "DESVENLAFAXINE",
            "fr_name": "Desvenlafaxine (Succinate de desvenlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02466988",
      "brand_name": "APO-DESVENLAFAXINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152509001"
    },
    "created_date": "2018-03-27T11:49:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02466988",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX23",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-07-31T00:00:00-04:00",
    "actual_start_date": "2018-03-26T00:00:00-04:00",
    "actual_end_date": "2018-06-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-03T10:05:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DESVENLAFAXINE",
    "en_drug_common_name": "DESVENLAFAXINE",
    "fr_drug_brand_name": "APO-DESVENLAFAXINE",
    "fr_drug_common_name": "DESVENLAFAXINE",
    "en_ingredients": "DESVENLAFAXINE",
    "fr_ingredients": "DESVENLAFAXINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44105,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23060,
      "drug_code": 85643,
      "updated_date": "2025-12-03T01:29:15-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8350521,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8350520,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02371251",
      "brand_name": "APO-LOSARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168002"
    },
    "created_date": "2018-03-27T11:51:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02371251",
    "company_name": "APOTEX INC",
    "atc_number": "C09DA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2018-11-02T00:00:00-04:00",
    "actual_start_date": "2018-03-26T00:00:00-04:00",
    "actual_end_date": "2018-09-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-11T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LOSARTAN/HCTZ",
    "en_drug_common_name": "LOSARTAN/HCTZ",
    "fr_drug_brand_name": "APO-LOSARTAN/HCTZ",
    "fr_drug_common_name": "LOSARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "25MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44111,
    "drug": {
      "current_status": "MARKETED",
      "id": 8016,
      "drug_code": 5222,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250723,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00592277",
      "brand_name": "APO-NAPROXEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "60000",
      "number_of_ais": "1",
      "ai_group_no": "0109634003"
    },
    "created_date": "2018-03-27T12:02:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00592277",
    "company_name": "APOTEX INC",
    "atc_number": "M01AE02",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2018-05-04T00:00:00-04:00",
    "actual_start_date": "2018-03-26T00:00:00-04:00",
    "actual_end_date": "2018-04-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-10T14:03:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-NAPROXEN",
    "en_drug_common_name": "NAPROXEN",
    "fr_drug_brand_name": "APO-NAPROXEN",
    "fr_drug_common_name": "NAPROXEN",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44114,
    "drug": {
      "current_status": "DORMANT",
      "id": 15858,
      "drug_code": 76606,
      "updated_date": "2025-05-15T06:55:34-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367974,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02280396",
      "brand_name": "APO-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332003"
    },
    "created_date": "2018-03-27T12:13:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02280396",
    "company_name": "APOTEX INC",
    "atc_number": "N05AX08",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-05-28T00:00:00-04:00",
    "actual_start_date": "2018-03-26T00:00:00-04:00",
    "actual_end_date": "2018-05-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-15T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "APO-RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44123,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19674,
      "drug_code": 81031,
      "updated_date": "2025-05-15T04:14:33-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8346954,
          "ingredient": {
            "id": 1474,
            "ingredient_code": 156,
            "en_name": "FAMCICLOVIR",
            "fr_name": "Famciclovir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324873",
      "brand_name": "FAMCICLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127885001"
    },
    "created_date": "2018-03-27T14:37:45-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02324873",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "J05AB09",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2018-03-27T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-03-28T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "FAMCICLOVIR",
    "en_drug_common_name": "FAMCICLOVIR",
    "fr_drug_brand_name": "FAMCICLOVIR 250 MG",
    "fr_drug_common_name": "FAMCICLOVIR 250 MG",
    "en_ingredients": "FAMCICLOVIR",
    "fr_ingredients": "Famciclovir",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44135,
    "drug": {
      "current_status": "MARKETED",
      "id": 5258,
      "drug_code": 3383,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8250506,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00402257",
      "brand_name": "STERILE WATER FOR INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54123",
      "number_of_ais": "1",
      "ai_group_no": "0105143002"
    },
    "created_date": "2018-03-27T22:47:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00402257",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "actual_start_date": "2018-01-29T00:00:00-05:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-06-11T19:33:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "STERILE WATER INJ",
    "en_drug_common_name": "Steril Water",
    "fr_drug_brand_name": "Eau stérile",
    "fr_drug_common_name": "Eau stérile",
    "en_ingredients": "WATER",
    "fr_ingredients": "Eau",
    "drug_strength": "100%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10 X 10mL vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 44143,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16378,
      "drug_code": 77172,
      "updated_date": "2025-05-15T04:11:42-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8343236,
          "ingredient": {
            "id": 598,
            "ingredient_code": 11162,
            "en_name": "ACEBUTOLOL",
            "fr_name": "Acébutolol (Chlorhydrate d'acébutolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02286262",
      "brand_name": "ACEBUTOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131282002"
    },
    "created_date": "2018-03-28T11:50:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286262",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C07AB04",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2018-04-18T00:00:00-04:00",
    "actual_start_date": "2018-04-17T00:00:00-04:00",
    "actual_end_date": "2018-07-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-01-22T15:27:44-05:00",
    "status": "resolved",
    "en_comments": "Business decision made to discontinue product. See Discontinuation Report # 73233",
    "en_drug_brand_name": "ACEBUTOLOL",
    "en_drug_common_name": "ACEBUTOLOL",
    "fr_drug_brand_name": "ACEBUTOLOL",
    "fr_drug_common_name": "ACEBUTOLOL COMPRIMES",
    "en_ingredients": "ACEBUTOLOL",
    "fr_ingredients": "ACEBUTOLOL",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44171,
    "drug": {
      "current_status": "MARKETED",
      "id": 23488,
      "drug_code": 86078,
      "updated_date": "2025-05-15T02:33:05-04:00",
      "company": {
        "id": 1652,
        "created_date": "2017-03-09T13:25:05-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 17112,
        "mfr_code": "",
        "name": "SERB S.A.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "480 AVENUE LOUISE",
        "province": "BRUSSELS CAPITAL REGION",
        "country": "BELGIUM",
        "city": "BRUSSELS",
        "postal_code": "1050",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258477,
          "ingredient": {
            "id": 1952,
            "ingredient_code": 4971,
            "en_name": "HYDROXOCOBALAMIN",
            "fr_name": "Hydroxocobalamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02375370",
      "brand_name": "CYANOKIT",
      "brand_name_fr": "",
      "descriptor": "LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION. SINGLE-USE VIAL.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108455004"
    },
    "created_date": "2018-03-28T17:59:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02375370",
    "company_name": "SERB S.A.",
    "atc_number": "V03AB33",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2018-06-08T00:00:00-04:00",
    "actual_start_date": "2018-03-27T00:00:00-04:00",
    "actual_end_date": "2018-06-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-06-08T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Please note that product is in transit and we are expecting to fill backorders by Friday June 8, 2018. For more information, please contact Methapharm Inc. at 1-800-287-7686, sales@methapharm.com, or by fax at 1-519-751-9149.",
    "fr_comments": "Veuillez noter que le produit est en transit et que nous prévoyons remplir les commandes en retard d'ici le vendredi 8 juin 2018. Pour plus d'informations, veuillez contacter Methapharm Inc. au 1-800-287-7686, sales@methapharm.com, ou par fax au 1-519-751-9149.",
    "en_drug_brand_name": "CYANOKIT",
    "en_drug_common_name": "Hydroxocobalamin Powder for Infusion",
    "fr_drug_brand_name": "CYANOKIT",
    "fr_drug_common_name": "Hydroxocobalamine Poudre pour perfusion",
    "en_ingredients": "HYDROXOCOBALAMIN",
    "fr_ingredients": "Hydroxocobalamine",
    "drug_strength": "5G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "5 g / vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44185,
    "drug": {
      "current_status": "MARKETED",
      "id": 30110,
      "drug_code": 92145,
      "updated_date": "2025-05-15T02:34:39-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8260969,
          "ingredient": {
            "id": 3622,
            "ingredient_code": 20565,
            "en_name": "DEXMEDETOMIDINE",
            "fr_name": "Dexmédétomidine (Chlorhydrate de dexmédétomidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02437147",
      "brand_name": "PRECEDEX",
      "brand_name_fr": "",
      "descriptor": " SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152679004"
    },
    "created_date": "2018-03-28T19:34:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02437147",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N05CM18",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2018-05-04T00:00:00-04:00",
    "actual_end_date": "2018-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-06T05:00:07-04:00",
    "status": "resolved",
    "en_comments": "Inventory on preventative allocation with possibility of supply shortage from end May 2018 until approx June 11, 2018.",
    "fr_comments": "Inventaire actuellement en entrepôt est retenu pour allocations préventives considérant une rupture de stock de la fin mai jusqu'au 11 juin 2018 approximativement.",
    "en_drug_brand_name": "PRECEDEX",
    "en_drug_common_name": "Precedex",
    "fr_drug_brand_name": "PRECEDEX",
    "fr_drug_common_name": "Precedex",
    "en_ingredients": "DEXMEDETOMIDINE",
    "fr_ingredients": "DEXMEDETOMIDINE",
    "drug_strength": "4MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "20x50ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44197,
    "drug": {
      "current_status": "MARKETED",
      "id": 5514,
      "drug_code": 3678,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250544,
          "ingredient": {
            "id": 174,
            "ingredient_code": 8174,
            "en_name": "SULFAMETHOXAZOLE",
            "fr_name": "Sulfaméthoxazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250543,
          "ingredient": {
            "id": 176,
            "ingredient_code": 8452,
            "en_name": "TRIMETHOPRIM",
            "fr_name": "Triméthoprime"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00445274",
      "brand_name": "SULFATRIM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "55039",
      "number_of_ais": "2",
      "ai_group_no": "0208901001"
    },
    "created_date": "2018-03-29T11:33:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00445274",
    "company_name": "APOTEX INC",
    "atc_number": "J01EE01",
    "atc_description": "SULFONAMIDES AND TRIMETHOPRIM",
    "estimated_end_date": "2018-06-29T00:00:00-04:00",
    "actual_start_date": "2018-03-26T00:00:00-04:00",
    "actual_end_date": "2018-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-04T17:24:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO SULFATRIM TAB",
    "en_drug_common_name": "SULFATRIM",
    "fr_drug_brand_name": "APO SULFATRIM TAB",
    "fr_drug_common_name": "SULFATRIM",
    "en_ingredients": "SULFAMETHOXAZOLE\r\nTRIMETHOPRIM",
    "fr_ingredients": "Sulfaméthoxazole\r\nTriméthoprime",
    "drug_strength": "400MG\r\n80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44200,
    "drug": {
      "current_status": "MARKETED",
      "id": 15786,
      "drug_code": 76525,
      "updated_date": "2025-05-15T02:31:44-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255651,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02279649",
      "brand_name": "APO-TOPIRAMATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938006"
    },
    "created_date": "2018-03-29T11:37:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02279649",
    "company_name": "APOTEX INC",
    "atc_number": "N03AX11",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-07-31T00:00:00-04:00",
    "actual_start_date": "2018-03-26T00:00:00-04:00",
    "actual_end_date": "2018-06-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-03T10:37:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TOPIRAMATE",
    "en_drug_common_name": "TOPIRAMATE",
    "fr_drug_brand_name": "APO-TOPIRAMATE",
    "fr_drug_common_name": "TOPIRAMATE",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44214,
    "drug": {
      "current_status": "MARKETED",
      "id": 3260,
      "drug_code": 1830,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250326,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250325,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00284106",
      "brand_name": "XYLOCAINE 2% W EPINEPHRINE 1:200000",
      "brand_name_fr": "",
      "descriptor": "20 ML SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "44825",
      "number_of_ais": "2",
      "ai_group_no": "0201284006"
    },
    "created_date": "2018-03-29T13:43:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00284106",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB52",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2018-04-06T00:00:00-04:00",
    "estimated_end_date": "2018-06-11T00:00:00-04:00",
    "actual_end_date": "2018-06-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-06-25T11:17:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "XYLOCAINE 2% W EPINEPHRINE 1:200000",
    "en_drug_common_name": "Xylocaine® 2% w/epi. 1:200M 10x20mL SU Vial",
    "fr_drug_brand_name": "Xylocaine®",
    "fr_drug_common_name": "Xylocaine® 2% w/epi. 1:200M 10x20mL SU Vial",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE\r\nEPINEPHRINE",
    "fr_ingredients": "Chlorhydrate de lidocaïne\r\nÉpinéphrine",
    "drug_strength": "20MG\r\n5MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL",
    "drug_route_fr": "Épidurale",
    "drug_package_quantity": "10 vials",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44217,
    "drug": {
      "current_status": "MARKETED",
      "id": 2568,
      "drug_code": 16163,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252092,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252091,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "01976206",
      "brand_name": "SENSORCAINE WITH EPINEPHRINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77949",
      "number_of_ais": "2",
      "ai_group_no": "0204884002"
    },
    "created_date": "2018-03-29T13:46:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01976206",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB51",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2018-04-06T00:00:00-04:00",
    "estimated_end_date": "2018-05-28T00:00:00-04:00",
    "actual_end_date": "2018-05-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-06-25T11:15:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SENSORCAINE WITH EPINEPHRINE",
    "en_drug_common_name": "Sensorcaine® 0.5% w/epi. 1:200M, 10x20mL SU Vial",
    "fr_drug_brand_name": "Sensorcaine®",
    "fr_drug_common_name": "Sensorcaine® 0.5% w/epi. 1:200M, 10x20mL SU Vial",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE\r\nEPINEPHRINE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne\r\nÉpinéphrine",
    "drug_strength": "5MG\r\n5MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Bloc/Infiltration\r\nÉpidurale",
    "drug_package_quantity": "10 vials",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44220,
    "drug": {
      "current_status": "MARKETED",
      "id": 8440,
      "drug_code": 589,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250161,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.01",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250160,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00001791",
      "brand_name": "XYLOCAINE 1% W EPINEPHRINE 1:100000",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "23890",
      "number_of_ais": "2",
      "ai_group_no": "0201284001"
    },
    "created_date": "2018-03-29T13:50:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00001791",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB52",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2018-04-15T00:00:00-04:00",
    "estimated_end_date": "2018-06-11T00:00:00-04:00",
    "actual_end_date": "2018-04-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-04-26T12:26:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "XYLOCAINE 1% W EPINEPHRINE 1:100000",
    "en_drug_common_name": "Xylocaine® 1% w/epi.1:100M 10x20mL MD Vial",
    "fr_drug_brand_name": "Xylocaine®",
    "fr_drug_common_name": "Xylocaine® 1% w/epi.1:100M 10x20mL MD Vial",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE\r\nEPINEPHRINE",
    "fr_ingredients": "Chlorhydrate de lidocaïne\r\nÉpinéphrine",
    "drug_strength": "10MG\r\n0.01MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "10 vials",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44235,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1068,
      "drug_code": 12455,
      "updated_date": "2025-05-15T03:38:48-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8289797,
          "ingredient": {
            "id": 608,
            "ingredient_code": 11258,
            "en_name": "DOXAZOSIN",
            "fr_name": "Doxazosine (Mésylate de doxazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "01958100",
      "brand_name": "CARDURA-1 TAB 1MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73560",
      "number_of_ais": "1",
      "ai_group_no": "0131431001"
    },
    "created_date": "2018-03-29T15:29:50-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01958100",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "C02CA04",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "discontinuation_date": "2018-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-12-19T16:54:00-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "CARDURA-1 TAB 1MG",
    "en_drug_common_name": "Cardura",
    "fr_drug_brand_name": "CARDURA-1 TAB 1MG",
    "fr_drug_common_name": "CARDURA",
    "en_ingredients": "DOXAZOSIN",
    "fr_ingredients": "DOXAZOSIN",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100's",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44240,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1070,
      "drug_code": 12456,
      "updated_date": "2025-05-15T03:38:48-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8289798,
          "ingredient": {
            "id": 608,
            "ingredient_code": 11258,
            "en_name": "DOXAZOSIN",
            "fr_name": "Doxazosine (Mésylate de doxazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "01958097",
      "brand_name": "CARDURA-2 TAB 2MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73561",
      "number_of_ais": "1",
      "ai_group_no": "0131431003"
    },
    "created_date": "2018-03-29T15:33:31-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01958097",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "C02CA04",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "discontinuation_date": "2018-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-12-19T16:55:50-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "CARDURA-2 TAB 2MG",
    "en_drug_common_name": "Cardura",
    "fr_drug_brand_name": "CARDURA-2 TAB 2MG",
    "fr_drug_common_name": "CARDURA",
    "en_ingredients": "DOXAZOSIN",
    "fr_ingredients": "DOXAZOSIN",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100's",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44245,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1072,
      "drug_code": 12457,
      "updated_date": "2025-05-15T03:38:48-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8289799,
          "ingredient": {
            "id": 608,
            "ingredient_code": 11258,
            "en_name": "DOXAZOSIN",
            "fr_name": "Doxazosine (Mésylate de doxazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "01958119",
      "brand_name": "CARDURA-4 TAB 4MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73562",
      "number_of_ais": "1",
      "ai_group_no": "0131431002"
    },
    "created_date": "2018-03-29T15:36:47-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01958119",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "C02CA04",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "discontinuation_date": "2018-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-12-19T16:58:07-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "CARDURA-4 TAB 4MG",
    "en_drug_common_name": "Cardura",
    "fr_drug_brand_name": "CARDURA-4 TAB 4MG",
    "fr_drug_common_name": "CARDURA",
    "en_ingredients": "DOXAZOSIN",
    "fr_ingredients": "DOXAZOSIN",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100's",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44248,
    "drug": {
      "current_status": "MARKETED",
      "id": 3532,
      "drug_code": 18862,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252393,
          "ingredient": {
            "id": 558,
            "ingredient_code": 8970,
            "en_name": "ATROPINE SULFATE",
            "fr_name": "Sulfate d'atropine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02148358",
      "brand_name": "MINIMS ATROPINE SULPHATE",
      "brand_name_fr": "MINIMS SULPHATE D'ATROPINE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81142",
      "number_of_ais": "1",
      "ai_group_no": "0104748001"
    },
    "created_date": "2018-03-29T15:39:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148358",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "S01FA01",
    "atc_description": "MYDRIATICSAND CYCLOPLEGICS",
    "actual_start_date": "2018-03-28T00:00:00-04:00",
    "actual_end_date": "2018-06-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-07-04T18:11:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINIMS ATROPINE SULPHATE 1%",
    "en_drug_common_name": "MINIMS ATROPINE SULPHATE 1%",
    "fr_drug_brand_name": "MINIMS ATROPINE SULPHATE 1%",
    "fr_drug_common_name": "MINIMS ATROPINE SULPHATE 1%",
    "en_ingredients": "ATROPINE SULFATE",
    "fr_ingredients": "Sulfate d'atropine",
    "drug_strength": "1%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "n/a",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44251,
    "drug": {
      "current_status": "MARKETED",
      "id": 3456,
      "drug_code": 18744,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252366,
          "ingredient": {
            "id": 1470,
            "ingredient_code": 6598,
            "en_name": "PILOCARPINE NITRATE",
            "fr_name": "Nitrate de pilocarpine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02148463",
      "brand_name": "MINIMS PILOCARPINE NITRATE",
      "brand_name_fr": "MINIMS NITRATE DE PILOCARPINE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81018",
      "number_of_ais": "1",
      "ai_group_no": "0107359002"
    },
    "created_date": "2018-03-29T15:43:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148463",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "S01EB01",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "actual_start_date": "2018-07-10T00:00:00-04:00",
    "actual_end_date": "2018-10-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-10-05T14:19:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINIMS PILOCARPINE NITRATE 2%",
    "en_drug_common_name": "MINIMS PILOCARPINE NITRATE 2%",
    "fr_drug_brand_name": "MINIMS PILOCARPINE NITRATE 2%",
    "fr_drug_common_name": "MINIMS PILOCARPINE NITRATE 2%",
    "en_ingredients": "PILOCARPINE NITRATE",
    "fr_ingredients": "Nitrate de pilocarpine",
    "drug_strength": "2%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "n/a",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44281,
    "drug": {
      "current_status": "MARKETED",
      "id": 10732,
      "drug_code": 66471,
      "updated_date": "2025-05-15T02:31:11-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254061,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02242681",
      "brand_name": "TARO-WARFARIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104597006"
    },
    "created_date": "2018-03-29T17:13:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242681",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "B01AA03",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2018-05-07T00:00:00-04:00",
    "actual_start_date": "2018-03-28T00:00:00-04:00",
    "actual_end_date": "2018-05-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-25T14:35:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-WARFARIN",
    "en_drug_common_name": "TARO WARFARIN",
    "fr_drug_brand_name": "TARO WARFARIN",
    "fr_drug_common_name": "TARO WARFARIN",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44284,
    "drug": {
      "current_status": "MARKETED",
      "id": 27502,
      "drug_code": 8974,
      "updated_date": "2025-05-15T02:30:42-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251117,
          "ingredient": {
            "id": 186,
            "ingredient_code": 9152,
            "en_name": "DOCUSATE SODIUM",
            "fr_name": "Docusate sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00716731",
      "brand_name": "TARO-DOCUSATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "67694",
      "number_of_ais": "1",
      "ai_group_no": "0104351002"
    },
    "created_date": "2018-03-29T17:43:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00716731",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "A06AA02",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "estimated_end_date": "2018-11-09T00:00:00-05:00",
    "actual_start_date": "2018-10-29T00:00:00-04:00",
    "actual_end_date": "2018-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-04T21:51:43-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-DOCUSATE",
    "en_drug_common_name": "TARO DOCUSATE",
    "fr_drug_brand_name": "TARO DOCUSATE",
    "fr_drug_common_name": "TARO DOCUSATE",
    "en_ingredients": "DOCUSATE SODIUM",
    "fr_ingredients": "Docusate sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44305,
    "drug": {
      "current_status": "MARKETED",
      "id": 4294,
      "drug_code": 20256,
      "updated_date": "2025-12-03T00:30:34-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8252691,
          "ingredient": {
            "id": 36161,
            "ingredient_code": 23888,
            "en_name": "HEPATITIS A VIRUS, INACTIVATED",
            "fr_name": "Virus inactivé contre l'hépatite a, inactivé"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1440",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02187078",
      "brand_name": "HAVRIX 1440",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "82560",
      "number_of_ais": "1",
      "ai_group_no": "0165325001"
    },
    "created_date": "2018-03-29T19:27:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02187078",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07BC02",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2018-12-31T00:00:00-05:00",
    "actual_start_date": "2018-03-27T00:00:00-04:00",
    "actual_end_date": "2018-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-11-08T17:36:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "HAVRIX - SUS IM 1440 ELISA UNITS/ML",
    "en_drug_common_name": "hepatitis A vaccine, inactivated",
    "fr_drug_brand_name": "HAVRIX 1440",
    "fr_drug_common_name": "vaccin contre l’hépatite A, inactivé",
    "en_ingredients": "HEPATITIS A VACCINE, INACTIVATED",
    "fr_ingredients": "Vaccin contre l'hépatite a, inactivé",
    "drug_strength": "1440UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1's (prefilled syringe / seringue préremplie)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44310,
    "drug": {
      "current_status": "MARKETED",
      "id": 4294,
      "drug_code": 20256,
      "updated_date": "2025-12-03T00:30:34-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8252691,
          "ingredient": {
            "id": 36161,
            "ingredient_code": 23888,
            "en_name": "HEPATITIS A VIRUS, INACTIVATED",
            "fr_name": "Virus inactivé contre l'hépatite a, inactivé"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1440",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02187078",
      "brand_name": "HAVRIX 1440",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "82560",
      "number_of_ais": "1",
      "ai_group_no": "0165325001"
    },
    "created_date": "2018-03-29T19:32:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02187078",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07BC02",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2018-05-04T00:00:00-04:00",
    "actual_start_date": "2018-04-11T00:00:00-04:00",
    "actual_end_date": "2018-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-05-02T18:06:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HAVRIX - SUS IM 1440 ELISA UNITS/ML",
    "en_drug_common_name": "hepatitis A vaccine, inactivated",
    "fr_drug_brand_name": "HAVRIX 1440",
    "fr_drug_common_name": "vaccin contre l’hépatite A, inactivé",
    "en_ingredients": "HEPATITIS A VACCINE, INACTIVATED",
    "fr_ingredients": "Vaccin contre l'hépatite a, inactivé",
    "drug_strength": "1440UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1's (vial / fiole)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44326,
    "drug": {
      "current_status": "MARKETED",
      "id": 552,
      "drug_code": 11196,
      "updated_date": "2025-12-03T00:30:30-05:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251477,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00851744",
      "brand_name": "ELOCOM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71699",
      "number_of_ais": "1",
      "ai_group_no": "0121732001"
    },
    "created_date": "2018-03-29T19:54:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00851744",
    "company_name": "MERCK CANADA INC",
    "atc_number": "D07AC13",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2018-04-03T00:00:00-04:00",
    "actual_start_date": "2018-03-29T00:00:00-04:00",
    "actual_end_date": "2018-04-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-04-04T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ELOCOM CREAM",
    "en_drug_common_name": "Mometasone Furoate Cream",
    "fr_drug_brand_name": "ELOCOM CRÈME",
    "fr_drug_common_name": "Crème de Furoate de Mométasone",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "50g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44373,
    "drug": {
      "current_status": "MARKETED",
      "id": 5878,
      "drug_code": 408,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250150,
          "ingredient": {
            "id": 2068,
            "ingredient_code": 8282,
            "en_name": "PHENOBARBITAL",
            "fr_name": "Phénobarbital"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00178829",
      "brand_name": "PHENOBARB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "14691",
      "number_of_ais": "1",
      "ai_group_no": "0105950002"
    },
    "created_date": "2018-03-30T20:13:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00178829",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "N03AA02",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2018-05-14T00:00:00-04:00",
    "estimated_end_date": "2018-05-17T00:00:00-04:00",
    "actual_end_date": "2018-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-05-18T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PHENOBARB",
    "en_drug_common_name": "PHENOBARB 100mg TABS 500",
    "fr_drug_brand_name": "PHENOBARB",
    "fr_drug_common_name": "PHENOBARB 100mg TABS 500",
    "en_ingredients": "PHENOBARBITAL",
    "fr_ingredients": "Phénobarbital",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 44376,
    "drug": {
      "current_status": "MARKETED",
      "id": 5872,
      "drug_code": 407,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250149,
          "ingredient": {
            "id": 2068,
            "ingredient_code": 8282,
            "en_name": "PHENOBARBITAL",
            "fr_name": "Phénobarbital"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00178810",
      "brand_name": "PHENOBARB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "14690",
      "number_of_ais": "1",
      "ai_group_no": "0105950004"
    },
    "created_date": "2018-03-30T20:16:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00178810",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "N03AA02",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2018-05-22T00:00:00-04:00",
    "estimated_end_date": "2018-05-22T00:00:00-04:00",
    "actual_start_date": "2018-05-22T00:00:00-04:00",
    "actual_end_date": "2018-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-05-23T05:00:06-04:00",
    "status": "resolved",
    "en_comments": "remove duplicate entry",
    "fr_comments": "retirer doublons",
    "en_drug_brand_name": "PHENOBARB",
    "en_drug_common_name": "PHENOBARB 60mg TABS 500",
    "fr_drug_brand_name": "PHENOBARB",
    "fr_drug_common_name": "PHENOBARB 60mg TABS 500",
    "en_ingredients": "PHENOBARBITAL",
    "fr_ingredients": "Phénobarbital",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  }
]